var title_f2_5_2128="Four chamber view fetal heart";
var content_f2_5_2128=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61751&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61751&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Four chamber view fetal heart",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 288px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEgASADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UpaMHHtTwnJXnpxQAwKSaniQlsAk5wOKfHEMjOenSuo8C6fHc61E1ygMEY3EY4oA1dKt7GOxhU5WXGWyta9tAxGbdkkXup61e1eXTZSfIUR84wRUthp73Vuf7OKNKP7p5oA5/WJnjxGsWw98CkGnxTxLI6ybv4lxXfx+Gppoo31a3ZHHR1FWLrw/NHZM9qvnEDoo7UAchpk8OlhWjBJxwTWdqFzfX9w7lGeL0rpNO0ZNQZ4nkEU39xhUr6NqGmmSKCHz1x1FAHPW+pQ6fAitbsGA+bPeqlz4qhibzIFYNnkVHrDzz6kkFyvlAdQRVLVNKe3ZZYoxJH7UAMvtQh1KZGY4djyavXdtbgIpuMMRxkVhMWe7SSKLZt/hx1rXu7U6hb+YV2SAcUAacOk3Etj9pFyoEY+UKetFtp2oX0iSyNlF4y3asPT72a0Jt5CxBHau28L3MzyIs+Wtj/CTigDU0qC78gwRxK7HjOKdp95caVqO64hKrnaQK6/TfE+i6ZGqfZTuHBxzRrOt+HZ41kmQgt2IoAv6dd6bKqzRF4Zn9e5rXiKSEfaHLrXEXmt6Zb28f2HbKeyntVabxBqFzbOsCKgxgY7CgDr/ABBY6ZcQEh4lc9DmvN/EFmohMRkLRZ4xT9Pvp4UdrmLzpAcgE1i6vrVxc3JTyGiY8DaKANey0u2ttPWS0iJlbqTxU/8AY0HkM5kLzMM4Y9K5618STWQFu4JPfeKuXWspLbIysvmexoAdpeiObwj7wJOec4r0Tw/4N025i8xzukHc8VxWl6jCbdRBMqTn72TW3oPis6c7R3G2TJwuKAOtm8KwxgmOISoOtedeJNAna+aZBIkQ4EYBr0OHxpazFI7UAkn5hW5LM15CpjiTkUAeKWGn2cEfmXEUnmZzyK56+1K0stTJMBZc53N2r2zxBbW3kt+7AkxjpXiXjTQ7uW4DIrOpbogzQB09h4lsLq2VplDqvCr60Npmo+IIz/ZwFrbscFiOcVxmn2kmmQgyRqhxn56S68Z38SfZ47ny4jwRHxxQBifEDw//AGLdKn2lbiQ/fK1xJQ7sV6Fe6jYT6TcwmGWa6lGfMOSQa4GVTuY/MCDjGOlAEVBFKy45HI9aTFAFhFynHU08dOQc9DinqnQ9qeucHAzzQARITgAEkc13/gyaCysnSQMskn8RFcv4eshe6jbxEkIzAPj0r3KTRNLh01TCkbKFAweDQBy8mlDU4gbaEysOTt71JpOgalBcrLp7PEwPzRmt7R5ItOLSWXynupNX5PE72xEotUx/Ey0AX4fEN1bxi01G3JkxjJHFZDT3cE01zp02wk5MT9CKZP4uttQ4uLfJ6A45ppmhnkQMGUAfK39DQBmxX73V4ZpoPJnU8kDANdYNUsbS3W4Eu9sfMOvNcvq9tcxDzYJozEeoNZNlqlvC5gutpDdcUAUPEWs2F5qbyNb7mJwMcVHY3ypJtkgcQtyARUOvxWDalHJZgnHJArd/fahBEljbjKgAgigCErYRSpLLbqIyeCKtHS47sqY1ZIzyMd6ll0lJmSK9Bhk6rjpXT2WiXLQRraXCkD+9QBx1xpFlaOC8Ts2OuKztYW7hhQ2TfKOQF6gV6LqenzWyJ9vaIqepWsyZNLhjPlje57DtQByul6ntCrcQ4YdS1WPE939rtohYwtwvzcVNfG3FwoWHzST0AqxPHqDxRyWtmViUfPkdqAOKiZxIMM0cmcDNbJ1HUbKEpKvnKehXsKbqYhlkQJbusmecVWuI9RYqtqrbT1J5oAiTxHdJP5ccQBY960YbzUpbtCtoCSOuKvaToKyRl7iSHzRyATzmtWK21iAEJDGoxwx9KAKGq2kBjWfUgFlI6LWLJ/Zqxl1DDFb1x4duLmVZ7+7QjrtHaqeq22n7Ps8AYuRgkdKAMhLmCSMLZY80960bbRNQkjEhnVc89elP0jQooo2ZRlhzkHpT73WxpxWFV80d8HmgCJL6ewuRGzooXq1dXp/jqGxh3PcbyBjFeaa2Lq9k84xmMHoKybZXKuJANwPWgD1TV/GUutQ7LQLEhPzOTzU2m3VzJZCGyVXlxzI/OK8amkngkAVz16CtGPVtStYdsVwwz2FAHV+KtJc5F5fI079kPSsbTfDCGdEdGlJxk+gqhp0l3e3yeYWkYnqTmvbvDGgTvaIUgCEgZkbtQB5vqkFrofleXGhJ65HSvNvEKodUmkhHyP8ANgcc19K6t8OG1RT5ZDt3cnoa8n+Jngh/D8aO/J6EjoKAPKpARwBgHtUbHjpirkyfN3ytVdpPXI+goA0EX+8MD1p6Jx0IB7mpEUgBcDHfNSxoxcKoLEnAFAHb/DK2hj1AT3UeY/uqT0r2i+03TtRtV8mURNjgjpXjOjTqtrHazJ5bKcgjrXQRXv2AjF2zRkdCaAOot9HvLO4y8C3MOeCD1ouNNhlZgsEkBbqpHFcdbeKL8aj5dpOQuehPFejWGp6hf6Z5twsWQOD3IoA4WayhXUViimVGDfxDirurTJbRCN3UEdCOhqLXrhLuQgxxxSg8N0OaxZfDuoag26KfzR9elAGVqWqTS/u2l+XPrTomhijSQASN6GtjTvC0VwDbTMVuh2I60v8AwjEVhKVvmYLngigCmLAaioktomDjsoroNDtPs6hZZJYn9asafpxtWV9KleRDweOK6rTvDc903my/KT1460AOs7HSprZWu7otKP4j2qyk1rCD9luVO3t3NR6lokNtb+Xdt5Sn+IcVy+m6TnWMRTM8AP3vWgDX1K6hvFZpoycdRmqUZ02CIyG0kXjkjmum1Tw952ns1sp84cjHevMtbt/ENjvZ0dYM8mgC5qGp2DyebaxiLZ1zwTWx4e8W2sllJDcDHGB71wUdxFOjNcplu5qhel0JNqhEY7igDsp7i3nmYCIxktwwrasbEwWkjRSJMSPlU9a8s065LXUYlumHzdK7qS5HlJJaXA3ouevU0AZd7HfWV+ss1iUXdn73UV01x4hF7aIghYMq4+WuP1DWb+/JW5Y4TgYOM02y165tH/exL5Y6ZoA6bS7GbVVkaSZ4gvQMKdP4flsUaSaaPaecnv8ASqVp40AyiorMTkcVuhbXXQi+ZIz4yV7CgCnoq285kjUneRjg1zmvaO+mu8x2uSe5r0GDw0LGISLLHGOue9cnrGnSTXLGe48xD2oA4K5vrt85OF6VUuQwjypPPJNd9b+G7e4ch1IX61X1WPT9LlSBoFcdKAPN5LjYP3cZL9yTV+1lh8jeVLyt27CtjVEtTJv2JGvUKBVrTbWK8iIt4BH2LMMUAavgXSoxcfbLmeNAuMJmvW7LUUmg8uO4YYHAXvXlOi+G7dJM3F4xPZVNdDGs2kRl4ZgXY/KucnFAHq/h+/kjtvKB5z1brXOeP45tV0y5tItONxJKp2kjODWVo/iT7FD5l2QZTyATWzYeNBLOHKhUB5xQB8o6paS2V5Nb3CGOVGKspHINZpHHTrXo/wAZ0tH8Wy3diW23PzsD69683OO7cjnFAGqEHJ5JbtXSeENFOpXTFmKKg4Nc+gyMEV6h4IdIdKEdusbyE7n9aAJ7XwrK7lpAcryHqhfRRR77e5UkjgMO1el2esWklg8EyGGcjGT0Nefa5BGl4zC4RSTyD3oAXw14ctrlHbzMyfwgHmppb2502U2t0XhwcKzcDFWPCmmzzXgubCQEoeVDcGt7xhYPe25N9bbHxw1AHKXUhmg3GJZu4cVseFNkcLSMXt29+lU/CHh1pZZB9tEe37qMetd9pM62jfY9T0uN4x0mUZzQBm7yZfOigSbj769aZLZ3GqRMsdkfNH97tXR3OiA3Ec+lEwRHkrjitqyIs0bfMjNjp3oA8qhg1fSd6RRFDnnAzWnp2paxIoEskobtgYroL3WWlu3Flaq0g4+boa0NIsr69uo3ubWKNCOcGgDmZry7lUxamPOj7HFR6bNb6fI8gkCj0PNeh3FhbtKbVbZC543Grmn/AA+BtpWlto5VkGRkjI+lAHjut+L54iVsblz7BazL7WpL7TMX14Ru6qeM163F4f0Dw9esdVsCPMb+JcgU/wAV6L4Mu9JLJbqjEZDIuKAPnuKwuw4lt4jNbeuM5qXUL+SKFoo4FjBGCCK9CMulQ2xsrJ2jA4DHivNvEy/Z9TBeZXVe2etAHNtb+ZId6lZCeAK19K0ud1AmuDb+gJ604sl3JG1sVVx7Vc8mM/8AISuCpxwAKAL39gZRWW5VwOWwaZcPp7p9neMFx3JqLS0WaUxiVoogcD3ram0iyuFCtKqtjgj1oAydMtIBPlFUr04rqLeRbWINCuwkckDmsO28N6obj/QZEKjpzV0WV7ZOv9p3KKg6jNAFu01OH7Ypl86Zx2J4qTVHnkYzRWjAdsiqEdo1/fLLpr5ReDk1uXZntLF1u3UnHY9KAONubzUt7PlYwp+73rnJ7iXULhnlxuXua05dTto7iXzg8pJPPTNY11FO0LTWkMiIeaAM+RpmusvlgOmelaV1rchtxbhNqgdV4zVFXU25Uxv5uOrdKk06ygmmAdzvJ6UAdL4Z1QiZBMoVDjJJra1cT398BpYYqOrdarWeiQWlqj+W8zseMdq1oLq8gXydMtwJW7ntQBzGsx3VjEHkLnB+bcev0qC08YupEFvEox/ERV3xLpesXCs+ozc4yFFcXHpjvKU85VINAGh4oeK9szLvMt0GyzAcAVw0gIPQsf5V19s8Vsston7xpBtLHpXLXsRjmeLgFScEc0AdJotmt1fRxscJ1Nd3pehypdiTT2bAPI9RXMeGItl0ryEKG6E17doGnyyKlxZFMgdMcN7UAZ1zp8GoWbLdKbedF4YdDXMnSbKa48maQlgeGz1r1bUbjTrixa31CBrS6xjdjivHfEFubC8O5vMiJ+V1NAELXl14Z1HOlSZQnBGc5rpIvG6anD9m1JGDHjI7VwRnS1uVkk3SIT3NF+6XNyk1sGX2HegD2PSdLsVthPA+9ycgZxW/p9zAYis8OGHHNeVaPqAlthBcStA46MDXQaO8004iS8WX+eKAPTYtQUQmNFTA6Vh6rp1rey+akrQyjn5TUcfhi/uoQ9re7WA+6e9EOkatYyj7REJF/vA0AV7fw67ASm8wVOfet2wnht2GLhi2MEir+naT9tVfODID1wetZXiXwybVjJaXLIfSgDWt1H2n7VHMGZT0JrftfGnkv9m2KXHbOa8ilvZlXysssgOAQcZrNSfUNNvFvGSUj1bmgD13xXq819bky2iuoGeRXCw+I7Y+ZDdwqqDopHSq0/jySdNkgTbjGDxWDqty+qr5tjCCcfNigCv4umS7XFjBHG3cqOa4u/trdbVvtY/0gDrXTpJczwmGO0cyDgkVymt2N9FMz3ERWPvuoAxra7FsrGIbT2NT2zz6pKFnkAxwDirun2mnSYM8jgHrXQQW+iwRk25lc+o7UAVxYjTbZZGuElPXbWTfT3vMqQssec/LWzcSWt4VhhgkJH8WK6uy0SO709EedYgRhhjmgDn/AArr0tuFJjaRsdDXS6lfJqdq0ctgDKwxvA5FVo9FttPdNlygwc5I610FpPFgeXcw8EEkAZNAHnjRz6QStsJgrHsMCp7+Wa7iXzrmNVHUZr1HVLq1eAFoElyMEha5Kbwza6lOzOfLU+lAHIRz6W7LDNbbwg+Z8VoSSRXlm0NnAscION2OtT6/HBoMZtraBZS3dhmuSudQ1NVZBGERum3tQBV1u2t7RSFU7zXN2ks8c5NvHyDnNatxbT3b/v5SHJ6ZrTsNHm4XGAe9AG1pt9qLWKtkE4wBT4dUv7eZF8rdI3pVK7sL2GLbEzA/7NHh+K8ivSbqbap6l6ANbXpNSmtTJKAgZe/WvOdQuUtGY53PXo+s3Ulzbva2itcEjG5RXnetaHc2yNLdwMuOmR1oA56a833Id+Fz0FM1ZopZlkgG0Ec/WmSxsW6fL9P60rmPyCgQlxznNAHsEnhe80iGKS4TzIBxkDp+NdLo+oSafCr6bdpIOphY8itUa6IbQJcQmWE9VxnArz/Xre0u9RU6PI0DOc7c9KAOu1nxtcTK0VzYblb5c9xXCajc3DySKpCxnoG61oR6DrqL50bmdM59aHPmhoNRtttz/fAxQByPkXU10kLqWyf4a7y10GF7RUmDRPjIyKzNNhNlfq6EbRyA9buseJBOoDxqrKMZHegDnbjSZIL1fncj1xXp3gWxs5FjlKFZF4JxXI+FpZtYuGhYLsBwua9L00R6Lp7SShCooAdrl1Jp8ZlgdlccgE8VnaD8VLeJvs+tR/P0DDoa5Pxn41hlg8qFs89K82l1Q3E/Mavzw3pQB9H6n4/0eO3EtpOFfGQK5eL4lG8vRbyxxlWPDE14td3znCHj2qq9xnBBYP65oA+mYjpWpzxtO0SnGRtNdzZ6JpF1ZrH5kZGOmQa+O9P128tyAk7fX0robLxnq9o4a2vHz35zQB7b4j8KaAJnjJCt13KcVxt3YaZpUciW144PpmuRHjqafJuYmll7sTWnZa/ZalsjvLHa7DBf0oAk0fUJra7do7mEpzjcetcx4t1G4mkkEzjBJIKnIrspNC0vYHVQwI42msrVdB0+8gWOFgH+vNAHn9vJbNbMgY7z3NW9IurjTGYRxCZGPXrVnUPD8enQsS5JHvSeG5JzKVto1Zc/xDNAHW+HtWF2wjFukT9yRW1LpN05aW1mDyt0QVHo+izS4kliCZ5+WnrcNp2rrDH5nXrigC7pOkTq6nWoVDdQM1D42Sw0q3jNhEfMPOFrbu5zJH5txuBHb1rm9W8QRSMI0sjLtwASKAJ9BfUNWgQSDy4R3xUeu3n9kOIY2ZpD044q9pHimGHZGbdlbuu3pXSeXbarAZJIkBxnLCgDyO8v4piZtQnV5MfdxWEdcuLeYuluhi6DcM11uqaTazX7xQxK+Cc1i3/hi8cnyeB/CtAGCdUjcPM1vmQ+lT6ddS3r7mlaJVHA9anHhq9iw1xKFXP3RWjbaSYFLyGNU9WPNAGVNqF+GKBtqD+Imn2Fz577FjknlPcdBVi402KWQPPcYQn7oNb2jNZ2K5WE7QeoGc0ASQrfabZ7reNVZh3FcT4n1G8vJRFdFi3QDHFe02t3ZywIRb4x/eWvOfiPC7yiW0tGAz94igDzLVbR7eMO5AB/hFYpBR2yMZrW1GK88zM24f71ZLgMcks3pmgD197q8srJlndgwGMGuPGoyx3jSxMTzzmu4k1i01ONjLGEbHKtXFalbwG82xnYme1AHbeGviFJZlY54WYdOnGK1r7UF10PJZwKZAMjA71x/h7S5Y5VnEaXEWeQa6efUILCdJbOP7LIoyyDoTQBzd7e3UMnlXWBIOgIrIvL7cxDLh/XtXU65rOn3sHmyov2oe3WuPvNQiu1wsQU9DjvQBNp2t3lgd0LsuT2q5deM9UuFaIzF0PqelZiW8FxCfKlKyf3TVYadKNxJ59aAGXF49wx83GarI7KwMRx7mtDT9M+0XQR3VR/eNd7pnwsu9Sg82zuYjxnFAHmwlkaTdIQatzXCSRgBMEdCK6nV/hvremMTLbl0HdeazE8J6k6GQQvtX2oAxlRpAFVDmrdrpl05BOQpra0rTbiYmMxHKHDHHNbMei39pIsyxMYgehoAq6XpZCI0CmWTurCuusvs8VsRdWxjcdSV4FXNC8YaXpCAalZIrDuMVV8TfErR7m2khs7QZOdpIGKALukXOkFZftN0gT0HWua8SnRbPdPpuoN5xOcZ6V5/qWrLeuSEMZzzt4rOuMt0UkHuaAN6S+N6/764L5NWo9TbRARaoHz1Jrl7ZPmVQ+1vQ1YujOWG7pn86AO20jxTrOoXCwrIyJ/s16Lo9nqEkBP2UyykfffrXk2h68LdUjEaq443DrXo+ga5dywqUnYr3oA2ru2dDu1IsMdh2q1p8Ghs6+XIPNPY1FZsdXdoric/KeSV61pWOkWNtcAhFkcfrQBnX1pYx3asu05POBVi9tbe9gVIJpIeMHbxXVBbJU/eWQBI44rOvfDM+pE+XILeM/3etAHnVx4aMLPJbXMrtUZd9Osyb64CNjjPU12GtaHquk2hjtLhDHjOW6mvLLq3udV1DbexTuqnAwDzQBW1FrzVGP2ZWCE8PmktfDeokeZNckxjojHJroEa8s4fKhsGjiUffei2162R2jklzKO3pQAuheG2u5N16BtXoKsXawaTK8hkiKLwFaqjSz3VzHHBcymNwdzKeFrJ1/Q47V/MvLmRs+hOKAOw8O+Ira8bM5jRV/Kq/i3xdpUUDIdkzr/AAgVyEFnZQ23m4KgDPXk1kXGnm+nMkdqwTqCQaAMTVLuXXrs/ZolRM1z97C9s4jIG4DtXVXVpdRB47a1aIHqwGM1iXULwKROo8w9yelAHQ6ddiceTJbGV+zDrXT+HfDtjrFwUlle3k6YcVxFhdz29x58Iw2a9B07xSotCdQtBvIwHXgj3oA2bnwPqelwPPp8yzRryAOtcdfXNwl0TeQHI4PFbOneJtWed4bG4LQdlbvUepalIjMb2HOe+KAOO1yS0mIMIw/esHcVGwryO9dFrEMVw3mwrjvxWStrdXCHZEWUdcDmgCkZmVsrwQeDU8d07EZk/DNMks541+dGH1FQEMCGAxQB3Xg59NkvFXUW2A9zXvnh+xsEsC9hdqOMgButfJ4mdSO/uDWraa/fwKFgupE+hoA+ltQ1GW2JW6nV0A+6xHNctceK7aK7aFrYeWepWvLdO1e81GWOK7unck+td9/wi6XenJJHNIJD1wM0AR69faZKPNsZDBLnJGKoX3iVYtMZGnV2961tO8O3Niha4iW4jH94c1z3i260tbYw/ZVSQdSBQB57rGpPeyMeevGKzA/JJyD2FWZ2Xc5hGB2qozFl+YfMO9ADppCxBHQ80sUrZ2sTg9BVYOwPy8jpTlODnmgDVgtFeNn80LnqCea1NNsLe5dVFzjtya5mOT5hkkKav2N1FFIDsyAaAPQ7fwvpcdv5sk439SQ1bWkajZaWhitV85unTNcjpfiG0wIZIc+5rpbW7t7ogWqrFmgDettSa5fDv5KdwvGK0dIDDUklWVzaoc5J71R0rwisjme4vGYHnANbb+H4BAfLupVGOFz3oA7ePXNNljClwWAHFWZL6CO2MscmSOcA15fZeG7u6uirzyCIf3eK6CPS7uyCxoXkj/2qAOf8Ya9rd/cGHTbZymcEgdqtaTK9raB72ErKPvZHNa2pXklpGViaJHPX1rLub9HtHaUCR9uaAOR8a+J5pQba2iYI2BuA5rmNO0myJ826d0LfMSO3tWpe6kr3Dh0CoDxgV0lhBZXOlOTAWAHJoA4ubUobK9C6aJJVHatT/hKIbkol1Zb2XpkVPYxqbp0trAooz8xHUVi6zcNaXR2W43Z5PpQB0+kLBeXBmazBA6BulaXinUmg09UtYbeJgMbQBmuW0XWEjf8A0nJB7LVq/wBW05YmeSJ2djxkZNAGAby+liYXDRxxnr61j6xDbywfeRD+dT6q897kQ2skcPXJrmry2LjDScfXmgCzbTiCUxtHz69a6WG6iurYQScHs2K5m0gaWZmVgx963LW2m4zDyO4oA6jw3oIRw6SAjrkGutt9KiuMJcIJM9QRWH4O1PyLuOK6gKrnk4r12ytrG7RZLYqJCKAOOt/hppuoIWCvGfbpmrNn4Gj0APtiWeP3FdzZaillJ5L4ZunFN1DVTNG4S2kPGOBQB5b4lsNEuLRopYUhkzkEDGK8b8Q6THbSsbaUNHnjFfQ+peHYdchZfKeJzxyK8u8VfDvV7GVnihklhByCoJoA8tKNnDcgUoReors9N8HXmozNGsTRyf7QqW9+HuswH5YC2PQUAcpYXf2SdZFySK9V8GfE+308iPUbcOg6cZrzu58N6lbS/v7SZR67DSWlqkUojnXqedwoA9yv/idoF1aOETYxGQMV5Dr2o22oXEroww1Pg8M/bxm1PzegrK1jw5qGlN++TCk8UAYN24jYhOQT2qBpSVIIz68VNIjs5BAyPWhFWMkyH8B3oAhMROGUBRTU2h/m5qfz0LFFHUU6KEICTtb8aAGmCIx71bBz0quudx2ngd6sSRLtJGap4zyM9cUAWUkded3auj8N3EvnR/v8c9zWJbWymPc6tirduP3oMCkBTQB73o0jDSxJC29z+ldP4dnEqE3iqDjoRXl3hvxbPbWa2yWRlJ74r0HwnrF7LlrnS2APTigDo3gKZlhn2A8dKwtX1K9RfKt72ME8bj2q34p1O5k0qWO2s3jYjqK8qs9OvpblnvmnALH7xwKAOnk8LTSk3U+qeY7HOA1ZmpCfTlVXYKhOMnvW/oOhr5q3BuGcDGELcVb8WaHFe7HkG4AZ2rQBzNnpsV5Ar+Urc/exWlJdWWi2pjuBk/3AOtUllk03YqxP5S9qbdeb4ikWGCJYQvJZ+tAEN/rV/qMJNhbx28XTdjmuZ/s2BXL387TSMeVU1d1uwm068ige63xt78A11ej2NhZ2iyu0cz9eRnmgDmimk2NkHgt387GfnFVtIu7a8uWMke4DjJHArpLzSY9VmZt2M9EAxVG58KSQQvI9zHbw/wB1etAGJ4o1ayjX7LAqmU/KCtcVqek/ZrX7TLJkntWtq9xpdhMfKU3V0D941yOqXd1ey5lJjTpgGgCa0bMoMRIJrq9M+1xDdHJk5HytWN4durOOZftcJK5xmvSrewtLqAzWREi45weRQBJpXiZIXWK+s4SwwN3rXW20ss5EtgjxhhkBeleT6zZOJfMV8FTnmuk8MeOxpUSRSENt4NAHoUGnXUlwkiPLvXqCK67S9Qu9PK+dbmRR1+Wuc0D4l6XPsEhRWHXNbE/xI0+ObaIo5UPcCgDsrTXNOnT54E3emBS6lqmmtalVRS3oRisHSPEfh/UWVpI44yeTg1qX7+GbiMJLOi59GoAxYY7V5C8duFJOc7a1bHTY3nEhRT6g1qaZpWlLGDZ3JZAOm8Gn6lZ2qwEw3axMOnzDmgC3PaabNAEuLaFl6EbAa43xF8PdB1Vw8VrDGe20YOas2+ofZfknvY257tTLy7ZcywXkQGc5z0oA5qP4bw2jAwDyyOh96pa38Op761kynnkdGzXQ3es3xjzHcRShf7pyaqPqniGKLclsWRhzg0AfOvi74f6rpt1I62x2YPI5rg7u1mg4mByOORX1TcXbahIyXaOG6EFa848c+FoprlWgjKrnJAoA8U8thltpzSEn0xXtek+H9It4V+1WzliPm3CsXxj4fsJgTpNuyYHJA60AeZtP+7A5B71XDjPGRmtG80q4t3CPGw+oqpJbMifzx2oAtWz3RUjP7o9q6Hw3bQzylZ3aPnkmuTjklU4Rz7Cuh0G78qQNdfd96APX/C+j2aOs63Qkx0jxjNej2/iRLGHBsnbbxkDrXj2lamLhQLWFiB/ED0rZbVzaqGaWcv8A3SMigD0abV0uz5ps5tg524rKvr+w1GQQ/ZJI9vUkYqDw34ojlt8ybt3Q5Wo9a1xPJdo4mCjuFoApTWN8btP7P+SEHnJrWkuP7Nt/Muz55A+6OuaxdB1me9YrCpA6bj2p+t2YS0d5b0iTrjPFAHM694me6nASzeFS2MGug0i2srazF7PcqJSOhauKiktzeE39yZwDwo4rVlvI5YjDa2q+V/tHJoAXXNS0ie5BZfOcc4HY1nvqklxhLdUjQcCobmzSKIOLdVHJJrFl18W0Zgs7cZJxnFAHSW2tppPmM8hdyOSe1ZN7q194gZhbhjD6k4FVLG0udRJe4TI9KXX7a+is9lnE0UIHVeKAMS9ggsWO4K8h6/NmsG4NzId8cBxng4rV063jiDS3kbyydsirsFxJLdDEfyDoiCgCXw5/ZEqiO7IBPeutn0YWlkbjRdQAT+5mvKbS5jRl8wAGuvtbmK4tgsRcMOPlPFAGZe316l2wupCwzg+lU7uWEEuh+b2Oam1GEKGOWbPrWI5jQlWyKALsd26HKMw79avQ6tMq/NK/HTmsBJSPlz8uakkcbOGx6UAdVba/OiqI7lkI96uN4nvSuftDNjnOa4VZMZ75qZZwU+bI+lAHpWm/ErU7MBFuX2+lXbj4m300bK7nBHWvKY5Fdu9TjDEAPkmgDv38RXuohCJWDdjmrKzam8e17yVFPJO7gVxNna3IZTG5C+1dnoUM7FReSAp0yKAIlu7nTZRJDqMyfRs5r0Hwz8SLmKBYZ5llyBy1Yf8Awi0N26vDMFUnOGroF8O6Fa6eWujGHA6igDr7e+fWULWyRcj7wqK68Pyyr/pAG4c8V5jfeKo/DrH+xZg+B93NZ9z8YdWeEgqobGM0AeiyaUqTOJWLAdiOlI99o2nYW9MS54+7Xiz/ABE1ie6LtOdpHTtVDV/E9xeqDK240Ae16tp2gavZtIksa5B5Awa8yuvCunkPIJ9y7iAueT71zdlrUjbUMzqpPTNan2pIlGJHZiOOaAMu80uK0uiYQPLQ4+apfttlcxiF4RGVON1NuR9pbG12Oe9bXh/wqNRkEZQqxPJNAHZ+AbfTorTAuF8zGcVc1m7uPmWztSVX/loV4qzpngB9OXdFONxxgVa1G21OO3NuhRUxgt3oA5azv9RWQquCx/2auPa6ncQM+ZWYfw9qj02znsbjfKzTvknHpWlPrurxkCC1Hkg4PHJoA5+GXWbAnfbuI/RR1rTt9Ts5ImOqxTDI4BBrY03xXunWO6sAWzgnitrVTaXwCmGEEjoAKAPMtR1DT0UmzsCXz/F1NLoX2u7O42/lgHq1a+oaMsF155jXg9zUkE7gMZIsRA5+XvQBS1LT9Ru4XWNEEa8buwriLi2tLO6Mcl2WkB5AGcV6E/2nVQ0FpJ5EJ6knFcxf6RpemTM9xOss2eSvPNAFvRLtoygtFLqerMK61buJ7Uxz2/m+2K8+i1tYHAt4iVB4J4rUtfEmozwultbDnjdigDWlg0+7n2SRx28fcVk69HFADDocAIA5fFZoivnu902Dk5Na096wi8tGCMBjCigDzKHRnlwG4PY4610GmWV5p7ACHzAfQVJ4Z1GCcLBL97pn0r0mzK6fEkrKksB9uaAPL9VmGNslu8bHkkjiuSmwZmJOUr6SdfD/AIgszC0aCUjHBwRXkvjXwrBpM7PaMTEemaAOFYIFyM+1RhWPIGauPb5XkHIFNt2AYKyYHrigCqrdQRzSlztwQPath7K3eEMvWqDWLdAevSgCCJ2TJAB9alWVt4KgDHpU32O6RcmIsp7gVBLDKjgspUfSgDuPBesobmOC6hRlyOtex21t4fvIBv8ALidl4+bFfOOkzG3n3MzZz1FdGurx7MPM57ZFAHeeJNUh0NXhs5I5YxwDuya831HxHc3LuoLBT23ZqnqEkc8jFZ2J64NY04aNmIbJPSgC2zgkmR2qhMy4yhJ9qGJcAnOajyM8j2oAXdk0o5OS2Ki2YNTRsgHKKTQAokZMFDjnqasRahcAcNkD1FVN27sR7U6HcCNgyfSgDftNXmVcCEE+prp/DN3qmpXwht2eMnoQK4aHzjIoPHtiu+8KalLppSUyqqjrxzQB65pnhbxCsYxfs7MP4qy9Z8Ka5HL5k100ijqAaqD4nyQxhYHkeQDjC5rivEXj3W75mAneNCcYIxQB0n2qa2ufJkU5HBap7u4u9mI51UEZ+YdK8/0vUbproSXNxvY/wk9a615bjUY0VIs8Y+UUAYOoWztdZfVFV2P8JrovD2kTwFZDqZkPUc1HH4KmuiZnTYw/vU6DTZtLuC13dxpGO2aAJtchIYPNdSNg/dqrHf3jKIYoHaMfxYxmp7/VPtsixaTbmVzxuxwTXSeHvD2tPiS6KQoBnbxmgDk7221P7OzCCZYxz6E1giwtHRpb+Ux+xPNewarpGrXNsYrfcBj7+OtctafD1ZrstfTGSTOSM8UAcLa6bA8omi3PAnPNWLjxLbB/sVvB5CqMFh3rsfEtlFoNr5UXlhSMHnmvMby7tJJjFHGC5OC9AG5HqJkJhsvnc9STUz2moyxPkxwju3eqdppsFrAsizLGSOeeaimkkkHl28juc8sx4oAqeEtLt7u7B80Jj0OK9gtfD9ylqF3rcQEfpXl0PhW+hLS2jdOcA4rtPCPim900ra3bFiOAG5oALvTrKwvFZTNbSbu4ODXaaVp2jarZeTfpFcAj73eklnk1IqJNOWRWHDAU3+yXtl3RRNCpoAytS+G2mCQyWmAn92ub1/wHYrbEwx/OOuK7OW4v41ZVfIA4ya5DxPqWpxMSMYPpQB56dHe2Z9qEgZ4ao2a1TJmi2v2rqbW5S6X/AE3II6ketZl/o1pcOTHcDnoDQBnReI/sq+V9mSRPUiqF5qVtfAgxCNvWtyz8GteuVhmBOPWtuw+F1wzDzXQnvzjFAHmjwJEf9YTnmpbcyo22La4PYivZIfg8ZY1IuVB96ntvhfFYXIkmuIiooA8cntn275LYgnuKxrhG4BBz6V9daP4R8P3kSRTPCSABWN4w+EujyKX06aONqAPl0QSHlRmoXR+dyH8BXrmq/De7sY5Ggkjkx6HnFcj/AGFere+TsH40AcaY2XltwBNLtHVetdnrXhu8ig3sg+70FR6JokTlRcqQcdcUAcssEvl7guc9s0+3im3nGV/CvTZtB0mKyDxsGf8Au1X8O6cbq8EX2dCucAkUAc7pcEO3NzLg+prptE0ezku1ka53R55StXWPC8SP+/eOMLzgDFdD4S+wae6fuYpAP4moA6HQNO0d1ULZIAP4tnNZ3jXwrYTqzRRSDPICJXpOleMdFs4fmt4BgfwgUmp/EXRDGwWCIkjgkA0AfO2laRaWusxi4jYR994xXt2l6r4U0qxiaRoMqOgx1rxr4i+KBf37NaxLFGDjjg15zeai8pOHc84xmgD6N8SeJ9M1UFNLuEjB9OK831cQ7mJuWkwPXPNea29/PbfMN2e2TWvYGa/OXnCA9s0AdV4a15NP1D5m3YPCgV6zoni5JmQm1mk47rxXlXhnRVN2rSMhX1r2/wAL6TZzhBwox2FAG5Z63JeW/kx2mwH25pJtAVkMgk2O3JPpXW6fotlDGPKfPFOvdCjngYLK4PagDwrxh4b0wF5L28kmY/dQGuAXwgt45aziKLnqeK9k8ReGhbXEszP5mOVU1wmpPqSsyIqwxnpigDjbrwu1q+65uQqg/d3VLodpZT3yxXEuyDPJB5NaCeCNc1+5zFKQhOeScVd/4V7qWlzIB5Z/vMTQBr2N9aF2tdSiMEo43DirFz4XtrgfabN9zDpg8GvQPGnhK1ngZ1QBiPvAV55pWi61aSMLZmeMHgGgDofDmrpp8iW+pL5XYE9K7u7u9Pu7ZfKljKkZ6g1wraSdThEV8pikPGSOtJB4K1aww9kWmgH8PXigDektrVSdwXae9ULnRops4iR0PqK0NO8xFEWoWrKenIrXjtElUeXwvTg0AcQ/geCRxLDtA/iTb1qC98E2LQ4eDZJ03Cu7k0+e2YtGzYPY1GUuLkFVZQx6BqAPNLXwG8cxa2uXjY9M1uW/hrX4EJSbzQvTjrXYpod5KnLDd6rSMNX04MsMiMDx81AHmur6t4h02N0ltSPdc4Fea614h1VpCTcSAHqpJr3jVLjUrgMk8ELKwwa848T+EJpy0lnArMedq0AeYL4i1SF2a3uZVfPUMa3NO8Xa4EHnSyS/VjU9v4I1KVmEtnKv0Fa1n4cay+WeN85wCRQAy28X3b4FxEygj5uamu7y2kXzopFWQjnPrV2XRY3iYKp5/Ssc+C5ppcrMxU5AAoAdZzrcbjduWXpgGqWpXUduNltaOw7EDNTT+FLzTySGlcdflFWbC/axASQjPT51oA4uS7u5JMlfKTPpWraajcWWGt2LSY6KOa6m+ntpbUu1nGTk5fFY2hX0C3pEUQ3g+lAElrfy6iv/ABMVdD/t8Uy5tpzxaTDHYA1e8VazHbRgT26cj+EVxzXt1eMGtP3aZ4oA1YNJ1KaXElxIAfQ1pf8ACO3YQZmkJArJ0+bUIWV2vAB6da6ey1xsBbiUuRx8tAHB69YPbuVkV3bPeucYOkuVTg/pXrdyi6jOPKttqn7zNXX+HvDfhaKAS6n5W8dQxoA+d5TcOg/dk/hWho0vk7d6MzZ6Yr6N1dfBTWvkWUMBkxjKivMde8OiI7rM7d3I4oA6TwRE06oyQRAf7Zr1/SbTy0B8xEXHOBivG/A+iTsEa5v1iQdecV6zbx2Mdh5ct6ZMDkq1AHQNr1hpy/8AHwjyehasXU/iIyZS3VCT0IPSuP1V9Ft5G8qGSdyOTnOa5jUtdjt4yYtP8tP9rqaANHxN44ml3oN5lbpjpXN6Rpet6teG5bzNh6K1M0m+k1W8QRW8MQ3cs1ez+Gf7NtLZftdwryY6KaAK/h3TdQsLVTJMo46CtJ5bNJAb2WOST03Ua3rVm9m0VoChPGa4GGzgW5dwzmR+dztmgD365tLa/g2yIGQjgjiuYv8Aww1oDNpzscclav6NqxitljuY3wP4gM1u29xFcLuicMKAPPbfV9P842uoFFmBxg8GtO01T7A5eKQNbHs3pV3xB4N03V5/tLR+Xcj+Na5PVtEu4Lcw2s+8KCMNQB6Da3dhq8WFMch7qeoqhf8AhtGUtYzPDIOQpOQa8UjvdY8PXzyOZEXP3geK9T8H+N4tShVL2RBJj74OPzoAhuLTWbbcJ4t65+8DniqE4nKj90+Se1d02vaYH2NdIM+tXIktZ0DxLE6nuoFAHEWGrfZlKSiZSB3FSnV7eXdlSx9xXYvY2r53Qoc+oqlJplnbZldF2g8jFAHFajJbREyMnGK5i91WJnP2UBCO4PWvU510W8Vo2MWSMYrldZ8L6KzMIJkiPsaAOFk8Qa7bf6m1guVHcdakXWmukK6hZ+W/XgVrNpBtMLa3kbjpgmpm06TZvLRF/WgDjNXtpDE72qyA4/CsrRrPWJpyDI8aFuDXoUMMzyGOV4/LzV2W3s7RN8kyrQBw2rWOu26f6PJ5wx3FclPeiO4C6rAoce1eha/rscBP2ORZBjtXGaxNaXsbNNCTJjt60AW4LjR5bP8AeMoU9RWbcJoak/2eGEnqM1yYtbqfUFhtwQmeldVFo2paZCs8VsJWHOKAOd1yGRmyYnlGcjIwMVy8puRMPLjKc4x2rvtS8Qaom4XOnpGMY5XiqFppL603mtcxQ99ooApaXp95dRYKhB3JrXh0lrIByPMY84BpWSXTonjjaOTA65qgmq6rK4S3gXANAHUaS19IDtSOFfVqttotrO+/UNTT1CIetcpcLrDDdOuAecCtvQLaKZc3YO/HAxQBt+bo1lBst4hK4/iIqhea5GrFprcCID0qZ9HmuxmBmWMcfdNZOvWAgtPLlZ3bH92gCK5urbW5fItLl4VB52cVqRanb6FabFMtxJjG5jXm0Vzd6fO/kwuFB64qvcX2oXZbeX5/CgDa1bxhfNeEowjTPAWkuPEMuoWyRXHyL/e6ZrmTps0hDSSFB70saxwyiOWXK55oA7vwu2mzzLG08gGcHBxzXc3OvaZowCWgE0uMbuvNeZ2N5pEcEcayEPnnAqebUdL06Iy7jKx5waAO8g1271BiWAj3dMelbGmCyiImuJzKQOAzcZrxWTxrczvttUCJ0BpkepXM8ga5uXZh0RTQB9YaDrRSLyp8v25Fdfprwn54BkkcgV5B4X8RQyRoLmNlPSvQ9OvzEoks03qR0zQB2CncM4I9jWDrdqj5YKyMe+Opqa11+3kcJcK0L9Pm6VrApNHkbXQ/jQB5Rrmn3Uqt8qTA9qo2egW/lAtEYm6kjiu28T6TcI/m2JIz2rjLt9YtdwZGYAdhxQBlXmgZn3W9/Iu05wxzW5ocWp2gKxX2BnpmsWK5muLr9/EwI9MiujsbSWTDRk57DFAHRJeapDGDJIxH97Oay9ZutVv7Zls5m39MNV6ETQ7UuX2L71q2URT5lZJM+lAHl9tBq9jLnUYiwPJZc1PcG3uMMzzIPxr1Ca5jGftFsG/CqF5caaYXAt0DMOmKAPKne18zb5zHB4BJFWI4YAofz5znnGTVjWNK8y9EqW/yZzkVZhsoJoVj+ZT+tAGa0ls+QJJIvesnWIEmhIa9mlT0C810L+HY0cPH5gJPQnNZerR3mn7jDDv57LmgDCsdNTAMO5l6fvBg1Tv7ZRhAvzHPStcNqN5jCGLBBPFK2nTsfunzB3xQBhaVo13FeCWSIiL+9XcjUIIoFQPkjrxXM6guu2luWLqYRzjvXPaZre+7ZJFO/OD9aAOg8S6eusJtHAIyeO1ebataz6M5EDNtr0+6ncxgRMFyOuOleaeLp7ssUVg2etAGTBrVtG3+lFy2PWtnTPFke5Y7S2+YHhjWZpmjveDJs2Y461rQ+F5h80aeXQB1SatM6K94sITHQVp2XjHSNNQboFPrgVwtxo95bLulkYrUdl9mZz9qYNj2oA9u0fxRaanCWt4gE9CKq6oq3G/ZGhOOCw4riNP1qwsVQQRyMQMbVWtY+MbNIW3I8fHRh3oA5jxHplyXYtPHGp7AVz+lWcS3LfaJS7A461e1/wAQvqDP5ET7R3rhbyRzIzBpRJnnnFAHc+IP7Os4QXlQn+6KxdJ0KbxFdgWFqzLnrWNoGkXOrXYXDS8/xGvffBls/hi0G/yF+X1oAxNN+FSw2xku1CvtyfY1yXiDwUkV0Y0kXnoM12njPx5dIXjt5AT0+UZrzO68RXEkvmyRu8p5zk0AOPgVo7dpFuAB1xVOw0eO0l3XU4CjvUz6jqN4pDyGMdcetQLot/qC5USumfzoA6bw1q7DYIbwbuu2TvXpWg+LL+xljEsOVJ6rzxXztYanLGEGOnQ122ieM722VYpUBX+8wzQB9S6XrljqFvm5iXd1yRWxDrVnEiojosY6jNeAaN42uDEge3R0PpXUafr9pqIw8EkT9OlAHo+oS+cS9jfjOPuk5rC+3X8bslyiPGe4rmbtPLG+2meNj71b0mW8cgTOZF6UAdLGbSfoiow68dakGpRaf8zDKjsBWHfTzWw3QKD7VNp+p+euLy0IPQnHFAHQPq+mamuJo9ufSqbz2tk5+zXLr7HmpLf+xpMDcqN+VVb7T4ss1vIrr3FAEd3rdzjKyrID1BFY66q73I82MDJ6iqWoXcNu5V/MUewqgmoWfncySbvcUAduZoWt8/xGudvZ5Y5S0MIJ9qItRt41BWYHHY1X1DXYyuIAqsPagChqOr37KVKunHUCm6bqcygfaXDH/bqheahdXcTsksanpgDmuc1O5vbN/wB4SwPTbQB3cmuWkTjzAMk9QKd/ayXGUjKgf3q5HRrOS/AkZePeukTSoFiIlBB9qAJLrRlvoyzXw5/h3VjT6HpmnlnZ03H+I1I+jQbyI7iUt12hjWPrugXs0Z8syFSMKC3SgDK8Q6xAgZbWRS6jHFcFqV+JHzPndntW63hqW1d2u5vLGec1mano6zuVs5ll96AI9O8VGyKpGjMO9dro3iO5uIsJbNz3xXP+H/Bkcvz3k6Rt7mu1hh0/TLdkS5jYgdqAG3MNzcWu5gisT3NYEllcWcvmPHC2TwDzRfa4yylY5GZR2ptpeyTSr5mxkPYmgCe31C/dl8qCEEHjCVtWOlLeyb9SzkckKMCmWt1Ha/MsSGqeqa9duCkDGJcckLQBHrjaPp6lWIXA6GuIvtV0tXzDDvYdz3p2q2wu5BJdzSse+azhYqSVtoAwP8TGgCW11+8+0bLFEgB/iHFdRpQurjEuoXskmf4V5rhHsJ45/MZuF/hWtnRNeks7pYvKyB3agD03TfD8mrsFtrVhkgbmFd/4e+FMaqr3Vqrnqd3ArC8D+L0iWIkxb+y167pHisXO3zmjCnjigDk774aaRA4kuolX0Cdq1tJ8K6PDFvVQmBkA966e/vrOcKxbPHOaxbrVrC2baGDcUAfFfh+wivJVDTqrE/xV6NpXgSadP3d5ByeOa8u0mEbkyT65Fev+B1s7gok93JE44HNACXPhrU9H/ePF56f3ojWhpWsvbkY4K8bXFeiWHh2eSDNrfmRMZwxrLv8ARI45Ct3DhuzAUAdP4Ys7PxHAou1COy9jzWw/giS1YNp94cDorVxWkxm0lQWs7p2xXbafa6xIVeK6cAn1oAy9R8I6zIpdJ1DDnA7Vzcja/pcyxTRpKmeWAr2yAOsKCU5cDk1V1DTYLxTvG1/7woA87sbCDUY99wvkufQ1bOmxwptiuckHoTVjVdD1azctZhJ4fbrXNzXt1buftlqU5wTnNAGrNCSxEiRyDvkVVnhs1Ul4Ywf93pVa0kgmlyJ2Vvc1prpS3HW5Bz60Aclq7R7D9kMQbPesPSxevN/pKxMmcfKc8V1viHw/awK3mFM9Tg1zmnWenwykQ3Qjb/abIoAo69Z2752PLCxPVOKx4NLuiGaG680eknWvTrKz0i54ubuFiB6isXW5PD1ixEdypYdlNAHIie5s1YyTKpxwFNZE3ia/iuQhlLIa2byG2un3W00Hl5zgntUU9ppwjYedGJQOwoAu6XriyxAOziT+8BUmq6xJHAfs08jkeorjJoriG73xXX7v0FXhcSzxhIBKXxjJHBoAy73U7/UGdJ1+XPVq53VLq5sM+Syrg9BXVz6HrLKWIUg8gCuZ8QaHqC8yKB60AWfDWpm5Kfa5Tz6muqj0uG5BKXCcdQTXmljBNathifbAroLASsAZbkouaAOyGiQMg6Enipf7G0yy/eSXEZfH3c1hprItYHAkEmB68msV9b33QZbQuTzzQB2g1q1z5SQ7kXuFzTNR1qKOIGOydzjoVrOtvEcyWy+Tp6B/Tb1q7ZarqF1MDPZ/u+xxQBy2o3bXu7zYTAhFUI7rT4EC75HI7Cuu8XzQm1xFbJ5gHOK83F79klLz264B6UAbE2s20O5Y7d8EdxWMzrPcCWRtinsOtZ+oa/JcyMsEIUH26VRQ30jBhEXoA9R8OS+WVaJflHcnmu1tPEK2x/dy5bHILV4OJ9WhXDMyIO2aF1y4tztBy3c5oA+gL/xdMkALXQBI+6DXK3XjGVTukuiEHQA815b/AG4rDdIru/1qC41N5I+IgOc8mgD/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial view of the fetal chest in the second trimester. The four-chamber view of the heart is demonstrated. The hyperechoic spine and ribs are shown. Anteriorly, the ventricles are seen and are of similar sizes. The atria are posterior and are similarly of comparable sizes. The atrioventricular valves are both demonstrated, with the right atrioventricular valve slightly more apically positioned.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joshua Copel, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2128=[""].join("\n");
var outline_f2_5_2128=null;
var title_f2_5_2129="Pulmonary LAM lung biopsy High";
var content_f2_5_2129=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F53690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F53690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gross features of pulmonary lymphangioleiomyomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 220px; height: 200px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photograph of autopsy lung showing advanced lymphangioleiomyomatosis. The lung tissue has been largely replaced by nearly confluent cystic spaces. The rust-brown color of the pulmonary parenchyma attests to the presence of abundant hemosiderin pigment, a frequent finding in late stage lymphangioleiomyomatosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey L Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2129=[""].join("\n");
var outline_f2_5_2129=null;
var title_f2_5_2130="Bilateral TRAM reconstruction";
var content_f2_5_2130=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F75822&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F75822&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 571px\">",
"   <div class=\"ttl\">",
"    Bilateral transverse rectus abdominis muscle (TRAM) flap reconstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 551px; height: 268px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immediate TRAM reconstruction following bilateral mastectomy. Left panel: preoperative appearance. Right panel: postoperative appearance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jorge de la Pedraja, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2130=[""].join("\n");
var outline_f2_5_2130=null;
var title_f2_5_2131="Cervical block";
var content_f2_5_2131=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F82712&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F82712&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cervical block anesthesia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 298px; height: 590px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) A superficial cervical block is administered posterior and deep to the sternocleidomastoid muscle (1). B) Local infiltration is also performed along the anterior border of the sternocleidomastoid muscle (2), and a local field block (3) is performed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Udelsman R. Unilateral neck exploration under local or regional anesthesia. In: Minimally Invasive Endocrine Surgery, Gagner M, Inabnet W (Eds). Lippincott Williams &amp; Wilkins, Philadelphia 2002. Copyright &copy; 2002 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2131=[""].join("\n");
var outline_f2_5_2131=null;
var title_f2_5_2132="Methoxsalen (topical): Patient drug information";
var content_f2_5_2132=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Methoxsalen (topical): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/19/21811?source=see_link\">",
"     see \"Methoxsalen (topical): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8770767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Oxsoralen&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8770768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Oxsoralen&reg; Lotion",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024358\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700508",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad burns may happen if this drug is not used the right way. Follow what your doctor told you to do closely.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024360\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692188",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat white patches on your skin (vitiligo).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024359\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700954",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not give to a child younger than 12 years of age.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702500",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to methoxsalen or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703689",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Melanoma or squamous cell cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703878",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you sunburn easily.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024364\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696812",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not go over the time you are told to use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696953",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sun or UV rays may age the skin and raise the chance of skin cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024365\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698359",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sunburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024367\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696164",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a rubber glove to put on.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024363\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12247 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-C80C007BE0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2132=[""].join("\n");
var outline_f2_5_2132=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8770767\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8770768\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024358\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024360\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024359\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024364\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024365\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024367\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024362\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024363\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024368\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024369\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?36/59/37813?source=related_link\">",
"      Methoxsalen (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?23/41/24212?source=related_link\">",
"      Methoxsalen (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/19/21811?source=related_link\">",
"      Methoxsalen (topical): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_5_2133="Psoriasiform sarcoidosis";
var content_f2_5_2133=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50608&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50608&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Psoriasiform sarcoidosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hyperpigmented plaques are present on the knees of this patient with cutaneous sarcoidosis. The lesions resemble psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2133=[""].join("\n");
var outline_f2_5_2133=null;
var title_f2_5_2134="Sonogram abn ut bleeding1";
var content_f2_5_2134=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55785%7EOBGYN%2F50777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55785%7EOBGYN%2F50777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transvaginal pelvic sonogram of a perimenopausal patient with abnormal uterine bleeding",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The central uterine echo measures 14mm (calipers).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Saline infusion sonohysterogram of a submucous myoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 268px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A posterior mid-segment submucous myoma measuring 1.6 x 1.9cm is identified after infusion of saline. The distance from the back of the myoma to the serosal surface measures 1.2cm (calipers). The endometrium surrounding the fluid is thin, compatible with early proliferative phase.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2134=[""].join("\n");
var outline_f2_5_2134=null;
var title_f2_5_2135="Petroleum gauze";
var content_f2_5_2135=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F73579%7EOBGYN%2F50531&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F73579%7EOBGYN%2F50531&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Petroleum gauze",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David G Weismiller, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Circumcised penis wrapped in petroleum gauze dressing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 305px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAExAdQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDl/wC1bg/xUf2ncH+KssGng15Wp6ehof2jOf46Pt85/wCWhrPzwaUHpSCyL322Y/8ALQ0fa5T/ABmqYNKDQMtfaZT/ABmj7RIern86rUtICz5zn+I/nSea394/nUOaAaAJ/MP940bz61DSigZNv96N5qOgUATBuKTdTBRQA7fRupuKKAHbqN1NNJRYB26jcabSZp2EO3UmabgZz3pRRYBcmjdQRxSYpWAN1JmlxRimAmTSZpxFNxQK4hNMJNPIpuKdhXGknFNJNSEU1losO5GelV5atlcioZUwM4ppCbM2YVV2fNWi0TSNhFLH0AzV7TfD91dyrvQxoT1IrWCZnNmOsfHSpI7dpHCopLHsK7qHweiuhLll7j1rorDw9a25DJCAwHU1tGm2YuaR5zaeG7ufquwe9b2neC+puGyO1d/DaxxjlRmptvHA4rZUe5k63Y4efwLEbeR4mO8DIFcHPavBM8cilWU4INe5xsUfnpXK+MvDgvM3dko8z+IetROnbYqFS+55l5dBStJtLvQxHkEGlGj3rf8ALI1g5JG9mzM2CkKitcaFfH/lnTh4evj/AA0uePcfKzF20YFbq+Gb09v0p48LXh//AFUe0j3DkZz5ApuBXSr4TuiOSacPCNx3Y0vaRDkkcvgUEV1S+EJj1Y08eD5O7Gl7WI/ZyOPOKTFdoPBx7k1Ivg4dyaXtYj9nI4faMUhArvB4PUdacPB8fej20Q9mzz8gUV6EPCMI7UU/aoPZs5ZaeDSBD6U9UPpUWKuJS04Rn0p6xt6UrDuMFLUgib0p4haiwXIhml57VMIW9KcIW9KVmFyDFOAqwIG9Kd9nb0osHMVwKBzVkWzZ6cU4WrUWDmKwFGKti1al+yNTsHMVQKAKuC0alNoaLC5ilS1dWzJp4sqOUOYzWpgzWqbLik+xe1PlFzGZQBWobIZ6UotB6Ucocxl4PpSqPatQWY9KctoM9KOUOYzNtIVPpWt9kHpThaj0o5Q5jHCn0pdue1bH2QelJ9l5+7TsLmMgofSmbDnpW6LM/wB006LTmlfAWi1gvcwPKZiAqkmrlvo93PjbHj612OnaPFHhmUE1u20caYAQUveeyKsluzz+LwzdN97+VWF8KygfMxxXoEh4wAAKiAycMa1hRnLczlVhHY4uLwoMZZjVgeFIWUB+RXWgDnvTsDsK6I4ZdTCWI7GHZeH7W1/1cSj3q/FYxoMYHHSrpXJ56UbfeuiNJI53VbIoolUfKKk2nvSjjilNaKKRm5XI8DqaTHHBqTHrTSMdqdhXIGXNEb7MqeQakNRMmTnvUSjcqLsMktYWbcUHNOFrEP4B+VSwYKlT26VJivMxELSuenh53jYrfZ4x0QUeSn90flVnbSYrnsblfyV/uik8oegqcikIpWAgMY9KQxj0qbFJijQCHyxSGMVNijFNJAQbKQoKnxSbaLAQbB6Um2p8U3FMRDiipCKKAOSTww3fNTL4YPoa7dSPQVIMegreyMDiU8L8dDmnf8Ix6A124H0pw+lHKBw48Mn3pD4acCu6A9hTsD0o5QOBHh+TsDS/2BL2Fd7sHoKcqD+6KOUDgRoUvpSnQ5QOlegLEv8AdFL5S/3RijlA89/saf8Au0g0mf8AuV6J5Kf3RSfZ4+yijlA8+/smbH3aP7Jn/u16GLeP+6KX7PH/AHaLAedjSp/7tSLpMxH3a9A+zx/3RSiGP0FKwHALo82fu1J/Y83pXdiKMdhSMqAZ2imFjhG0iUDJHFVjZNuwK7DUbmNFK4GayR83I70BYxvsJ6UhsTxW6UO3JGM1RuN27igCsmnArmrFppJlPSkNw0UZrQ0jUFEZL0WAiOkxR/exmkNjEOOKbdXEk1zhDwamaNggY9aLAT2+lwuOAKn/ALIhXlgMVQi1EWr/AL1wB71R1TxSpylsCx9amU1E2hSlPRI1ZrWBBhQKhjWKNxjFcrJqdzM2WfHsKry3F2FYhyT2rB1bs644OVj0uZI/ISSIAKRyarp6isvwNqq6laPaXJ/fJwQa2ZozBKVxhRXqUnFxTR4teMoTcZBg4PrTBzy1Kr5PFKAfSt0jmbAYHNKD6UpX1pCMEVokSw55zSY5NOPIpMUxADilxnkc0nPejOOMUAHNIw4pM80pz1oAjPHFNPAp5xmkzjtQBB91siqus3kttAtzCu5V+8vtV6TGMfyqvJGHjaNhlWGK561NSjY6KFTlkmZ+n+JLS6YKzbW9DW1HNHIuUdSPY15XrFm9lqLoAQM5U1DFqF7bN8kzY9Ca8dvldme77DmXNFnruM0hFea2ni29gOJRvFbVn40gcgXClTRzIh0pLodfikIrOtNbsblQUlUZ960I5Y5BlHB+houRYMcUYp5FG2mSR4pCtSYpCKLhYZtxTWHNSGmkU7oViJhz0opxBzRRcLMshSOopQPSuwisbO7OBtyfSkuvDKhN0T1Xs5rZk+0i9zkgzCniTHWtKfSJYicDNUpLWRPvLU8047lcsGIso9KlV0PWq2zml2UKsw9ki6Ch709QvqKprbyMPlBoMUqdVYfhT9uhexZfwvqKX5fUVm7npNz+tP2yF7JmplfWmlhWduf1NKHf3p+1QvZM0A4pC9UQ7U/zWp+0QezZaLGkAJqv5zUCZqOdC5GWQp71FcyLFGSaj85qr3KNOMGjnQ+RmLct58xPYUsVxFEQDitFdPAXFMGlJnLcmj2iD2bGi4ikUADrTZLNXXIq2mnIvSrAhCJ8xAHvR7QPZnNTWbFulSRWZWLgYNWtQ1ixs8ruDyDsK5q+124uSViAjT9aiVZI2p4WU9jTM0FkSZnGR2qhqHiAyL5don/AjWLJukbdIxY+9KEA71hKu2d9LAxWstSGUzTyFpGJp8cYHarCKOrDj1qVY9x4INYOTZ2xgo7ECRAipwu0DIqQREVIoxkd6VwZnxNLpOpx6hb/AHcgSj1X1r1Fmiv7CK5iO4MuQRXnjxB0O4ZB4Irb8DX/AJUkmlzsdpy0WfT0r08JW+yzxcxw917RG2Dz0xipEbI6Uk8MkEmHIKnoaROnBr1UeCx5UDvmmgdeadjjmggAVaIDNA45pDx16UEg9aYCMDj2o6AZpd35UHnrQA0gCkPrSt1+X9abuoAU/lTDzSscY7mkJY8dBQAwkDOKgkapm471FJjualjTsc94psftFqLhB86Hn6VyEkWQa9GmG+J4zjawxXCXkJguZIuwNeRjKfK+ZH0GW1uaPI+hkPGN4qGVRk1cmXmqNySD71x3PW5bkQLIcxsV+hq7aa1fWhGyUkD1qnGCTz0pxTceRxRch0k+h1Wn+Npk4uEJHqK6Sw8WWNyAGcK3vXmPkYBNRtEQeOPpTuYywy6HtkF5DcAGKRT+NWfwrxW0v7uzOYJWwOxNdJpXjWWMhLtePWi7OeVCUT0QikIrL03X7S+UbHGa096kZB4oTMWrDdtFLuHrRVCLGjeK9NlK+ZK9s/8A00GB+ddbDrCvGDHOsikcENnNeHKoZBkZIxge1WLczwD/AEeV4+eCDjFONd9TqqYBbxZ7S2ooRzg1QubmOTOAK81j8T3llCrXTRypk/eOCfp61taV4r02+ALSGI/7XT86r2ylsczw8om9Jgnio/u8npU0bRSIHidXU9CpyKcVUrgjNZvUErE1tc+XjK5FbVhd20jqJQAPcVgZGOBR5gTktiodO5an0Ok1O1s5RuUJn1Fc9PbqrHb0qvPqkcSnMnT3rCv/ABLEuQrbj6CnCm0JzSRuSBIxliKhFxCW27hmuDvtX1S9fbaRFVPc1e0LTNRa5Wa7kY+3atlFLcz5m9kdtsyMikKVJEdqAHqKf1pco72IRHTglPPFNLgd6drBcQqB2pQvemmQ9hSYdutK6QWY7gdTSGRQKimeOCMvK4AHrXIa74ieTdDYjC9C9JzsaQpObsje1TXbezQ/MGf0FcfqGu3d6xG/ZH6LWY29yWclj6mhEyAMVjKo2ehSwkY6vUFALEk8+9OA+bFPjjwSe9SKgz61k2dSikRqvY09B6jn2qTbn+lOSMkE+lAwBBXGKfEuKVUXjFO5U5UGkIdtIYdakbg7toPrUsKPMAAmTVmPTXIBDLhjgDrWkYSlsjGdWMfiZTUhkIBqszmGeOaMkSRnINbH9mhVYiXn/cPpTf7IDDDzYOOyVrGnOLujnnWpSTTZ1MNyNS0yO4iw3HIqqFGeTj61neGZl0vU5NNkctHKA8ZIxk9xWrdxFJ2G3AzkGvZoz5lc+bxFLklYTOQOaU88Z5pikBsnP0qTIJ+XrXSmcrQ0Bj14HrS9+cUpY7SDUefoaoQ5mXPPWgn0pm0gHHNAJHOQKAA49aQsCeaRmzj3pCAByf8A61ACkhR6Uwtkc/hQST0pjnHpSAG468mo3UE80M/Xmq01xj3oAWUbR1A9K5fxNCEdJlOcjDVuSySODsQ596q6nZGfTZFYfOOa5sRT54s7MHW9nUTOInbPIqm67sk9KmlO1ip6jjFROSzADpXitWPqou4wfL0qzCgIyaSOPNTqm2szUYyAiovKxz1qZ8mjB2gDvTQmiq0eSajaMEcjmr2zAwaYU9BmqIaKcLyWzBoWZW9q37HxVdQBVm+YCssIGByOag8r95yKpGEqSkdzB4sgaMFuDRXFeUKKdzP6qjr1A5wfpmpQ2FAyD1JPpVJZ0VhvPyeg9KxdZvyX+zRNhW++QevtXOlc7pGney2d6jxRMs1zAMtGvdT3H0rDtp00iEho2MbEDzCMkZ6A1ymtR3lpci902Ro5F7r1H/1varFl4rN3AIdQhQmTAZ14yR6itVScVdbHHKpaVmdxY64YZA1rcmM9eD/Sur0zxjLlUvIhLn+JODXkN3d2nmKbVXQ9CWI4/KtDT7kNcRLGvnuFJdgT07DjgU1daomXLPdanr8/iWNh+4yxPbvVKS+1G7OI02A1zUyxiwSdZ9zAhGGOAx7Z9q0NK8Q3FkQkyrNF6n7w/Gq5+hi8M5K8WasWi3Vw2biRiD6mtW00C3iwWAJq1per2eoJmCQb+6Nww/CtDeo6c09XuY8vK7WIILKCL7iDP0qxtA6cCkLMego2E9TS0Q7McHAo3segpVQelSBad2FkRbWbqaesY71Jij8KLdwv2E246Vn6rqMGnwF5nAPZe5qvr2sx6bEecynoK87vbye/maSZi2T68CplK2xvRoOpq9i7qurz6hKdzER54UGqcQPPoar4+TFTRnao3NmsWz0owUVZEzRnOAeKBlSM9armUZ6n2qRZVJAJzWbZqossAr+NSQxmRwkZAZjgZNQ2qCa8jjLfK7Bc16DpGgQWMHnf62RudzDOB7VpSpufoc+IrxorXc4yKxunJUQSsy8HCmnbGjykilW9CMGu+UlRhCQOgAqlqNnBeLsuRiT+GReoraWH00ZyRx137y0OOA2vk/dpPmJACn2rbj8OuHJe5j2D0Uk1s2dlFboBEuCMZZuSfrUQoSe+hpUxcIr3dTL0vT2iXzZsByOB3UVqhPkxzjA+h6VJKyqyrxnPTP1/wpoClce2eRx2rthFRVkebUqOb5mV2VSwXBZiAPfvUrQoqruKhj+VTwIiuQDnv9OtUr2VRcDLKPr+HWrsZ3uzC8TJJbtbXkP3ojyQK6eC7TUdGjuUPb5vY1j6siTac0Wc7lyP0rP8EX/kXk2mz8B+VB9e9FOfJUt0Y61P2lHmW8fyN7dkZHK05WU4xwMU26RoZ2VV+U1GJDnOOe1ehFnkSROW4xkCmZx79qaGDAEgAmmknHB/OtUZsUud3XGKXPPHp1poYDrj3qNn28g/hTES7jg+tRs3v+AqB7gKnc+lRIzzEhQQp70DLMkuwckCq0kxkJVMkirEVqvV2JB9anzFFjAFGwasoLBcSL/cHepo7RFOX+YippLrr0AqvJcZzjilzdg5e5I7RqeBVG7bcCinrSSy88mqk0vy8Gs5q6NYaM4HV08jUZkHJ3cU62tW+9JxmtG/gVtRaUjJpzYPSvErK0mkfV4aV4JlbyVXtTWQ9qtOPl4qFvSuc60yuRt96QjcM05h60AgGgTYiBieakxjoOaaGJalDEtzVIlkYX5utMdMNirHGSKYyktVEkIQ0VODiigYy5uWVWG3JAJrnbqcrJDI2dsi8n3rpLuz8y1kwBk9zWElqs8D2s42Hqp7j3qY2LknuSCQSxSbgGHpXH6haFbyb5SsRPBxwTWvM1xpsxiuVO3s4+63vUn2pJExJhh2z9R/hW1P3TmrR50YKyyWsSH5ZI8dTzj610Hg+/WTU9jO0Sy/IUHAY9gPyqjcxwMGVV25zgiq6WrJLHLbT7TCd6A9MjkfStZQjKJw/vIs9K8RG3tLKLyTtlmk37PYCoYp9shjbsAR9K5+yu7nX7xLi9tvs6QpgHP3+cn9asx3Bl1cKechia5eRpWe520n1R0KOUIeJirDoQcYrp9F8WSQ7YtSXzI+nmr94fUd64+zkwrI557e9WG4JHapTsbzpRqLU9fsriC7hEtvIskZ6FTVoCvGrHU7vS7jzLOQqQRlTyrfUV6F4c8V2up4iuNtvdf3SeG+hrSMk9Dgq0JU9eh0oFKBzQCKWrMLCECsPxHraafCUjO6c9AO1SeIdXj021Ztw8wj5RXl15qUtxM8spy7Hv2qHLojoo0efV7Fm9upLqUyzNuc/pVdWOeMVT+0ZJz39KUSnscCsj0Yqysi4ZAo+bvUTM5PBqAvxzmjee3FRI1iidDkfNzUygY9DVUKSclvwqYMynoDWV0aamro1s1zqESIWAB3kjsBXqtkw+xFeODxXCeBovNjuZipG3C5/U12VrIFgdBz346V6GHjaN+54ePm5VOXsMZgH9qSSETREZweoPpTXBLn61LGexPStzjFtrfy1AOWPdjUpUZXB5BJqRQCF5/GmyAjHsO30poVyCRMMXIye35GopGK7t2RggH8xUkgYElTgnjOD7/pWbeSurgDkqAM5PHK5xxVoNy5E5MbNhuv+PSuXnmD3ExlCoSWwSRz976c+9as9zIumSs5VXKnoD7+veuXW5ZhMwP3lIBPQ8NxwTjr1oY4o3JZN0MYLAkL+HbpWPdoY5o7+D5JoSGIH8S96vMzt5Y/2Mfjx7Vfk04fY3Tq7pjn3FTJDjKzNG4lF5ZwXcByrLzVMSZKsozVHwZOY0u9JnZWkhY4wc/lVtlIkbqmP4feuylLmSZ5tanyScSYSdx3NMllCngH/Cq6g7sKrOetWUgaQZcFQa6UczK5uAW2vx7ipEtzMCTnHrVoJFGu0heKjedFA2Hr2qroVmwjt4lO5zk1I7onC4FUZ5+fvbfWq7MjHO459zUtspRRblufmIX5qgkk3ty2PYVUknAG3cD24qubhsfLgH1oSBl2SUJ3AprSg9O/OaphlYhm5apC4VeAKYrjy3c9KrzFcE7akaQHgdarzfMOallR3MLUCfPyOAar7u5NS68wj2FTjsayRPkda8fER95n02CnemjRMo6DFQyOMEiqvncZyKZJOMdcVy2O5MlLHqTTWkFVzKM9eKRpAenWnYGy0j808OAOKpxyDOM5NWYLa4mb91DI/wBFoE2iQvyDQ7qR15rStfDepTgZi2A92NbNp4KkIBuJseyii5m6kV1OSDDFFegR+DbMKA25j65ooJ+sROfa1BRieOdwqtd6VHcKGGVfPDA1txKojBIydtCx7OwINYXsdlznX0x3i2Tojpj5TjIPsazJPCFrcMTD5lsw6hDkfrXasvyhQOvPPFNwCpG0F+nWqU2jOSTRwR8EOJdr3x2YzlUz/k1oW3hXT7ACSUvcSDkCQ8D8K6aaV0QAEY/QVQuCWRt3OOg6VftWzL2RzupykE+Wv3hx2H1qvo1q6SNcSdX4BPpWrJb+Y5MnIJGcd/QU/Z5YLAcgYAo59C1T6AIwxJzgEk05QyNhjxjg1JABjjnGRilAHAyMcDmoubJEL4JIB6rVduCOoParAQiXA5G01FL84yOCOtRLyLXZnT+H/GlxYhYdQDXEHQP/ABD/ABrc1Xx1Zx24+xhncjuMYrzVvvfjUTkjjt6U41XszmnhI35kaWo6zNfzGS4kyc9PSqYaNiSTVBwwUugyB1X0p8bLIBg1XOVGKXQu5Xjb+tKNhOO9VAGHQ04SnjKg1m2zeMo9jTiiGPQ1MIcY4P51mxXWOGzir8F4F5yGX0pMvR7E6xkjlc4qW3tGnnVIT857NUsM8MwBQ7SP4RXX+HdJXdGzp+8Iy5Pb2qqVP2jOfEVvYxv1NCytU0jQI41xvc7mPqas6eSYsg5J5LVT8Qy+dd29tGflLdumB/8AXrZsIQsQwO1enFWWh4E5Nu73Yxk+XJqEMUbnj0Jq9OuBwKp3Ue5VMY78kdqCWyzG5OSOT9aV5BuOeR61nW0xVyhPzD0p7yNuJBwfy7/oKYXLe+N0KnhznGazLlEyQx6HOMUjzbCSSB69qY7oo3hyHfp2wOv9KuJLZl6iJblfJjQ7D6HaD/Wqun6Gm9muiSegUc8cDnj6/nV5Cu/g7sEj5mz3Iz1PrV223SNuYgAevUcA/nVBzNEkFrFH8wUYHc9RUs7fJwB+FSkFh0GR0JPPeopVGMcYHoKlkpnEQ3BsPFzTLnDNhh65rstTAaRJlkCq46YrhvEy/Z9Z3jjeoIP0roo7oXWlRMTngHNPDSesS8bTVo1F1Rc88gDyzlh1pWuHbhmCkdAO9UVl2hQWI9SBQ86/w9RXetTy3oW2kAbjgnnJqtLMAwOR9Md6qSyNI2McDkEGmEEk7mIq0IdJKWyQahlb5DnPTJx2pJZlVhjA44Jqu8pkz0C+opiHbwOh5pUk5JYZFRIgPXkVPgYHYe1AmLuJHI+WpEBJGeo5zTR82R2qRQ3OOmKBCYGD2NROcnHQ0/ByCetISDkBCW+lSy4nL+LhstBJno1crHd7uhr0LW/Dl/rNr5VvHtz/ABPwBSaR8LVUK2oXTOe6xjArysRONz28JJxhqef/AGg7sA1etLG+vSBb20r577eK9i03wdpNiAY7VGYfxMMmt2GzijAEcarj0FcnNfZHY6/Y8gsPBWq3GDKEhB9eTXQ2Xw+hXBup3c+g4FeiiLFGyizZm68mc1Y+FdNtMFLdSfVua14rKGIARxqv0FXsY7U2jlM3NvchEQHYCjaBUpWkK+tOxNyM49KKftFFPlC55+p+QKM0ucv0PIwBSSbVbY5IHoKj3dTk4/h461yM9seWwg9fX0pjsCSMEEnHFITtHXOKjLAnnj29M0ARyspB6kiqUoJ5GOKtyD58kjgdRULAEgA5BNAyp5YJGOM4/DFNdepPJJz07VZcAHPTuT/So3U7eT35pjIwuxRzgAcU7C5BHbjFKVy559TVa4fBznj+dTKVioq4pYb3PXC4qrKS3GMEmpeNhHT5cfrTAu6XBx8vJzWPMzVJFeR+SGHrzSSAHOP8ipGQmJlPUmq1wCjkr0p3uDQyFv37IejDNVUTyr5oein5lpYJt2oqP9g5pLkj+0oz/smr12M0kaax8cflSNGD2pUkwv4UZPH61N2a8qI/Lx1oaMD60jTgYGfwphmO3GKq7FyI3/Bln9q1cuxJSJd20nqTwK9btVW0tC38X9a81+H8L+Td3QxhnCKB145/rXX+I9RMOly7GwSMLuPVjXfSXLC54WMblVaMu0uGutbuJicIG2p74rudPYGIAjmuB8NoAFycn6V2dnIFO3P4V0JWicUviL9z0yTjHrVGSfaCOvb/AD+NTXEwCkHIzz6YrJmmYDoOTjj/AD+NOJEivdSGOQSr65OeKuLMsqBuCG5H19fr6Vl30gKN8uQBgEZJyRn+QrN0TUdt0bWc5+bKZ9e4pyQk76GoN000jOu23iOB6yMOv4D+lMlmyxYhuOp5xng+v1rSkH7sEYBzziqclqJG2qSueOP8+9NMTQyCENKzFe+dx59DWvAoyF7Adhx3H+eais4gqghhkjp/Wr1uAQp55yQ3brnNUIAgOCQBnnn/ABqnc/LkHrV+ZgqlVIHbjt+FZVy+5s4JA5znj/61SwSOU8YW/m23nqMmM/pVfw9d50vB5KZGK6K6gWeJ0fBVwVNcPoUxgnu7cnhScGlRfLU9Tap79C3Y6ISFiXQnJ/hPagZ3EsACKqRzMw4ORTy5J4XJxmvRieVLcnZ+CeaiZsHfnPsahlcAjcfmHX6VVeQsxIcEDgCquTYnkkDHa/HtSRspJCLuP8qhRCx+cc+tWshAPLAzQgBFL9GwtSquFxnp61YstOuroDyYWAPc8Ct+x8Mng3cmT6LWc8RTp7s0hh6k9kc9GN5whJPpWhbaXdXB4jKg924rrbXTLa2H7uJQR3NW9oA4riqY9v4EdkMClrNnOWvh1QQ1xIWPoK1YdPt4MbI1z9KvcUlck605/EzrhRhD4URiMDoMU7bTwB3pM1mXcQCl4pe1GKpEiUEZoo69apCGMKaRxUhFNIoGNxRjtRznpxRTQmJtopfzopiPM3dgysBgdRSMCybi3bAyaifLEck8dKUOS6lwSBxj0+lcVj3Lg7EZVMnuR15phGwkA8jqajLBQdpJXtimu25hggE4IAOcCkUh8v3fc9PeoiQOnuaWRiFyc89AfSo89MH64/OixSFbOMZ/Oo5G/djjBPzEfyFKW3KRzkjP4U0Y8xgOQgyTjr7UANZcoW3DJx3qkSDIQTtweT7VcnJIdQo6BTjsapSDAbHXAHP+fpWVQ1pjiRzjpjkH86ZFnGeMvnmmhiUVf4nAH4UMwVd2DsJ4GelZGlhFBcKOB/F+tQP82R1wefyqZdxAHTgkVBOwCFlIwSTjPtVCZm2cJlvZpCPugIPT1p8EJl1KQ5ysYx/n9KtaemywMzHl2Ln+lP0ddyGXHMhLf4VblYmMbl2OAAAAcmlaAdfTmrn3Q2c+uO+aa2B/dIxkdef/ANVZJmxmy2gH3SPriqzRFQfUmtVeRyd2TRIit93GPrVpieh1PgExw+HZJ5CBmViSeBmqeq3T6lqAWNcxK2FGeo9cf57VV0a1e60+S1jcDy5iygcFQQOT69/yrR02yewuS9wTIoIX/aH49+or06ackux87iLRqS7nQaVAII0XgY5rVilZHBGTj0qjayQTZ8hw+wBiuORn2oNwqFfNIQ5wMsBXR1scXQ0ZplbOCCemc55rLuJQpBLHA49OP/1ZqCa/tH5Eyl1JzsBPt/XpVN76PK+WVkQngpzkD/8AV+vSnsRa5PLOgTaxDBt270AHLf0GP0rl9fR3Vrm3kCuGyVbpx8zEH2O0f1rYgljuAzK28yDAA5BCn2z1b9B0FJNHG7JAgYtjIdu53cZ57tzn0HWi99x2tqO8KeIje7bS74ulBViR8r44JHpzXTNgKSMcVyC6Nsdp4WUSPgBwfTp7c/M3bt1rdsbuRozHdLicZwf73/1+lFmmF0y4bzy3wU4xnoa0La7WTGTyD2rKmQuG+UZ6ZIpdOt5lmOR09T2/z+tMmxqyzByEUjoTxz+tQOpRiWPOM8nke3+farGzDhieMZ+U/p6+4ri/HPjWy0AGCBo7jUWOBCpzs93I6fTqam9yki14n1qHR7TJZTcScRJ6+59hXn2lXBGoAuf9ZkE/Wucm1OfU7p7m8laSZzy3p7D0FXbeUrIjA9CKwhN89z05YeMaLj1Z3kChEOT8x4z60omZUGCDjjNZ1vOAmXY8jpWnp9hdai/+jwsU/vNwBXq86irs+e5HJ2RCxJGXbr3p1tDJO4S3iZ2HYDNddpnhGNQGvpPMP9xeBXUWllb2qBYIlQD0FctTHRjpHU6YYKUvidjjbHwxeXG1rlxCvoOTXSWGgWdrg+XvcfxNzWuMCnA1xTxNSpuzshh6cNkMWNUGAAPpS4oJorC5tYKTHHNOGKCMtVJCEwAKbtqTpS4zVpEtkWKNop7KQeBQQcU7CuMxjilxS7TmgimhDTim4604g000wEHNGKBTj0poTGHNMI5qU00igVyPHvRT6KAPJ0I3MckY56fpTd7E53ZBPpRI6/wZAwO+KiDMMbvun37elctj299SRl2ScfMPXGKglODySuDyQOSac7DexKk4xkdsUxuGJQcN60rDQjOznAK5xnGe9JxgDAPPX1FRxNkdDuHJ7UvJHX260FEikbQDwxOfaowwcZz1bOPxpPmxtzjIOT9e1MLKOBuwWAH0/wAaAQvUBmyMsWx7CqsnLkHnrmppG+8ASM/Lx9aqyERyMy8sThef1/lWFRdTamND4j8zkk8D2x0psxLHYpG08/THFK4wuAfT86WEAyTnnaOM/j/Ws0jRyQ+bashRQ2FXH1NUtQG5THHjczeWoH86ucopkP8Ae3EVVgQyTLI4+VQQOOpzkn+lWkRcj1JhFarAnOcRg1qafGFjVQQBgCsg4u9RVB92LJPpk9K3oExIIyMbfftSmraDjLS5OvK4YAd+mKruCCMAgdgRTnIBAQjJH0pZdqsqqxyuATjGaFEfMMJwoyAaj+bPBwDnOOfpQx2HC92OB1ocsc4P8RzVKInIaS63Amt5GhnC4DL+oPqKztb1DWxC5t7/AMpU+fbGoGc9STyc8mrwYYwWAJxnH41FcMhUhxkEH+Vb06kobHNWpRnq0cXJdaski3K6lctKhyp8xj7/AI9a6XSfGSXW2LUzHA/d8Eq59z/Dz+Fc9fwG3mwMhW5+h7ism5RZGJIw2Oq8Zr0IS5keRVhY9ltoY0VJYpA4lb90Q4IYDPQgkHoT3+gq5GzwhpMDG0gDOB+IHXGB+VeG6brOoaLKfskzGHPzwtyj/Vf6jmvRtM8aWGq20KALBOq7TbvJhiT1KuTg/TirlF9DmTXU6y2kV4FkjHlKvK7uMYGMkfTJ/wCBDmtO3D4/egRyvgsQM9vU+g4z6k4NYmnypEJZpTsHU+Y20Kc5yQfWq91458P6fkXOoidwMbLcGTJ68kcZz70khM7oKqQEZAxwV4AA7j+n41XhECsIWXduJJBGe/OD9Tj8PSvMr74u2KkfYtNuZiM4MjhO3tmsK4+KusOoW0sLOAcBSQz4447itLMjlPeIrVGOUuPl/wBr734Gm6rqGn6PbtcXt1FbwJ993ONw9Pc1863HjfxRJIwfVTDntCqqB9MCsSae4upRNeXM1zIQMPOxbP50uVmkYHp3jD4n3N+jW3hrfbwNkNduuHb/AHB/D9Tz9K808gy5LSM0jnknqT6mmA4xn9OlTwcuMZOaNkacqtYmgkME3zdO9dToOlX2sTrHYws4zy/RR+NVfC+hx6tqa+eGeIHlF4z9TX0LoNpbWdlHDaxJEqjG1RjFebUq8r0PQ5lypMxtA8HRWyRyagwmlUfdH3RXWwwpEoWNQoHYCnA80+spVZT+JmEacY7IUHFOFNApwpXG0FOzxSU4VaZLGminYo2+tUkSNwKXHSjA7UoOOMVSExBnignBp+BSsBirsS2R7jRknBPFGBnige9CYmgBpDQaKdxBSEe1KM+lLtNUAzFJTiKKaExpppp9JQIbRRRQB40OchQNwGeeKGKjI5BA6mmsRuYk/N7igMvBZRnHHpXKe4AZuPmBHHXv/wDWocEOPMJ55OO1JG+2Rc7WBOailmMju7jBJ4I9KA1uO+83HC569x7UOx3jldo5H1PrTYhv25bpyR0xUTlSWccDJ/EelAyRnJ5zwAc0wncVKgfdwBmoyzGB85zuFIXXBJJGBtApWGSM2SDn5R3qrsLSEgfdy3PHSp1x0yV28cdM0x9oJwexP1qZRuVF2IFJI+YDPSpeTEIiuDIwJ9+/8qbhlHAOV4x7mh2yxJzlQFGDwDWdrFtjWDSFYscM+5vpTLyVYLaSQEAEcAcY5qYN5SMQAZArM2ex6D+dZOpk3d7FaIxKKBu+gq0u5Ddy5oUDJCJnyC53En9K1ojtfbu55HP+fWoQvkQrtxgjjb69OaaOSqE8dBn+f86i13cu+li0r5Us24qD0zx6fyqKZwAApOB1bPfPp2qN5Ag69BgLTXz5RXjsSfenYVxPMJQyOSOp9+elNVyYdzEYPy7aguWbEcYxuYjjHSmviGEYJwvOOhz61SQmyUnaSD1PXI/AVXd8g+49fYVX88gkZ5J545x1qrLcAE4Oc8ACrSIbHXcMdxGwkAy2QK5W/heBijDOOh7EV0nmDODu59KrXkSzwFHBz6+lb0pODOKvT51oco4L5GDvHTHpVBhsYkZ4PT2rRvYZLaTY+CD91h0NVJArjcTn1r0Yu6PIkrMmudZ1C7s47S5u5prZSCsbtkA4wPf8KrRoMjcM98dqYoCsTn/61OyO3U9KoSZNwGXb8p3ZxnvT2bue3OareYAVJOTRv/iP60rFKRaBABwDg/nSo2BkHj0PcVU35PbnvQH56/rRYtTL4lwMgDPrVi3lKt5j/wAJz7E1mLl8DP4k9Kkgf7RcRQp9zcAPeoktBc+p758PdPjg0yKdQC0g3bulehWLYkXtniuU8PKsWmW0acBYwK6G0bMiY9a8h63Ojm1OhC4qQYpkZzUyAVgtDouJtp2KeFpxHFaITIsUnNSYoxVpktDFpxGaNvNBGKtOxDGmkpxFHFNMBvQ0pfjpQfak+tO4rCZpNxp2BQQO1MQmRjmjIoxTTxVXFYfuFLuFRZpM0+YXKSk001HuzTx05pqVxWsITSE0ppM07isJmijPtRTA8VPzYbjP1zilLkMEYYUHnJphOPugge1NyQhLDt3HSuY9sNwQ4CjPQn1p92YFaJIQxIXLE9zUUfDAkjaDxkUoY/MzDhup9aA6gV/dEfxscYHXFRAeWpIcjHAAHWpJdxk5AUgZAPaq0uRhcfX/ABpDH5G3JyQv86cV+6dp9hnqe/8AhUaEMQy52L7dTT1YIoZsljnHPSgBHAJCk4wMnFKpG9XUBs9j/KggndgggjnPakVgHCn7gHGR2pDHTJ8hG/axOTz196rW7Yk+fbgHODzntU7kykM20ZG4/Sq7uuGAKgkdPxqWuo76WIJ5xGryyMOvGfQVDocLSLJdycGU/L/u1UvWN7eJapwpOXx6AV0SReRDHGBwvUD0AoeisCetxkhyuDnPG0dRUMQyGY8qcrmknk6FWBbtz07D8OTU3ywoEBOAMDPfH/16VirjXPIOQwHqcf54qNn+T5jwMHn0pRkqu/69OgqreSsYjGAcu2AKZIliWmuy+3coz1Ge1MvXLTHB+VRVqGMwWwzje2OtY99IFUjj1Jz+lJasGV5pCCOcAiqj3AXsB6VHc3APTgdqoyynqAT+Ga6YwOec7GktyM47Dge/vUolV8c4P6Gsq2gu7nHkwyEeuMD9a17TQLlsNcTLGP7qjJpycI7shRlPZGfex+bGweEyLjPy81y92nkv8pJX0YcivT7fS4IV+YyOB2JwKkktrXZgQIPcDNVDGRjoY1MvnPW9jyYFicqrH6DNPMUoGTFJj3U16Y1uqt8gTH5VE0Lf3RWyxkX0Od5dNdTzQkg4II+tNzXpElvuBBiDZ9gaoXGlWsmd1qoJ9Fx/KtFiYsxlg5o4ff7UqnNa2oaFLExa2+dP7p6j/GqC2x5DZB7gitlOLV0YeymnZkEknG1Oh61reF7czatbKB/EDWXLAY2B5xXbfDqy82+MzDhOlZ1ppQ0KpwfNqeyac4WGNewAFbdhMPOXmubt3IxWlZy4kBBryrWR0dTsoZ+BzV2OYHFc1Bc+9X4bjpzUWNbm6rjsakD+tZMc/vViOf3pWHc0QVNLsB6GqiTA9amWQHoaaQcxKUNNHzDpSrIfWniQH7wFUrhdMi2+tNK+lWh5bd8UhgB+6QadwsVStIVq00DAdMio2QjqDRcVivTcGpivtTCvNNMQymmpSOOaQ4xV3ER001JimkUwEH0oNKeOlN/OmmS0B6daTtRnnmlB96pMVhoJopw/A0VQjxB8BtxJwOmKVVLd+nP1pjbVZRI52jBOO9SOw24DAKAOnOPbNc57DYwrIZAnAJOOlJMwHCD5QdvI5psRKsTliVPY/lUbMSSF+VQCAfX3oK6iswMmSTx0J6U2QghtpITuT1oQNnaw4U9PWmudpPbPHHf1NAxxcYQAtjPAAoJI3AkEnnj9AKY3GAOuAOtIxwGwF2r796QDyQpCockn5uetMYgtk7uegpBtXl2J29hTGA6knOM4HY0WGPMhG7I4Hf0rPv7kLDkuOBnrUtw+xcHkgZwO9Y4Rr/UEtgfkB3OfQelVy3E2a3h22xFJdygrJJ8wwOg7f596v3EmwZU5J9OcDt+NTM4VfLACjABXsPeqMsvmKsKF1Ukscnt/+qs3qxxC1UySs7ZcqMcdAf8A6wq3KG3KAeSM889M0kP7sHAXbgnbng//AF6iMpy0h3dMD/P6UimF7J5UQQlcqfXkVXs4fMf7TODt/hB9KdBbtezl5MeUpy2O5/wFTXkpXEMA3u38IqWEVcoapqG1tqje7HCqP8KoSWMsvNy2GP3Y1/rWvBYmFiyqHuH+/Jj7vsKt29gARxw3JZu/ual1VHY2jRvuYVvpUSgEx7j7nir8VmNuQiIB6LitlbdM4X5yemOB+dMnjYbs529MGsZVpM0jRguhnhFTpg49aTcTkAkZNWXjBYD86jMeGGM1KbNHYbsbJGP/AK1H2Y7sbgTjPBq7b4C/OobA4FNkLZwmVHYA00zN6lKS3ZQc7QT7VCIS+QR0rVEZOTJ1JwAOtM8pdxUg+pp3FZGY9soHD5J9qh8o9VJNa72xPKKAB+dN+yMx+ViPoKakxOKMgxZHzLkfSq0+nQT/AOsiUn1xg1vNZDrkmo2tABnJrRVHHqZSpRl0OXuNAiZCFJx6Guj8H2IsLXaeuetP8kjjmliWWBt8LAeoPQ1r7eUlZs5KmFT2OqR8AVbt3w4waxLK8EyBWXZIOq9j9K0YHw4NVe60PPlBwdmb0UlW4psd6yIpOnNWo5KSEbEdx71ajn96xI5KnSUiqEbiTe9TpP71iJOeOanSenYRtLP71Ms4NYqz+9TJP70WC5srKPWniT0NZCz+9SrP70WC5rpMw4zUq3GOqg1kLP71Is9LlGpGu08DEfu9ueuKUR2zn7+361liYGnrIPWjkDnNBrFGP7uVTUcunyqMgAj2NV0mGe496mWQ/wALkfjRysOZED20i9VNRtG3pWgDK3STIoZJTjcAe3SnyyDmiZZT2pCK0GjbONlRNHn+E09QumUsGkPSrJjxTSv40JsCtRUxTnpRVXEeFuwdu3Tp6fWoCcBsHC9T7+1MZxjA4XqR0pWOPvDhuwOamx6qHmXy4M8b3OT7DP8AWoXlGchdi9hUc7E8qSI1HQ+vpSRMWdQxyc9AM4FOw/MnZ/LXaR8zjG30FML7W2gEsO/oKHb5mIYbz1J/lTd67S3YHAI7mkCYpYFuBjPYelNOzJA5GePb3xUZJz5mct2z603zcRkIScnGc4NFh3JGcscqTgHJz3prSfMWJ5J5I9aiaQLjC8ds1XmmABDL6kCiwNla/uRDG/8AkmruiWwtrXzJBieUh2J7egrItoftl98/EURBb3PYV0NxJ5YRQwJ6Z9B3/rVS00IjqxJZVLMcjCDJ/wDr063XchlOF3HO0jt2qBE8xjHt3RqcsfU9vyq6AY+c5IOc/hWT1NloPbcCwBGGOfrVdEa6lwpCIvy7h6/570ssmThWUscjd1+pq3bw7YlYbeBge3uaewJXY1f3aLFEPlHQDqfan21owmYtzO3Lt2WprdNieZkly3y54JPc1aiKxqV3cjl2Pc1yTd2dMUorQWO1CjaoA7jJ/U9qSRV5GQeMAAdff6VNMGGze2eRhR/WkWPOXnwo7e//ANbpWaiHPbUZGJWUKPlXHXpTGgRs4Zc4yT1/yadJdO0pVAdo6cdQKa+SpY/KrcFQf0qrCuynOBu+UcE96jjUZ3EZPr2q1LHkjhmP5YpY7VycMAqnrjtRbsi7q2rKxkZn3YYZ5OB1qWNWV+mM9/SrkVvhkzjjjGO1WVTYSBkk85xT5JMhzS0RRWz3MXJZj1bHBNS/ZnJOECAdc960JFCoOg74ApnmEL868E9atU0tzP2jZU+zAHc5BxxwKeIokyGGQenNSqpYk54zmmHHcZ96tRSJcmxvlqf4cDtUbQAgnAx6VYXlegA9R2pC+Bn1p2FexUNqpB+UCmS2Ufb86uebxjv6Ghn+UA9e3NHKgcmZhssEFGYEVZhmeMgSfOB3HWpmboAOKYQc8KeaajbYzmlNe8aVvMHGVIPrVyOT0rntp39Sp9jg1bt7t4jhvmXHXGDVI454dr4TeR6mV6y7e6STAUg+vtVxWq0czTW5dV6kV+OKpq3vUgamQXFlNSrNVJWqRTVIRfWb3qVJves0OakWSgRqLNUgmrLWTHepFk96LCuaize9SCastZaestOwXNQTU8T+9Ziy+9OEtKwXNRblh3qdL5l71iiX3p3mn1pptBob66me4BPrVlNViYKJI1IHXjk1zPm+9Hmn1qudoVkdcl3p0n3oypIqaODS5uk5QY7iuNE59acLhh3qlNdUTy9mdi2kWpOUvF2+9Fch9rYfxH86KfND+UOWXc8IX7yqw+bP3cdPepGZN+VY5AOSO31qqzYHynLZ5JNOLokIVG3kk7zjrWJ7TEPOMEkk4UeppZB5ZwhOTxu9fU06OQRuNrDeAeewqtI5ft14HoB6U7DTuSs6fdQZHqfSmlw+0DO1enHWopSBFyu0dR6mmrkqADhemPWlYZJI425zu7f/AKqYxXaAzYbGTTJJDsJfAUcAVAzsAACGZvTmnYVyWRxsBwQo9azb65Kx4UZcnAHqanuZcDAJOOp9Kg0yA3Fz9pkx5UZwo9+5qkurIcr6GlpluLS1AOC7fMx9/epCzSSMw6k7Qccc9TTDKHPlkZ/iPuKsxKcLwd/14Gf/AK1Zy1NoqyLUCeWiqOQDyff3qO7k+YoGG5hzjjvTZZxBGSCPl5471DGREhmcfO5yM9c+1SkV1LNtFkn8vb6VowIr7VkJESnJxzVW2zFGOAZCeFz3qzGWVQGI7nI7ntUs1joWdxBZ8EckKpxlR2pI1xtJPfvzikwcKqryRkev1pF27gRgZH1wKz5UNyJJrl8IuSqryqjrmmYnuWG8529B6e/FLHD+967vT3q8f3Y2gFSDhgT3+lLlQue2xWgtlQBjlsHk5qVLdcbu3THUmniTy0OAp3dcUoZiBjnjoOAKFFITk2GwJjGQpGcipfmAHJP0pmQVO05PY06RmTZuBPGevNMhk6xsFDOMBuBjvTN22Rtw5x0FRPIWOSTSPIwHHJoEkyQtk5Xn19qYXJUseGzwPamqN3B6d8d6e8ZOAvHNAxnmKyDdnI4AAqPDEnIwcdKmEBORnGOaWSPj3Hb1ouBVVDxnIPv0qxtwoYDj3p/l5ILfjSlQBjrRcGVsMxyQPenmFcE5GR6VPjC8Dg03cSp6AHuKAGFRtIAxxkk01xkYUk0/cpUdSfWkG8gk8CncViNlOAMY9ajZew6VO0e7kDGKREJHU0XE0VmQp90HPrVu2vZUIVlLfTrUbjPHehJBbSrN02nNVFmVSCktTrtNs2liWWcFQeinqatSWUZPygr9DT9H1CHU7NZYSD2I9KutHXqwpQcTwKk5Rk1sZD2jIflORUZBX7ykVtGMYqMxjpiplhk9hKu+pk5pc1fe3VuwqJrTjIOKylh5LYtVosrhqeHpGgce9RkEdQazcXHdFqSexOHpwkPrVXdS7qkZbEvvThJ71T30u+nYLl0S04S1REnFOElKwXLwlpRLVESUokphcvCSl8yqHmUeZRYC95nvRVHzKKdh3PGQpl4Jwq8k09SpjLJnaOv0qJsuMcrH0A9adI5VvLTII4wPWpPXuDFjtUgjqeT0FOK/KSoK8fKSaZvYsxkALKOWanuyYPqq4AB6nuaLCbGMd+Hy2AOBUDOS3yDJ9T0prOXY/MevAFRkneVLcKckiiwXHSErvDZJ9c4FQSTFD8jZY/xAU13ByD055J6mq8suIyWJq0iXIRhJc3CwqSq559q2SUhgSFF6Ek4PX0FUtMjCQSu3MxPHORjHX+dSRgyygsDweMnOTSnpoFPV3LlpFgs5IOTnP/1qtOwDEsR0+nFVnIhULnt0pskh8xUUjzJVJ3ddo7mskrm7dhY8Ty72/wBWvb1P/wBap42824BAOE5A7A1TlcQ24Rf4uAKs28vkRDjLDBznj8aGXEviQNMST8uCAAOSwFW7cHG5h8xGR7Gsm3OduCTkZJHbNXTcALjaMdsHvWbNV5F64bPyB8tjB29KIlYxjcSqj+7/ABVHCgMAPJY8FiOhq7GVVFjbg/wnrUieiHxjCALh8Djtip1ZFzkbs4Oarn5QV4x9MVJtYrtIORyfwpE2HuQE2AAg89ORTlViBjj/AApkYOwHJ3enrTnDF8Hr3pXCwPtBwOSaNvGSeemKVYmJOB05zUixDAODnFK47JEO0kd8DvUgjOMjvU/lcqM9alKgZHpQK5XVMLxjdUojOVHGacpVGyeTShtwJzigTDywD6mmFcsCBgVIRuwCcUAFhhSOvSgRGIyDnPy0xsk8etWA2yPawJzULYJHJxTBMFUbfmyTUMnzfL09qkaXDbF5NIqYbPUmkMREAQcAEVFI49zzUj/OcLn3qPYA3TJ9qBoeCX6LSOrBuOM0DcPYUNIAMuelMLC7Rt561VuULRNtBJxipWZpOVB2iuq8PWiSWK+dGpJ56dq6MPSdWVkcmLxCw8eZq5ynhe4l0znccO3zIa9JtZEniVlOcisS68P2BuBMgZZB1APFT2Ra1uf+mTdB6V6tOnKCszwMRWhVlzR6mwyj0qMqfxqbdnbtUkGlKAk46mtLGFyttzTWWrRTAzTWTg0WHcqFcnpUbxg9uKuFMDpTdvynjpRYLmc9upzxioXtmHQ1plM0xh2rOVGMuhaqSRksjqeRTCa1jGD1FQSW6t0FYyw38rNFW7lDdQGqR4COh4qFlZeorCVOUdzVST2HFqN9Rk0magol30m+os0hNAEu80VDmimM8pZh5mVYsOoxTFLZ3Dhuwpsz+XGTgcnmoVYseO/YCpsesTAb25ADDJxnrSO5UlA2M4z7UxpFQYQfN6ntUMpACnJw3UH+dNITY4sUyqEBc8sajeQKh2k57e3vUUkmT6L2Bpu8yP8AKOcZOTnNOxLY1nCoRglvWoYEFxOAeVT5iP6UTkqMEHLHJxVy0iEcZBGAeTnrV7akN30LH3VCAj1xjipYvlXC53Z5NRx5xyc59aH4wF5NYvU6I6IfJOgYlztA6nFLCDy7HlhkjOdo7CqWftE4AH7tD19TVyd1ihY7cnH3uxot0C99SMM097wCVUc++avoclV2gAZNUNKiYBnddzHLdcda07RdgHHPovpUTeptDYtwIAjdpDxg1aijV1Usp3jjI6fjUaKGOArY43EdatRqY4sHA3HOc5NZNmqJvL2rtVzsBz0pw9vXGc1GMMhPG2pV4jGSM9gKlhYeBnLMcn+tTRFlyx5PTmo4htXacnnFPXJcDaAB2zUjsTAdDkAkcinIuPunikUZ5brnFSxDqSeKl6i2Q9enTNAJByR1ODTgduCTgdqTI49KaIHyZUg5+gph+7ycUO2WyD09aaG+Yc9KbBDlI28jnFKMZGKQtuIA9OaZkckHnNIB4Y1LuUFTj5jUIPGQOlIW5Vs8CqQnqS7iwIUHr1pgXnnoO1KWO04/SoJXIZRjk0AkSLH+8Jx1psrAMFHNSMSEUUxVxkkcmlsFxDtjUY79aRSOo6mmOAZOeAvWqtzdhEyoy3YUIe5YupvLG0DLHpUMcLHDSNk9cUy1Bb97Pyx/SnzTZbCDB9apFbaCvIVA5xmu50bK2cY54UV59a/vtShib5stzXpdsoWABfSvWy+Fk5HgZxU+GHzGXi5KlDg1mzXJ2nIwwNaib92OCM1BfWySKzYA78V6aR4d2i5pN2txBtLDeOtaKjBrhVuZLS8EiKfeut0+/S7hVhwfSspR5TSEuYukgiozgmkLYyBTc+nWpsUOYZ59KYy5pwPFIOvNOwXGBcZNRsvPFWPamEc0rDuQMmCO9RslWtuWxmmFeee1A7lVouKgaHPar+OfWomXJpWC5mSW4B6c1WkhZeRzWwUzyRUcke4cCsZ0YyNY1WjFPFJ2NaEkAOSRxUCW+ZQpPyk1hLDyT0NlVTKtFXXjAchAMDiiq+rSJ9vE8QlY/NwNqnOOuKcoxlsnIAJ56ZqtkjO3of1p0zKrHacEHnmuex7bY5SpY7iNg65pLmQNnG0N04HT2phkwDluOuAO/vVYSBeTz6gd6dibjpG2tyeR1qLzto+XJ569z7U133dMEnk0WrfNkBcg8c4x71aREpEkSl5Sehxkj09q1UXchL7jnjPTmqlsg8zG0H1AHU1exj5cghRjjpUTZUFdgSEQ45YnGT6VUuZGSMbPvscL6/WrByASCPcf1qC3iM0huWyFPEefT1rNaas3euhJbLDDAAVdpccDtk9zUd2fMZYj26/57VbiX5gS27uBUFsjO7ysqZZu9K/Uduheto/LVdwwe3uK1bdEX7u4Sj5vbb3qlbKGQAcFOvPXNacUO7Zv69wOvFYs6EiSMNESA2AW5xU5BLFv4D3pn8IAPAOcE54qRnUoq7T0yfc+tSyhNmFXkc1MIwqhjn61GmB8zHnNTl92MgYB6+tQVcePl7A44x6U5CRkgjJpoO4lduTijcM88UgRMjjkHmnBsYA78VAfvZpySZxkZAzRYGWwwOCDzihW6c9PWoA+AOlDSevemZ2JC3yk4FNLfzqFpcgAU48jGRx3pWK2JPMA45PalBGSewqBzypXpS+YOQOnenYRNKxyMH5TzTWcH5fTk1CH/hPfpUZcmTjgDrQBfVgOp2ioVlDykjGBwKY7jYN3YUi42jHfkmgktA5G5jwO1MNztBbHPaos5i685qneTquVzgAZNNK4bjb262oSW+9UNjC8riWT/gIqhblr653n/VqePettD5SD1ptWLvYnICjBGT2qlcuIkJPWrLSFU65Y9fasjU5MDC8sRVRRDZP4TlNz4jVVydgLGvUywWIcflXnvgCyEU8sv8fQmvQ1ACdiT0Fe5hI8tM+XzKfPXfkRwEMSFJA96mxxuJz2xUKZXbuXnPOKezKQy8gDmum559jI1S2IUuBlvSqNtJPaujhuM8iuilXeowclhjmuU1aO6iYrEc88+1Wve0J+HU7W0nFxCHB6ipehFcRpGqS2kwR23A8GuzikEsasp4NYyjyuxtGSkiVTil70wHqO5pc46mkUOzzQeTSdeaUflTsAg60EcGncZFB6mkAwpxTfLG0+tS0g5OKLDIjGD071E0XUVaPtRjnihIGyjJAcdKqtAVkz0xWwcAdOaoamwWP5SAxp20FcqLtUYxmiq3mleD1ooA8JP34vwqButFFeSj6YV/vTfT+tRJ3/AN00UVSM2VW+6asWfRf94f8AoQooqnsQzTsPvv8AX/Gpx978KKKymbUtyG5/49pv9w1Zj/49of8AcFFFZvY2W46P/WH6/wBaWx/485/ov/oRoopdB/aRct/u/jWsn+sl+h/lRRWbNxV/1Y/3aev+qT/dooqGWiVP9Un+8Kc3+uf8aKKkETW/+uP+7Sn/AFlFFAdRT1/z60qfdaiikgew4feFNP3RRRTERL1H1qRe9FFIGH8Jph6/jRRTAH/gqMdT9aKKESSy9qmb/U/hRRQBGP8AVrWNqv8Ay1+lFFVEURuh/wDHqtaf/LRaKKTBkj9HrGuv+PpaKK0gQzrvA33Jf96uu/5bJRRXu4f+Gj5XGfx5E46NTZv4fpRRWxysYeiVk6j92aiirhuRLY5Sb/j6T613Whf8eoooqaxVLc0k+9Q39aKKyNh6dPwpRRRTAWgUUUhiHtT06miigENFOHU0UU0JjD1/GsnVuoooqnsStzNk+9RRRUlH/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David G Weismiller, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2135=[""].join("\n");
var outline_f2_5_2135=null;
var title_f2_5_2136="Etiology and pathogenesis of small intestinal bacterial overgrowth";
var content_f2_5_2136=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology and pathogenesis of small intestinal bacterial overgrowth",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/5/2136/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2136/contributors\">",
"     Jon A Vanderhoof, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2136/contributors\">",
"     Rosemary J Pauley-Hunter, NP-C, MS, RN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/5/2136/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2136/contributors\">",
"     J Thomas LaMont, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/5/2136/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2136/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/5/2136/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small intestinal bacterial overgrowth (SIBO) is a condition in which non-native bacteria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    native bacteria are present in increased numbers resulting in excessive fermentation, inflammation, or malabsorption.",
"   </p>",
"   <p>",
"    In the healthy host, enteric bacteria colonize the alimentary tract soon after birth and, after the first year of life, the composition of the intestinal microflora remains relatively constant. Several mechanisms prevent the excessive colonization of the intestine by bacteria, and disorders leading to alterations in these systems may be associated with the development of pathologic SIBO.",
"   </p>",
"   <p>",
"    Affected patients may have one or more symptoms including bloating, abdominal discomfort, watery diarrhea, dyspepsia, and weight loss. The diagnosis should be based on the presence of the consequences of malabsorption or inflammation and should be confirmed with a positive result from a noninvasive diagnostic method such as a breath test or more invasive methods demonstrating intestinal inflammation.",
"   </p>",
"   <p>",
"    The etiology and pathogenesis of SIBO will be reviewed here. The clinical manifestations, diagnosis, and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11990?source=see_link\">",
"     \"Clinical manifestations and diagnosis of small intestinal bacterial overgrowth\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28454?source=see_link\">",
"     \"Treatment of small intestinal bacterial overgrowth\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INTESTINAL MICROFLORA IN HEALTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;At birth, the intestine is sterile. Within hours, maternal coliforms and streptococci begin to populate the alimentary tract, and are later followed by lactobacilli and enterococci. Within three weeks, the number of coliforms decreases and Bacteroides organisms begin to establish themselves as the predominant microorganisms in the colon [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The gastrointestinal tract is populated by 10 times as many microbial organisms as there are cells in the human body [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A typical gastrointestinal tract contains at least 500 different bacterial species. The majority of bacterial species in the gut remain unculturable. Their composition is modestly influenced by dietary factors [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/4\">",
"     4",
"    </a>",
"    ]. In addition, the types of microorganisms and their concentrations differ along the alimentary tract.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Stomach and proximal small bowel",
"    </span>",
"    &nbsp;&mdash;&nbsp;The stomach and proximal small bowel normally contain relatively few bacteria due to the presence of gastric acidity and the effects of peristalsis. Lactobacilli, enterococci, gram-positive aerobes or facultative anaerobes predominate in concentrations of 10",
"    <sup>",
"     4",
"    </sup>",
"    <span class=\"nowrap\">",
"     organisms/mL",
"    </span>",
"    in the mid to distal jejunum. The concentration of coliforms rarely exceeds 10",
"    <sup>",
"     3",
"    </sup>",
"    <span class=\"nowrap\">",
"     organisms/mL.",
"    </span>",
"    Bacteroides, the predominant organism in the colon, is rarely found in the proximal small bowel.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Terminal ileum",
"    </span>",
"    &nbsp;&mdash;&nbsp;The microbiology of the terminal ileum represents an intermediary zone between the aerobic flora found in stomach and proximal small bowel and the dense population of anaerobic organisms found in the colon. The concentration of organisms may be as high as",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      9",
"     </sup>",
"     /mL,",
"    </span>",
"    and include enterobacteria and other coliforms. If the ileocecal valve is dysfunctional or surgically absent, the microbiology of the terminal ileum resembles that of the colon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Colon",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the colon, the concentration of microorganisms reaches as high as",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      12",
"     </sup>",
"     /mL.",
"    </span>",
"    The organisms are predominately anaerobes such as Bacteroides,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    , Clostridium, and Bifidobacteria, although multiple species coexist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Effects on small bowel function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal complement of intestinal bacteria has several effects on small bowel function, which can be illustrated by animals reared in a germ-free environment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/5\">",
"     5",
"    </a>",
"    ]. The small intestinal villi of these animals is thin and consistently regular, with relatively shortened crypts. The enterocytes are cuboidal rather than columnar. In addition, the number and size of Peyer's patches, the degree of leukocyte infiltration in the lamina propria, and the rate of mucosal regeneration are reduced. The introduction of microorganisms rapidly restores the normal expected morphologic appearance and physiologic function of the small bowel mucosa.",
"   </p>",
"   <p>",
"    Small bowel protein and carbohydrate absorption are increased in germ-free animals [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/6\">",
"     6",
"    </a>",
"    ]. Similarly, the elimination of small bowel bacteria in colonized laboratory animals raised in a normal microbial environment is also associated with improved nutrient absorption. However, under normal circumstances, the degree to which nutrient absorption is impaired by intestinal bacteria is not clinically significant. In fact, germ-free animals have reduced digestive enzyme activity, decreased local cytokine production, alterations in the gut-associated lymphoid tissues, and a depressed migrating motor complex [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Enteric bacteria perform a number of important salutary physiologic functions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Colonic bacterial disaccharidases salvage unabsorbed dietary sugars, by fermenting them to form fatty acids, which can be absorbed through the colonic mucosa and used as an energy source.",
"     </li>",
"     <li>",
"      Enteric bacteria produce nutrients and vitamins such as folate and vitamin K.",
"     </li>",
"     <li>",
"      Bacterial-enterocyte crosstalk via binding sites and toll-like receptors differentiate commensal and pathogenic bacteria as well as food antigens [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/8\">",
"       8",
"      </a>",
"      ]. In this way, nonpathogenic bacteria protect the host by mounting an immune response to disease causing bacteria and preventing an immune reaction to protein antigens in our diet (ie, oral tolerance).",
"     </li>",
"     <li>",
"      Numerous resident bacteria themselves may also produce chemicals or bacteriocins which kill or inhibit multiplication of other surrounding bacterial species [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bacterial metabolism of several medications within the intestinal lumen is essential for the drug's action. An example is the splitting of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/28/8647?source=see_link\">",
"       sulfasalazine",
"      </a>",
"      into 5-aminosalicylic acid (which is responsible for its antiinflammatory action) and sulfapyridine. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20344?source=see_link\">",
"       \"Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Mechanisms protecting against SIBO",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several host defense mechanisms prevent excessive colonization by bacteria:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antegrade peristalsis prevents attachment of ingested microorganisms.",
"     </li>",
"     <li>",
"      Gastric acid and bile destroy many microorganisms before they leave the stomach.",
"     </li>",
"     <li>",
"      Digestion by proteolytic enzymes helps destroy bacteria in the small intestine.",
"     </li>",
"     <li>",
"      The intestinal mucus layer traps bacteria.",
"     </li>",
"     <li>",
"      An intact ileocecal valve as well as the antegrade motility pattern of the ileum itself inhibits retrograde translocation of bacteria from the colon to the small bowel [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The immune system plays a role as evidenced by the high prevalence of SIBO in patients who have immunodeficiency.",
"     </li>",
"     <li>",
"      The largest fraction of immunoglobulins secreted in the human body is the secretory IgA originating in the gastrointestinal tract, which aids in preventing bacterial proliferation [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/11\">",
"       11",
"      </a>",
"      ]. Pathogenic bacteria may be able to dampen the local immune system hence disrupting normal gastrointestinal function [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disorders leading to the perturbation of the intestinal ecosystem permit the development of small intestinal bacterial overgrowth (SIBO) (",
"    <a class=\"graphic graphic_table graphicRef81285 \" href=\"UTD.htm?9/2/9260\">",
"     table 1",
"    </a>",
"    ). Gut flora is influenced by external factors such as diet, medications, geography, stress, lifestyle, and alcohol use [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/1\">",
"     1",
"    </a>",
"    ]. The frequency of predisposing conditions to SIBO is not well described. A preliminary series of 100 patients suggested that the most common disorders associated with SIBO were intestinal dysmotility syndromes and chronic pancreatitis, which accounted for more than 90 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/13\">",
"     13",
"    </a>",
"    ]. More recently, older age, steatorrhea, narcotic use, inflammatory bowel disease, small bowel diverticula, and pancreatitis have been shown to be associated with small intestinal bacterial overgrowth [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Short bowel syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cases of short bowel syndrome shortly after resection of the small bowel, the gut undergoes an adaptation response causing a deepening of the crypts and lengthening of the villi, increasing the absorptive surface area. As this process progresses, there is a tendency for the small bowel lumen to dilate also as a compensatory process. This also occurs if there is any stricture formation distally. Concurrently, transit through the small bowel is slowed via neuroendocrine factors, allowing for increased nutrient absorption [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/15\">",
"     15",
"    </a>",
"    ]. The combination of gut dilatation and slower transit increases the concentration of bacteria present in the small bowel per milliliter of fluid. Dilatation of the small bowel makes peristalsis less effective or ineffective at removing gut bacteria. It is not uncommon radiographically to see to and fro flux of gastrointestinal contents in a patient with short bowel syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Chronic pancreatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic pancreatitis, although not a common disease, is frequently associated with SIBO, which occurs in as many as 40 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/4\">",
"     4",
"    </a>",
"    ]. The cause is multifactorial, resulting from a decrease in intestinal motility from pain, inflammatory changes, obstruction, use of opiates, or previous pancreatic surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Intestinal fistula",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fistula or surgically-created connections between proximal and distal segments of the small bowel are also a risk factor for bacterial overgrowth, overcoming the protective mechanisms described above. SIBO is being increasingly recognized in patients with Crohn's disease, which may explain why some of these patients respond clinically to broad spectrum antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Immunodeficiency and hypochloryhydria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunodeficiency and hypochlorhydria may also be predisposing conditions, although the latter is not usually associated with clinical malabsorption unless coexisting with intestinal motility disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/16\">",
"     16",
"    </a>",
"    ]. In one study, SIBO was detected more frequently among patients receiving long-term proton pump inhibitor (PPI) treatment compared to healthy controls (60 versus 6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/17\">",
"     17",
"    </a>",
"    ]. If PPIs are used for a prolonged period of time, it appears that almost half will develop some type of gastrointestinal symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Advancing age is associated with the development of SIBO, possibly from a combination of these factors [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/6\">",
"     6",
"    </a>",
"    ]. SIBO in the elderly has been speculated to be relatively common and has been associated with malabsorptive side effects and a reduction in BMI [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Liver disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;SIBO is present in as many as 60 percent of patients with cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/20\">",
"     20",
"    </a>",
"    ] or nonalcoholic steatohepatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/21\">",
"     21",
"    </a>",
"    ]. Treatment of SIBO with antibiotics may improve liver injury [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/25/34197?source=see_link\">",
"     \"Pathogenesis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Miscellaneous conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other conditions have been associated with SIBO:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There have been numerous studies that have suggested an association of SIBO with irritable bowel syndrome (IBS) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/22-25\">",
"       22-25",
"      </a>",
"      ] and improvement with antibiotic and probiotic therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/26\">",
"       26",
"      </a>",
"      ]. More specifically, SIBO was shown to be present in patients with diarrhea predominant IBS of female gender and experiencing bloating as compared to healthy controls [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/27\">",
"       27",
"      </a>",
"      ]. Children experiencing chronic abdominal pain, often considered a precursor to IBS in adults, have also been found to have a significantly higher prevalence of small intestinal bacterial overgrowth [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      SIBO has been described in patients with cystic fibrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/29\">",
"       29",
"      </a>",
"      ], jejunal diverticulosis, celiac disease, scleroderma, and in situations of altered motility including gastroparesis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Obesity has been associated with SIBO. In one study SIBO was observed in 41 percent of obese patients. This may be due to abnormalities in gut flora and motility. Obese patients with SIBO demonstrate an increased pattern of clustered contractions on small bowel manometry compared to obese patients without SIBO [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/31\">",
"       31",
"      </a>",
"      ]. Interestingly, this same motility pattern has been noted in patients with short bowel syndrome as well [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     COMMONLY IDENTIFIED BACTERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small intestinal bacterial overgrowth (SIBO) is usually associated with abnormally high bacterial populations in the small intestine. The gold standard for the diagnosis of SIBO has traditionally been the demonstration of excessive bacterial concentrations in a jejunal aspirate, which can be performed during endoscopy or by fluoroscopy with jejunal intubation. Clinically significant SIBO is diagnosed when bacterial counts exceed 10",
"    <sup>",
"     5",
"    </sup>",
"    <span class=\"nowrap\">",
"     organisms/mL",
"    </span>",
"    (normal jejunal concentration is &le;10",
"    <sup>",
"     4",
"    </sup>",
"    <span class=\"nowrap\">",
"     organisms/mL).",
"    </span>",
"    Multiple organisms are typically present in varying numbers. Common species include Streptococci, Bacteroides, Escherichia, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Production of toxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;SIBO has been associated with the production of toxins that may have a systemic untoward effect. Several examples are clinically relevant:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Enteric bacteria degrade protein and urea to produce ammonia. Elevated levels of ammonia are associated with the development of encephalopathy in patients with hepatic impairment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4346?source=see_link\">",
"       \"Hepatic encephalopathy in adults: Treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      SIBO may be associated with the development of D-lactic acidosis [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/34\">",
"       34",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18723?source=see_link\">",
"       \"D-Lactic acidosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Gram-negative organisms can elaborate endotoxins which can activate multiple inflammatory cytokines that interfere with the function of hepatocyte membrane transporters leading to jaundice and liver injury [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/35\">",
"       35",
"      </a>",
"      ]. One such toxin may be bacterial peptidoglycans, which can interfere with portal circulation [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/36,37\">",
"       36,37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The causes of symptoms in patients with SIBO are directly related to these abnormalities.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The degradation of carbohydrates by enteric bacteria leads to the production of short-chain fatty acids (butyrate, propionate, acetate, lactate) as well as carbon dioxide, hydrogen, and methane, which may be associated with acidic stools, abdominal distension, and flatulence.",
"     </li>",
"     <li>",
"      Hydroxylated fatty acids (and free bile acids) stimulate the secretion of water and electrolytes leading to diarrhea.",
"     </li>",
"     <li>",
"      Malabsorption of vitamin B12 may result in anemia and neurologic disturbances.",
"     </li>",
"     <li>",
"      Fat malabsorption may lead to weight loss, steatorrhea, and deficiencies of fat soluble vitamins A, D, and K.",
"     </li>",
"     <li>",
"      Inflammation and toxin production may be an inappropriate or overaggressive reaction to absorbed bacterial antigens. Immune dysregulation may be evident, especially large joint arthritis, which often resembles that seen with inflammatory bowel disease.",
"     </li>",
"     <li>",
"      Bacterial overgrowth may disturb small bowel motility, causing nausea, anorexia, and bloating [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     EFFECTS ON INTESTINAL STRUCTURE AND FUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of excess numbers of bacteria in the small bowel does not identify whether or not the bacteria are doing any harm, a point that is often misunderstood. A certain amount of commensal bacteria is important but inflammation occurring in situations of overgrowth leads to the development of symptoms.",
"   </p>",
"   <p>",
"    The nonspecific inflammation that occurs with overgrowth is likely due to more invasive strains of bacteria, which result in a variety of epithelial changes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/12\">",
"     12",
"    </a>",
"    ]. Extensive biopsies of the small bowel may give the best indication of whether or not the bacteria present are actually harmful.",
"   </p>",
"   <p>",
"    In addition to inflammation, a subset of patients appears to develop visible small intestinal injury. A study involving patients with intestinal dysmotility and known SIBO who underwent wireless video capsule endoscopy showed an increase in the frequency of small intestinal erosions and ulcerations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;On light microscopy, the histologic appearance of the small intestine in SIBO is usually not significantly altered. In some cases, SIBO is associated with subtotal villus atrophy and increased cellularity in the lamina propria, which may be confused with celiac disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=see_link\">",
"     \"Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Focal areas of ulceration and erosions also may be seen. The degree of mucosal inflammation can vary from mild to severe. Epithelial cell injury and inflammation may ultimately impair absorptive function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Nutrient absorption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impaired absorption of nutrients in SIBO results from either maldigestion in the intestinal lumen, or from malabsorption at the level of the intestinal microvillus membrane due to enterocyte damage. Facultative anaerobes may injure the intestinal surface by direct adherence and production of enterotoxins. Aerobic bacteria produce enzymes and metabolic products that are also capable of inducing epithelial cell injury [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/42\">",
"     42",
"    </a>",
"    ]. Patients with irritable bowel syndrome and evidence of SIBO generally do not have signs or symptoms of nutrient malabsorption.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fat malabsorption results from bacterial deconjugation of bile acids and the toxic effect of free bile acids on the intestinal mucosa [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/43,44\">",
"       43,44",
"      </a>",
"      ]. At physiologic pH, bile acids are fully ionized, preventing their absorption in the proximal small intestine, and permitting sufficient concentrations for solubilization of dietary fat. On the other hand, deconjugated bile salts resulting from SIBO are reabsorbed by the jejunum, which may lead to insufficient concentrations for normal fat absorption. Bacterial deconjugation also leads to the production of lithocholic acid, which may be toxic to intestinal epithelium, resulting in impaired absorption of fat and other nutrients.",
"     </li>",
"     <li>",
"      Carbohydrate malabsorption results from the intraluminal degradation of sugars by enteric bacteria. In addition, enterocyte damage from the effect of bile acids or from the bacteria themselves may diminish enterocyte disaccharidase activity and may reduce the transport of monosaccharides [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Similarly, protein malabsorption probably results from decreased mucosal uptake of amino acids, and the intraluminal degradation of protein precursors by bacteria [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/1\">",
"       1",
"      </a>",
"      ]. SIBO also may be associated with a reversible form of protein-losing enteropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2136/abstract/45\">",
"       45",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/50/3881?source=see_link\">",
"       \"Protein-losing gastroenteropathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cobalamin (vitamin B12) malabsorption is commonly associated with SIBO. Although enteric bacteria synthesize cobalamin, they also successfully compete with the host for its absorption. Anaerobic organisms are primarily responsible. Only anaerobes are able to utilize vitamin B12 coupled to intrinsic factor, and their eradication is necessary to restore normal ileal absorption. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23782?source=see_link\">",
"       \"Physiology of vitamin B12 and folate deficiency\"",
"      </a>",
"      .) Treatment with antibiotics is one of the steps of the Schilling test, which evaluates the cause of a low serum level of vitamin B12. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=see_link\">",
"       \"Diagnosis and treatment of vitamin B12 and folate deficiency\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bacteria also synthesize",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    . Unlike cobalamin, however, folic acid is released into the small bowel lumen, where it can be absorbed. Thus, patients with SIBO rarely have folate deficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1296615353\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Small intestinal bacterial overgrowth (SIBO) is a condition in which non-native bacteria",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      native bacteria are present in increased numbers resulting in excessive fermentation, inflammation,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      malabsorption. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several host defense mechanisms prevent excessive colonization by bacteria. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Mechanisms protecting against SIBO'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      SIBO may occur in association with anatomical abnormalities (eg, diverticula, fistulae, surgical blind loop, ileocecal resections), motility disorders (eg, scleroderma, diabetes mellitus, post-radiation enteropathy, small intestinal pseudo-obstruction), or multifactorial causes (eg, acid suppression, hypochlorhydria, immunodeficiency) (",
"      <a class=\"graphic graphic_table graphicRef81285 \" href=\"UTD.htm?9/2/9260\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      SIBO has been associated with the production of toxins that may have systemic effects. In patients with hepatic impairment, degradation of protein and urea by enteric bacteria produces ammonia and results in the development of encephalopathy. SIBO may be associated with the development of D-lactic acidosis. Furthermore, gram-negative organisms can elaborate endotoxins which can activate multiple inflammatory cytokines leading to jaundice and liver injury. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Production of toxins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Carbohydrate malabsorption in SIBO results from the intraluminal degradation of sugars by enteric bacteria leading to the production of short-chain fatty acids, carbon dioxide, hydrogen, and methane, which may be associated with acidic stools, abdominal distension, and flatulence. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Nutrient absorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fat malabsorption results from bacterial deconjugation of bile acids and the toxic effect of free bile acids on the intestinal mucosa. Hydroxylated fatty acids (and free bile acids) stimulate the secretion of water and electrolytes leading to diarrhea. Fat malabsorption may lead to weight loss, steatorrhea, and deficiencies of fat soluble vitamins A, D, E, and K. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Nutrient absorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Protein malabsorption probably results from decreased mucosal uptake of amino acids, and the intraluminal degradation of protein precursors by bacteria. SIBO may also be associated with a reversible form of protein-losing enteropathy. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Nutrient absorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cobalamin (vitamin B12) malabsorption results from anaerobes which can utilize vitamin B12 coupled to intrinsic factor. Malabsorption of vitamin B12 may result in anemia and neurologic disturbances. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Nutrient absorption'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bacterial overgrowth may also disturb small bowel motility, causing nausea, anorexia, and bloating. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Colon'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11990?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical manifestations and diagnosis of small intestinal bacterial overgrowth\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inflammation and toxin production may result from an inappropriate or overaggressive reaction to absorbed bacterial antigens. This immune dysregulation may result in large joint arthritis resembling that seen with inflammatory bowel disease. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Production of toxins'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/1\">",
"      Sherman P, Lichtman S. Small bowel bacterial overgrowth syndrome. Dig Dis 1987; 5:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/2\">",
"      Eggesb&oslash; M, Moen B, Peddada S, et al. Development of gut microbiota in infants not exposed to medical interventions. APMIS 2011; 119:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/3\">",
"      Bengmark S. Econutrition and health maintenance--a new concept to prevent GI inflammation, ulceration and sepsis. Clin Nutr 1996; 15:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/4\">",
"      Gorbach SL, Nahas L, Lerner PI, Weinstein L. Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology 1967; 53:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/5\">",
"      Hao WL, Lee YK. Microflora of the gastrointestinal tract: a review. Methods Mol Biol 2004; 268:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/6\">",
"      Rolfe RD. Interactions among microorganisms of the indigenous intestinal flora and their influence on the host. Rev Infect Dis 1984; 6 Suppl 1:S73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/7\">",
"      Shanahan F. The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol 2002; 16:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/8\">",
"      Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A 2011; 108 Suppl 1:4607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/9\">",
"      Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol 2000; 95:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/10\">",
"      Phillips SF, Quigley EM, Kumar D, Kamath PS. Motility of the ileocolonic junction. Gut 1988; 29:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/11\">",
"      Riordan SM, McIver CJ, Wakefield D, et al. Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora. Am J Gastroenterol 2001; 96:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/12\">",
"      Jones RM, Neish AS. Recognition of bacterial pathogens and mucosal immunity. Cell Microbiol 2011; 13:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/13\">",
"      Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999; 69:1035S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/14\">",
"      Choung RS, Ruff KC, Malhotra A, et al. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther 2011; 33:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/15\">",
"      Healey KL, Bines JE, Thomas SL, et al. Morphological and functional changes in the colon after massive small bowel resection. J Pediatr Surg 2010; 45:1581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/16\">",
"      Salles N. Basic mechanisms of the aging gastrointestinal tract. Dig Dis 2007; 25:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/17\">",
"      Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2010; 8:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/18\">",
"      Compare D, Pica L, Rocco A, et al. Effects of long-term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest 2011; 41:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/19\">",
"      Williams C, McColl KE. Review article: proton pump inhibitors and bacterial overgrowth. Aliment Pharmacol Ther 2006; 23:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/20\">",
"      Ouwehand A, Isolauri E, Salminen S. The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr 2002; 41 Suppl 1:I32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/21\">",
"      K&ouml;hler H, McCormick BA, Walker WA. Bacterial-enterocyte crosstalk: cellular mechanisms in health and disease. J Pediatr Gastroenterol Nutr 2003; 36:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/22\">",
"      Posserud I, Stotzer PO, Bj&ouml;rnsson ES, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/23\">",
"      Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009; 7:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/24\">",
"      Quigley EM. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. J Dig Dis 2007; 8:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/25\">",
"      Reddymasu SC, Sostarich S, McCallum RW. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterol 2010; 10:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/26\">",
"      Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006; 130:S78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/27\">",
"      Sachdeva S, Rawat AK, Reddy RS, Puri AS. Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors. J Gastroenterol Hepatol 2011; 26 Suppl 3:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/28\">",
"      Collins BS, Lin HC. Chronic abdominal pain in children is associated with high prevalence of abnormal microbial fermentation. Dig Dis Sci 2010; 55:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/29\">",
"      Fridge JL, Conrad C, Gerson L, et al. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr 2007; 44:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/30\">",
"      Reddymasu SC, McCallum RW. Small intestinal bacterial overgrowth in gastroparesis: are there any predictors? J Clin Gastroenterol 2010; 44:e8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/31\">",
"      Madrid AM, Poniachik J, Quera R, Defilippi C. Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients. Dig Dis Sci 2011; 56:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/32\">",
"      Quigley EM, Thompson JS. Clustered motor activity--the dominant motor pattern in short bowel syndrome: an analysis of regional and temporal distribution. Transplant Proc 1994; 26:1451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/33\">",
"      Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999; 94:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/34\">",
"      Bongaerts GP, Tolboom JJ, Naber AH, et al. Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia. Microb Pathog 1997; 22:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/35\">",
"      MacFie J, O'Boyle C, Mitchell CJ, et al. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999; 45:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/36\">",
"      Lichtman SN, Keku J, Schwab JH, Sartor RB. Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect Immun 1991; 59:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/37\">",
"      O'Brien DP, Nelson LA, Kemp CJ, et al. Intestinal permeability and bacterial translocation are uncoupled after small bowel resection. J Pediatr Surg 2002; 37:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/38\">",
"      Justus PG, Fernandez A, Martin JL, et al. Altered myoelectric activity in the experimental blind loop syndrome. J Clin Invest 1983; 72:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/39\">",
"      Hoog CM, Lindberg G, Sjoqvist U. Findings in patients with chronic intestinal dysmotility investigated by capsule endoscopy. BMC Gastroenterol 2007; 7:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/40\">",
"      Giannella RA, Rout WR, Toskes PP. Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterology 1974; 67:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/41\">",
"      Toskes PP, Giannella RA, Jervis HR, et al. Small intestinal mucosal injury in the experimental blind loop syndrome. Light- and electron-microscopic and histochemical studies. Gastroenterology 1975; 68:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/42\">",
"      Kirsch M. Bacterial overgrowth. Am J Gastroenterol 1990; 85:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/43\">",
"      Shindo K, Machida M, Koide K, et al. Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepatogastroenterology 1998; 45:1643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/44\">",
"      Donaldson RM Jr. Role of enteric microorganisms in malabsorption. Fed Proc 1967; 26:1426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2136/abstract/45\">",
"      Su J, Smith MB, Rerknimitr R, Morrow D. Small intestine bacterial overgrowth presenting as protein-losing enteropathy. Dig Dis Sci 1998; 43:679.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4783 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-6ED53622C5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2136=[""].join("\n");
var outline_f2_5_2136=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1296615353\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INTESTINAL MICROFLORA IN HEALTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Stomach and proximal small bowel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Terminal ileum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Colon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Effects on small bowel function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Mechanisms protecting against SIBO",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Short bowel syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Chronic pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Intestinal fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Immunodeficiency and hypochloryhydria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Liver disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Miscellaneous conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      COMMONLY IDENTIFIED BACTERIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Production of toxins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      EFFECTS ON INTESTINAL STRUCTURE AND FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Nutrient absorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1296615353\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4783\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4783|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/2/9260\" title=\"table 1\">",
"      Disorders associated with bacterial overgrowth",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11990?source=related_link\">",
"      Clinical manifestations and diagnosis of small intestinal bacterial overgrowth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/18/18723?source=related_link\">",
"      D-Lactic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/0/5130?source=related_link\">",
"      Diagnosis and treatment of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4346?source=related_link\">",
"      Hepatic encephalopathy in adults: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/25/34197?source=related_link\">",
"      Pathogenesis of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=related_link\">",
"      Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23782?source=related_link\">",
"      Physiology of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/50/3881?source=related_link\">",
"      Protein-losing gastroenteropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20344?source=related_link\">",
"      Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28454?source=related_link\">",
"      Treatment of small intestinal bacterial overgrowth",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_5_2137="Ethanol intoxication in children: Clinical features, evaluation, and management";
var content_f2_5_2137=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ethanol intoxication in children: Clinical features, evaluation, and management",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/5/2137/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2137/contributors\">",
"     Carl R Baum, MD, FAAP, FACMT",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/5/2137/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2137/contributors\">",
"     Michele Burns Ewald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/5/2137/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2137/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/5/2137/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite its abuse potential, ethanol is broadly tolerated in a social context and is therefore ubiquitous in society. It is available in a multitude of alcoholic beverages, but also concentrated in household products (eg, vanilla extract, mouthwash, perfume, or cologne) (",
"    <a class=\"graphic graphic_table graphicRef69276 \" href=\"UTD.htm?5/26/5548\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Exploratory ethanol ingestion by children less than six years of age typically results in minor symptoms. However, infants and young children are prone to profound hypoglycemia, coma, and hypothermia despite ingesting relatively small amounts of ethanol. Deaths have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Binge drinking and other forms of ethanol abuse are common problems in preteens and adolescents. Toxicity and treatment generally follow that recommended in adults. Comorbidities include motor vehicle crashes, physical assault, sexual assault, and mental illness.",
"   </p>",
"   <p>",
"    Supportive care is the mainstay of managing ethanol intoxication in children. Treatment of respiratory depression, hypoglycemia, hypovolemia, and hypothermia are the key interventions to ensure good outcomes.",
"   </p>",
"   <p>",
"    The evaluation and management of ethanol intoxication in children is discussed in this review. Epidemiology, pharmacokinetics, estimation of toxicity, and toxic effects seen in pediatric ethanol exposure are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link\">",
"     \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rapid overview provides an approach to ethanol intoxication in children (",
"    <a class=\"graphic graphic_table graphicRef76987 \" href=\"UTD.htm?33/51/34620\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to rapidly determine if the \"alcohol\" ingestion is ethanol or one of the toxic alcohols (eg, methanol, ethylene glycol). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/3/4154?source=see_link\">",
"     \"Methanol and ethylene glycol poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infants or young children who have ingested enough ethanol to cause a peak serum level &ge;50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (11",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    are at risk for profound hypoglycemia and require emergent evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H11#H11\">",
"     \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Estimation of serum ethanol'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other information should include the specific ethanol-containing substance, amount ingested, time of ingestion, and any coingestions. If the volume and concentration of ethanol ingested is known, then the blood ethanol level and degree of toxicity can be estimated (",
"    <a class=\"graphic graphic_table graphicRef69276 \" href=\"UTD.htm?5/26/5548\">",
"     table 1",
"    </a>",
"    ) (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?11/29/11730?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H9#H9\">",
"     \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Estimation of toxicity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Witnesses of the ingestion and emergency medical services (EMS) personnel who may have recovered containers at the scene should be interviewed. In addition, caretakers should be questioned regarding medications in the house. The patient's or caretaker's pharmacy may provide valuable information regarding prescribed medications, the date of the most recent refill, and the total number of pills dispensed.",
"   </p>",
"   <p>",
"    Parents of intoxicated toddlers should be asked about ethanol-containing beverages or household products that may have been transferred from or left unsecured in their original containers. Common scenarios include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The early-rising toddler who discovers and drinks abandoned alcoholic beverages the morning after a party",
"     </li>",
"     <li>",
"      The young child who drinks mouthwash in an attempt to imitate an adult's gargling",
"     </li>",
"     <li>",
"      The child who ingests a small amount of perfume or cologne",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Older intoxicated children and adolescents often binge drink in a social setting that is outside of adult supervision (eg, parties, rock concerts). Key concerns include coingestion or exposure to other drugs, coexistence of trauma (particularly head trauma), and sexual assault. Often, EMS reports regarding the patient's environment or state of undress can assist in identifying physical or sexual assault.",
"   </p>",
"   <p>",
"    Children and adolescents with depression or other mental illness are at high risk for intoxication. In some instances, ethanol may be ingested as part of a suicide attempt. In these circumstances, further mental health evaluation is indicated after the child recovers from intoxication.",
"   </p>",
"   <p>",
"    Ethanol poisoning in infants less than one year of age raises the concern of intentional ethanol administration or serious neglect by a caretaker and warrants involvement of social services [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Coingested sedative-hypnotic agents (eg, benzodiazepines, barbiturates, opioids, gamma hydroxybutyrate [GHB]) markedly increase the risk of deep coma with respiratory failure after ethanol ingestion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to other sedative-hypnotics, ethanol intoxication commonly manifests as altered behavior, lethargy, coma, ataxia, slurred speech, hypothermia, bradycardia, hypotension, and respiratory depression (",
"    <a class=\"graphic graphic_table graphicRef71268 \" href=\"UTD.htm?43/6/44140\">",
"     table 3",
"    </a>",
"    ). A characteristic sickly sweet breath odor is often prominent. Degree of lethargy is highly correlated with blood ethanol level in older children and adolescents (",
"    <a class=\"graphic graphic_table graphicRef64642 \" href=\"UTD.htm?11/53/12123\">",
"     table 4",
"    </a>",
"    ). Other important features include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Seizures caused by hypoglycemia (especially infants and young children). Ethanol intoxication typically masks the tachycardia, dilated pupils, and diaphoresis commonly associated with hypoglycemia [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H17#H17\">",
"       \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Ethanol-induced hypoglycemia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nystagmus with variable pupil size on eye examination [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/5\">",
"       5",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Signs of hypovolemic dehydration due to vomiting and polyuria",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All patients warrant complete physical examination to identify associated injuries, especially head trauma, and findings that are the result of abuse, neglect, or physical or sexual assault. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=see_link\">",
"     \"Orthopedic aspects of child abuse\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20602?source=see_link\">",
"     \"Child abuse: Eye findings in children with abusive head trauma (AHT)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20601?source=see_link\">",
"     \"Evaluation and management of adult sexual assault victims\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4250?source=see_link&amp;anchor=H7#H7\">",
"     \"Initial approach to severe traumatic brain injury in children\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Older children and adolescents may show signs of depression or other mental illness once their mental status allows for detailed psychiatric assessment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5289?source=see_link\">",
"     \"Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13779168\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history of ingestion from the caregiver or patient and characteristic physical findings, such as sickly sweet breath odor, altered mental status, and nystagmus with lateral gaze typically are sufficient to establish the diagnosis of ethanol intoxication. Detection of ethanol on the breath or in the serum provides additional confirmation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are many causes of coma that deserve consideration when evaluating the patient with suspected ethanol intoxication (",
"    <a class=\"graphic graphic_table graphicRef65571 \" href=\"UTD.htm?39/19/40254\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Other than toxins, isolated or concomitant hypoglycemia or traumatic brain injury is the most likely cause of abrupt onset of lethargy of coma in children or adolescents. All children and adolescents with altered mental status should undergo measurement of rapid blood glucose and assessment for external signs of head trauma. In patients for whom traumatic brain injury is a strong possibility based upon clinical findings, computed tomography of the head may be warranted. Asymmetric structural lesions (eg, brain tumor, focal hemorrhage, or infection) are typically identified by focal findings on a careful neurologic examination followed by appropriate neuroimaging. Symmetrical structural lesions often have accompanying signs of increased intracranial pressure, especially headache. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28136?source=see_link\">",
"     \"Evaluation of stupor and coma in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4250?source=see_link&amp;anchor=H13#H13\">",
"     \"Initial approach to severe traumatic brain injury in children\", section on 'Imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among toxic agents that may cause coma, other toxic alcohols (isopropyl alcohol, methanol), although chemically distinct, may mimic ethanol's toxic effects. Methanol and ethylene glycol, in particular, are important agents to consider since they have great toxic potential and frequently require antidotal therapy. They differ from ethanol in their delayed onset of toxic symptoms and inducement of profound metabolic acidosis. In addition, ethanol may mask coingestion of other toxic alcohols. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/3/4154?source=see_link\">",
"     \"Methanol and ethylene glycol poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The combination of central nervous system depression and respiratory depression closely resembles the toxic syndrome seen with opioid intoxication (",
"    <a class=\"graphic graphic_table graphicRef71268 \" href=\"UTD.htm?43/6/44140\">",
"     table 3",
"    </a>",
"    ). Many other sedative-hypnotic and psychoactive agents may also produce somnolence and respiratory depression and are often coingested with ethanol recreationally or with suicidal intent, especially in adolescents. Thus, even when serum or breath levels confirm ethanol ingestion, the possibility of sedative-hypnotic or opioid intoxication coingestion remains. An isolated ethanol overdose rarely causes profound respiratory depression requiring invasive airway management or cardiopulmonary instability. In such cases, the presence of coingestants should be investigated. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Other studies'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     naloxone",
"    </a>",
"    reverses the effects of opioid intoxication but will have no effect on central nervous system depression caused by ethanol or other sedative-hypnotic agents. However, naloxone may alleviate respiratory depression enough in patients with concomitant ethanol and opioid intoxication so that endotracheal intubation and mechanical ventilation can be avoided. Patients who respond to naloxone warrant close monitoring of respiratory status and frequently require redosing (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=see_link&amp;anchor=H27#H27\">",
"     \"Opioid intoxication in children and adolescents\", section on 'Naloxone'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Sedative-hypnotic intoxication is virtually indistinguishable clinically from ethanol intoxication. Rapid immunoassay screening of the urine can identify benzodiazepines and barbiturates, but a negative screen does not exclude exposure to benzodiazepines. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11080?source=see_link&amp;anchor=H9#H9\">",
"     \"Benzodiazepine poisoning and withdrawal\", section on 'Testing for benzodiazepine toxicity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Gamma hydroxybutyrate (GHB), an illicit sedative-hypnotic that is often ingested recreationally at dance clubs and has also been implicated in date rape, can cause psychomotor agitation and profound coma of short duration (several hours). GHB is commonly coingested with ethanol and is not detected on rapid immunoassay urine toxicology screens, although it can be detected in the urine by gas chromatography and mass spectrometry. Effects from GHB are not reversed by",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     naloxone",
"    </a>",
"    . Thus, diagnosis of GHB intoxication is primarily made by history or characteristic clinical findings of agitation prior to, following, or in abrupt alternation with coma of short duration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/25/31130?source=see_link&amp;anchor=H17#H17\">",
"     \"Gamma hydroxybutyrate (GHB) intoxication\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/25/31130?source=see_link&amp;anchor=H21#H21\">",
"     \"Gamma hydroxybutyrate (GHB) intoxication\", section on 'Laboratory evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diabetic ketoacidosis may be mistaken for ethanol intoxication because of the presence of ketones on the breath. However, it is easily differentiated from ethanol poisoning by the typical history of polyuria, polydipsia, and polyphagia in patients with new-onset diabetes mellitus or past medical history of diabetes mellitus in combination with laboratory findings of hyperglycemia and metabolic acidosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/32/41480?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical features and diagnosis of diabetic ketoacidosis in children\", section on 'Diagnostic evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Meningitis and encephalitis can also present with altered mental status but are usually accompanied by fever and other signs of infection that help distinguish these entities from ethanol intoxication. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21769?source=see_link&amp;anchor=H2#H2\">",
"     \"Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13779127\">",
"    <span class=\"h2\">",
"     Blood glucose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid measurement of blood glucose should be performed in all patients, especially infants and young children, with altered mental status after ethanol ingestion.",
"   </p>",
"   <p>",
"    If low, blood glucose should be corrected and then serially monitored, particularly in cases of younger children or others with limited glycogen stores who may be at risk for recurrent hypoglycemia. The specific clinical scenario, such as the time since ingestion and the age of the child, should determine the frequency of blood-glucose determinations, but these should be obtained until the patient demonstrates a pattern of stable blood sugars with normal oral glucose intake. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8201?source=see_link\">",
"     \"Approach to hypoglycemia in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Ethanol level",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of serum ethanol is an essential diagnostic step when evaluating symptomatic infants and young children after ethanol exposure. In adolescents with moderate to severe intoxication, who have only ingested ethanol, the level can help estimate duration of symptoms. In addition, degree of lethargy is highly correlated with blood ethanol level in older children and adolescents (",
"    <a class=\"graphic graphic_table graphicRef64642 \" href=\"UTD.htm?11/53/12123\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H7#H7\">",
"     \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Duration of symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Asymptomatic patients over two years of age or minimally symptomatic adolescents do not usually require serum ethanol levels.",
"   </p>",
"   <p>",
"    Quantitative and qualitative testing for ethanol is readily available in most hospitals. Headspace gas chromatography may be used to measure blood or serum ethanol. An enzymatic oxidation method also exists to measure serum ethanol levels. Most hospital laboratories use serum to perform the \"blood\" ethanol test. The serum-to-blood ethanol ratio varies from 1.12 to 1.18 depending upon ethanol concentration in the blood specimen [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serum ethanol levels are routine chemistry studies in most hospitals and identify ethanol exposure in the infant, young child, and obtunded or otherwise uncooperative older patient.",
"     </li>",
"     <li>",
"      Breath-alcohol meters rely on a relatively fixed partitioning",
"      <span class=\"nowrap\">",
"       (~1/2100)",
"      </span>",
"      of ethanol between alveolar air and blood and provide an estimate of blood ethanol concentration at the bedside in the cooperative older child [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/7\">",
"       7",
"      </a>",
"      ]. A confirmatory blood ethanol, submitted to a hospital or reference laboratory, may be warranted as well, particularly if there are medical-legal issues surrounding the intoxication.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Further laboratory evaluation of ethanol intoxication varies depending upon the circumstances of exposure. Other ancillary studies may be indicated in selected patients in whom ingestion of other toxic agents, trauma, child abuse, or sexual assault are suspected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28136?source=see_link\">",
"     \"Evaluation of stupor and coma in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=see_link\">",
"     \"Approach to the child with occult toxic exposure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=see_link\">",
"     \"Trauma management: Approach to the unstable child\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20601?source=see_link\">",
"     \"Evaluation and management of adult sexual assault victims\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other potentially helpful studies following ethanol ingestion include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serum electrolyte determinations assess for electrolyte disturbance and allow for calculation of the anion gap in the setting of likely coingestants or evidence for metabolic acidosis. In addition, electrolytes may be altered by protracted vomiting and hypovolemia associated with acute ingestion. Associated laboratory findings may include hypokalemia and metabolic acidosis.",
"     </li>",
"     <li>",
"      Arterial or venous blood gas measurement combined with pulse oximetry determines adequacy of ventilation in patients with serious and persistent respiratory depression and characterizes acid-base disturbance after ethanol ingestion",
"     </li>",
"     <li>",
"      Plasma osmolality, if coingestion of toxic alcohols is suspected (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/3/4154?source=see_link&amp;anchor=H15#H15\">",
"       \"Methanol and ethylene glycol poisoning\", section on 'Plasma osmolal gap'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Serum",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"       acetaminophen",
"      </a>",
"      level in patients who ingest ethanol with suicidal intent",
"     </li>",
"     <li>",
"      Chest radiography, if the history or exam suggests the possibility of pulmonary aspiration",
"     </li>",
"     <li>",
"      Computed tomography of the head in patients with clinical findings suggestive of significant head trauma",
"     </li>",
"     <li>",
"      Rapid urine drugs of abuse screen in older children and adolescents with significant signs of intoxication and in young children for whom intentional ethanol administration by the caretaker is suspected",
"     </li>",
"     <li>",
"      Rapid urine pregnancy test in postmenarchal women",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rapid overview provides an approach to ethanol intoxication in children (",
"    <a class=\"graphic graphic_table graphicRef76987 \" href=\"UTD.htm?33/51/34620\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Supportive care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supportive care is the mainstay of managing ethanol intoxication in children. Treatment of respiratory depression, hypoglycemia, hypovolemia, and hypothermia are the key interventions to ensure good outcomes. Unlike adults, children rarely need thiamine supplementation during treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20694?source=see_link\">",
"     \"Ethanol intoxication in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management begins with assessment and stabilization of the airway, breathing, and circulation. The ethanol-intoxicated patient should be attached to monitors with cardiorespiratory and oxygen-saturation tracings.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basic airway interventions such as supplemental oxygen (via \"blow-by,\" nasal cannula, or face mask) and nasopharyngeal airway usually suffice to maintain normal oxygen saturation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=see_link\">",
"       \"Basic airway management in children\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In patients requiring more than basic airway interventions to maintain the airway and breathing, administration of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      reverses the effects of possible opioid intoxication and empiric trial is warranted. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Antidotes'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      However, the emergency provider should proceed with endotracheal intubation and mechanical ventilation if naloxone is ineffective and if significant respiratory compromise or risk of pulmonary aspiration (eg, coma with absent gag reflex) persists (",
"      <a class=\"graphic graphic_table graphicRef51456 \" href=\"UTD.htm?17/26/17837\">",
"       table 6",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"       \"Emergent endotracheal intubation in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Intravenous access should be obtained in patients with altered mental status and rapid blood glucose level determined. Blood should also be sent for ethanol concentration. Other laboratory studies should be obtained as clinically indicated. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Other studies'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8057?source=see_link\">",
"       \"Vascular (venous) access for pediatric resuscitation and other pediatric emergencies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If seizures occur, airway and breathing should be supported, and evaluation for and treatment of possible hypoglycemia or traumatic injury should be high priorities. Seizures should be treated as outlined in the table with support of airway and breathing followed by administration of benzodiazepines (",
"      <a class=\"graphic graphic_table graphicRef55368 \" href=\"UTD.htm?29/20/30029\">",
"       table 7",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=see_link\">",
"       \"Management of status epilepticus in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypoglycemic patients should receive a rapid intravenous bolus of dextrose (0.25",
"      <span class=\"nowrap\">",
"       g/kg)",
"      </span>",
"      followed by a continuous infusion of dextrose (eg, D5W or D10W with",
"      <span class=\"nowrap\">",
"       1/4",
"      </span>",
"      or",
"      <span class=\"nowrap\">",
"       1/2",
"      </span>",
"      normal saline, depending upon sodium maintenance requirements) adequate to maintain serum glucose above 60",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (3.33",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8201?source=see_link\">",
"       \"Approach to hypoglycemia in infants and children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/20/6470?source=see_link&amp;anchor=H9#H9\">",
"       \"Maintenance fluid therapy in children\", section on 'Maintenance electrolyte needs'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Isotonic intravenous fluids (normal saline or lactated Ringer's) should be administered to correct hypovolemia. Potassium-containing solutions may also be needed to treat hypokalemia in the context of frequent vomiting. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=see_link\">",
"       \"Hypovolemic shock in children: Initial evaluation and management\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/2/9258?source=see_link\">",
"       \"Clinical manifestations and treatment of hypokalemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Attention should be paid to temperature, particularly in younger patients and those exposed to cool environments prior to arrival. Hypothermic patients merit active external warming with radiant heat, heat lamps, or warm blankets.",
"     </li>",
"     <li>",
"      Intoxicated patients with prolonged exposure to cold temperatures may develop profound hypothermia and frostbite involving the nose, ears, and extremities. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16056?source=see_link&amp;anchor=H11#H11\">",
"       \"Clinical manifestations of hypothermia in children\", section on 'Clinical manifestations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37671?source=see_link\">",
"       \"Frostbite\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     GI decontamination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because ethanol is rapidly absorbed, often induces vomiting, and does not bind to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/47/33525?source=see_link\">",
"     activated charcoal",
"    </a>",
"    , gastric emptying (eg, gastric lavage, syrup of ipecac administration) or gastrointestinal decontamination (administration of activated charcoal [AC]) do not prevent or lessen ethanol intoxication and pose a small but definite risk of pulmonary aspiration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H5#H5\">",
"     \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Pharmacokinetics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Multiple trials have shown minimal benefit and possible risk of pulmonary aspiration with progression to respiratory distress syndrome in patients undergoing gastric emptying after poisoning with many different agents, including ethanol. Thus, we recommend that children or adolescents with isolated ethanol intoxication not undergo gastric emptying procedures [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=see_link&amp;anchor=H9#H9\">",
"       \"Decontamination of poisoned children\", section on 'Gastric lavage'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=see_link&amp;anchor=H3#H3\">",
"       \"Decontamination of poisoned children\", section on 'Syrup of ipecac'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/47/33525?source=see_link\">",
"       Activated charcoal",
"      </a>",
"      cannot adsorb ethanol and should not be given after isolated ethanol ingestion. In patients who have ingested other substances, AC may be administered if the time from ingestion is less than one hour and if the benefit of AC for the treatment of the coingestants is expected to exceed the potential harm from aspiration. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=see_link&amp;anchor=H10032467#H10032467\">",
"       \"Decontamination of poisoned children\", section on 'Activated charcoal'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Antidotes",
"    </span>",
"    &nbsp;&mdash;&nbsp;No specific antidotes are available for treatment of ethanol intoxication. Dextrose-containing intravenous fluids may be necessary for documented and recurrent hypoglycemia, particularly for infants and younger children with limited glycogen stores and ethanol-induced inhibition of gluconeogenesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8201?source=see_link\">",
"     \"Approach to hypoglycemia in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H17#H17\">",
"     \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Ethanol-induced hypoglycemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"     Naloxone",
"    </a>",
"    administration is warranted for children and adolescents with marked coma and respiratory depression as empiric treatment for possible opioid poisoning. Although naloxone will have no effect on central nervous system depression caused by ethanol or other sedative-hypnotic agents, it may alleviate respiratory depression enough in patients with concomitant ethanol and opioid intoxication so that endotracheal intubation and mechanical ventilation can be avoided. Patients who respond to naloxone warrant close monitoring of respiratory status and frequently require redosing (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=see_link&amp;anchor=H8#H8\">",
"     \"Approach to the child with occult toxic exposure\", section on 'Altered mental status'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=see_link&amp;anchor=H27#H27\">",
"     \"Opioid intoxication in children and adolescents\", section on 'Naloxone'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Extracorporeal removal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe ethanol intoxication may require a prolonged period of supportive care. Elimination of ethanol occurs three to four times faster with hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/8\">",
"     8",
"    </a>",
"    ]. However, improvement in clinical outcome following hemodialysis for ethanol intoxication has not been demonstrated. Possible candidates for hemodialysis include patients with liver disease that significantly decreases ethanol metabolism or those with blood ethanol levels greater than 450",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (100",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Child protection",
"    </span>",
"    &nbsp;&mdash;&nbsp;A suspicion of intentional administration of ethanol to a child warrants involvement of an experienced child protection team (eg, social worker, nurse, physician with more extensive experience in the management of child abuse), if available. In many parts of the world (including the US, UK, and Australia), a mandatory report to appropriate governmental authorities is also required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=see_link&amp;anchor=H3#H3\">",
"     \"Child abuse: Social and medicolegal issues\", section on 'Reporting suspected abuse'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, computed tomography of the head, funduscopic examination by an ophthalmologist to assess for retinal hemorrhages, and skeletal survey may be warranted once the patient's clinical status is stabilized. The safety of other children in the home must be ensured by local Child Protective Services. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20602?source=see_link\">",
"     \"Child abuse: Eye findings in children with abusive head trauma (AHT)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Disposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Further management depends upon presence of symptoms and circumstances surrounding the ingestion and is based on small observational studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Symptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;All children displaying major signs of ethanol intoxication (eg, coma, respiratory depression, and hypoglycemia) require hospital observation or admission. These patients typically fully recover within 12 to 24 hours.",
"   </p>",
"   <p>",
"    Older children and adolescents with initial signs of inebriation who rapidly return to normal mental status within four to six hours and who are not suicidal may be discharged into the care of a competent adult.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Asymptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend that asymptomatic infants and young children with an ethanol ingestion sufficient in volume to produce a peak serum level greater than 50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (11",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    undergo rapid blood glucose testing (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?11/29/11730?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). Based upon the pharmacokinetics of ethanol and typical timing of hypoglycemia after its ingestion, these patients should be observed in a medical facility until six hours after ingestion and have at least one repeated rapid blood glucose measurement prior to discharge. Estimation of the ethanol volume that is ingested can be difficult. Thus, some clinicians may choose to evaluate all asymptomatic young children with ethanol exposure in this manner regardless of the reported amount.(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H11#H11\">",
"     \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Estimation of serum ethanol'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Initially asymptomatic patients who manifest altered mental status or hypoglycemia at any point during observation warrant inpatient admission [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H17#H17\">",
"     \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Ethanol-induced hypoglycemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children who remain asymptomatic for six hours after a limited exposure to ethanol may be discharged home as long as close observation in a stable social setting and ability to rapidly return for medical care, if needed, are assured.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Suicidal overdose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who ingest ethanol with intent of self-harm should undergo mental health evaluation, measurement of serum",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"     acetaminophen",
"    </a>",
"    levels, and careful evaluation for other coingestants. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Patients should be evaluated by the mental health provider before discharge from medical care. Psychiatric evaluation should be deferred in symptomatic patients until after they have recovered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=see_link\">",
"     \"Approach to the child with occult toxic exposure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most ethanol exposures in young children involve small amounts of household products (eg, perfumes, colognes) and do not result in significant toxicity. In the US, many of these ingestions are observed at home with phone advice provided by experienced poison specialists when the expected peak ethanol level is &lt;50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (11",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/9\">",
"     9",
"    </a>",
"    ]. Life-threatening ethanol intoxication is unusual. Delay in seeking care with prolonged hypoglycemia is a prominent feature of the rare lethal cases of ethanol intoxication in young children [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2137/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H11#H11\">",
"     \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Estimation of serum ethanol'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H11\">",
"     'Supportive care'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The intoxicated older child and adolescent typically do well with proper airway support and intravenous hydration, as needed. However, these patients are at heightened risk for major trauma, sexual assault, and significant mental illness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H2#H2\">",
"     \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Epidemiology'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H11\">",
"     'Supportive care'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The clinician should rapidly determine if the \"alcohol\" ingestion is ethanol or one of the toxic alcohols (eg, methanol, ethylene glycol). If isolated ethanol ingestions is confirmed, the clinician should establish whether infants or young children have ingested enough ethanol to cause a peak serum level &ge;50",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (11",
"      <span class=\"nowrap\">",
"       mmol/L),",
"      </span>",
"      the level at which profound hypoglycemia may occur. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H11#H11\">",
"       \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Estimation of serum ethanol'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/3/4154?source=see_link\">",
"       \"Methanol and ethylene glycol poisoning\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ethanol intoxication commonly manifests as lethargy, coma, ataxia, slurred speech, hypothermia, bradycardia, hypotension, and respiratory depression (",
"      <a class=\"graphic graphic_table graphicRef71268 \" href=\"UTD.htm?43/6/44140\">",
"       table 3",
"      </a>",
"      ). A characteristic sickly sweet breath odor is often prominent. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Physical examination'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other important features of ethanol intoxication include seizures caused by hypoglycemia (especially in infants and young children) and signs of hypovolemic dehydration due to vomiting and polyuria. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=see_link&amp;anchor=H17#H17\">",
"       \"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects\", section on 'Ethanol-induced hypoglycemia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A history of ingestion from the caregiver or patient and characteristic physical findings, typically are sufficient to establish the diagnosis of ethanol intoxication. Detection of ethanol on the breath or in the serum provides additional confirmation and helps differentiate ethanol intoxication from other causes of altered mental status. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Evaluation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other than poisoning, isolated or concomitant hypoglycemia or traumatic brain injury is the most likely cause of abrupt onset of lethargy of coma in children or adolescents. All children and adolescents with altered mental status should undergo measurement of rapid blood glucose and assessment for external signs of head trauma. In patients for whom traumatic brain injury is a strong possibility based upon clinical findings, computed tomography of the head may be warranted. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many other sedative-hypnotic and psychoactive agents may also produce somnolence and respiratory depression and are often coingested with ethanol recreationally or with suicidal intent, especially in adolescents. Thus, even when ethanol ingestion is confirmed by serum or breath levels, the possibility of sedative-hypnotic or opioid intoxication coingestion remains. An isolated ethanol overdose rarely causes profound respiratory depression requiring invasive airway management or cardiopulmonary instability. In such cases, the presence of coingestants should be investigated and an empiric trial of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/4/20551?source=see_link\">",
"       naloxone",
"      </a>",
"      is warranted. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Antidotes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Supportive care is the mainstay of managing ethanol intoxication in children. Treatment of respiratory depression, hypoglycemia, hypovolemia, and hypothermia are the key interventions to ensure good outcomes. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Supportive care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that children or adolescents who ingest ethanol",
"      <strong>",
"       not",
"      </strong>",
"      undergo gastric emptying procedures (gastric lavage or administration of syrup of ipecac) (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). In addition activated charcoal (AC) should not be administered to children who only ingest only ethanol. The decision to administer AC to patients who congest other substances depends upon the time since ingestion and potential efficacy of AC for the specific toxic agent ingested. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'GI decontamination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All children displaying major signs of ethanol intoxication (eg, coma, respiratory depression, and hypoglycemia) require hospital observation or admission. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Symptomatic patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that asymptomatic infants and young children with an ethanol ingestion sufficient in volume to produce a peak serum level greater than 50",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (11",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      undergo rapid blood glucose testing (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?11/29/11730?source=see_link\">",
"       calculator 1",
"      </a>",
"      ). Based upon the pharmacokinetics of ethanol and typical timing of hypoglycemia after its ingestion, these patients should also be observed in a medical facility until six hours after ingestion and have at least one repeated rapid blood glucose measurement prior to discharge. Estimation of the ethanol volume that is ingested can be difficult. Thus, some clinicians may choose to evaluate all asymptomatic young children with ethanol exposure in this manner regardless of the reported amount. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Asymptomatic patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children who are asymptomatic for six hours after a limited exposure to ethanol may be discharged home as long as close observation in a stable social setting and ability to rapidly return for medical care, if needed, are assured. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Asymptomatic patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who ingest ethanol with intent of self-harm should undergo mental health evaluation, measurement of serum",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"       acetaminophen",
"      </a>",
"      levels, and careful evaluation for other coingestants. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Suicidal overdose'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2137/abstract/1\">",
"      Dine MS, McGovern ME. Intentional poisoning of children--an overlooked category of child abuse: report of seven cases and review of the literature. Pediatrics 1982; 70:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2137/abstract/2\">",
"      Vale JA. Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:711.",
"     </a>",
"    </li>",
"    <li>",
"     Osterhoudt KC, Burns Ewald M, Shannon M, Henretig FM. Toxicologic emergencies. In: Textbook of Pediatric Emergency Medicine, 6th, Fleisher GR, Ludwig S, Henretig FM.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.965.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2137/abstract/4\">",
"      Ricci LR, Hoffman SA. Ethanol-induced hypoglycemic coma in a child. Ann Emerg Med 1982; 11:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2137/abstract/5\">",
"      Nawrot M, Nordenstrom B, Olson A. Disruption of eye movements by ethanol intoxication affects perception of depth from motion parallax. Psychol Sci 2004; 15:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2137/abstract/6\">",
"      Barnhill MT Jr, Herbert D, Wells DJ Jr. Comparison of hospital laboratory serum alcohol levels obtained by an enzymatic method with whole blood levels forensically determined by gas chromatography. J Anal Toxicol 2007; 31:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2137/abstract/7\">",
"      Hlastala MP. The alcohol breath test--a review. J Appl Physiol 1998; 84:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2137/abstract/8\">",
"      Morgan DL, Durso MH, Rich BK, Kurt TL. Severe ethanol intoxication in an adolescent. Am J Emerg Med 1995; 13:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2137/abstract/9\">",
"      Vogel C, Caraccio T, Mofenson H, Hart S. Alcohol intoxication in young children. J Toxicol Clin Toxicol 1995; 33:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2137/abstract/10\">",
"      Selbst SM, DeMaio JG, Boenning D. Mouthwash poisoning. Report of a fatal case. Clin Pediatr (Phila) 1985; 24:162.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6487 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-190.102.30.19-126470AF74-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2137=[""].join("\n");
var outline_f2_5_2137=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13779168\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13779127\">",
"      Blood glucose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Ethanol level",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Supportive care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      GI decontamination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Antidotes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Extracorporeal removal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Child protection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Disposition",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Symptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Asymptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Suicidal overdose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6487\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6487|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/26/5548\" title=\"table 1\">",
"      Ethanol content in beverages and other products",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/51/34620\" title=\"table 2\">",
"      Ethanol intoxication in children - Rapid overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/6/44140\" title=\"table 3\">",
"      Poisoning syndromes - toxidromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/53/12123\" title=\"table 4\">",
"      Clinical effects of blood alcohol concentration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/19/40254\" title=\"table 5\">",
"      Causes of coma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/26/17837\" title=\"table 6\">",
"      Rapid overview of rapid sequence intubation in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/20/30029\" title=\"table 7\">",
"      Management of status epilepticus in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?11/29/11730?source=related_link\" title=\"calculator 1\">",
"      Calculator: Blood ethanol concentration estimation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21769?source=related_link\">",
"      Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8201?source=related_link\">",
"      Approach to hypoglycemia in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22474?source=related_link\">",
"      Approach to the child with occult toxic exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=related_link\">",
"      Basic airway management in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11080?source=related_link\">",
"      Benzodiazepine poisoning and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20602?source=related_link\">",
"      Child abuse: Eye findings in children with abusive head trauma (AHT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=related_link\">",
"      Child abuse: Social and medicolegal issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/32/41480?source=related_link\">",
"      Clinical features and diagnosis of diabetic ketoacidosis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/2/9258?source=related_link\">",
"      Clinical manifestations and treatment of hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/43/16056?source=related_link\">",
"      Clinical manifestations of hypothermia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37913?source=related_link\">",
"      Decontamination of poisoned children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5289?source=related_link\">",
"      Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=related_link\">",
"      Emergent endotracheal intubation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20694?source=related_link\">",
"      Ethanol intoxication in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/5/23639?source=related_link\">",
"      Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20601?source=related_link\">",
"      Evaluation and management of adult sexual assault victims",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/30/28136?source=related_link\">",
"      Evaluation of stupor and coma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37671?source=related_link\">",
"      Frostbite",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/25/31130?source=related_link\">",
"      Gamma hydroxybutyrate (GHB) intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=related_link\">",
"      General approach to drug poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/59/41912?source=related_link\">",
"      Hypovolemic shock in children: Initial evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/9/4250?source=related_link\">",
"      Initial approach to severe traumatic brain injury in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/20/6470?source=related_link\">",
"      Maintenance fluid therapy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/50/30505?source=related_link\">",
"      Management of status epilepticus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/3/4154?source=related_link\">",
"      Methanol and ethylene glycol poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=related_link\">",
"      Opioid intoxication in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=related_link\">",
"      Orthopedic aspects of child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=related_link\">",
"      Physical abuse in children: Diagnostic evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=related_link\">",
"      Physical abuse in children: Epidemiology and clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=related_link\">",
"      Trauma management: Approach to the unstable child",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8057?source=related_link\">",
"      Vascular (venous) access for pediatric resuscitation and other pediatric emergencies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_5_2138="Treatment and prognosis of juvenile dermatomyositis and polymyositis";
var content_f2_5_2138=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment and prognosis of juvenile dermatomyositis and polymyositis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/5/2138/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2138/contributors\">",
"     Clare Hutchinson, MDCM, FRCPC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2138/contributors\">",
"     Brian M Feldman, MD, MSc, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/5/2138/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2138/contributors\">",
"     Thomas JA Lehman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2138/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/5/2138/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/5/2138/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/5/2138/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Juvenile dermatomyositis (JDM) and juvenile polymyositis (JPM) are autoimmune myopathies of childhood. JDM is primarily a capillary vasculopathy, whereas JPM involves direct T-cell invasion of muscle fibers similar to that seen in adult polymyositis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=see_link\">",
"     \"Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of JDM and JPM will be reviewed here. The pathogenesis, clinical manifestations, and diagnosis of these disorders are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/43/29368?source=see_link\">",
"     \"Pathogenesis and clinical manifestations of juvenile dermatomyositis and polymyositis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31079?source=see_link\">",
"     \"Diagnosis of juvenile dermatomyositis and polymyositis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of treatment include control of the underlying inflammatory myositis, and prevention",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treatment of complications (eg, contractures and calcinosis).",
"   </p>",
"   <p>",
"    There are several factors to consider in the treatment of a patient with JDM or JPM:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initial treatment varies with the clinical presentation [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/4\">",
"       4",
"      </a>",
"      ], which ranges from mild disease with muscle weakness and cutaneous manifestations to serious life-threatening weakness, internal organ damage, and ulcerative skin lesions. The intensity of initial therapy increases with increasing severity of the symptoms. For example, intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      is reserved for patients with serious life-threatening disease.",
"     </li>",
"     <li>",
"      It is possible that early treatment may limit JDM to a monocyclic pattern [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chronic treatment is determined by the response to therapy and the pattern of the disease. There are three patterns of disease in JDM [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/1\">",
"       1",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Monocyclic course, in which there is one disease episode that responds to treatment without relapse",
"     </li>",
"     <li>",
"      Polycyclic course with multiple remissions and relapses but typically a good ultimate outcome",
"     </li>",
"     <li>",
"      Chronic persistent course, typically with persistent complications",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Childhood Arthritis and Rheumatology Research Alliance (CARRA) has proposed several treatment strategies for initial therapy for JDM based upon a North American survey of practice [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9448576\">",
"    <span class=\"h1\">",
"     EVALUATION OF RESPONSE TO THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The International Myositis Assessment and Clinical Studies Group (IMACS) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/7\">",
"     7",
"    </a>",
"    ] and the Pediatric Rheumatology International Trials Organization (PRINTO) have proposed criteria for the evaluation of response to therapy in JDM clinical trials [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/8\">",
"     8",
"    </a>",
"    ]. The PRINTO criteria are provisionally endorsed by the American College of Rheumatology. Improvement is defined as a &ge;20 percent improvement from baseline of at least three of the six core set variables, with no more than one of the remaining variables (cannot be muscle strength) worsening by &gt;30 percent.",
"   </p>",
"   <p>",
"    The criteria include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Physician&rsquo;s global assessment of the patient&rsquo;s overall disease activity",
"     </li>",
"     <li>",
"      Muscle strength",
"     </li>",
"     <li>",
"      Global JDM disease activity tool",
"     </li>",
"     <li>",
"      Parent&rsquo;s global assessment of the child&rsquo;s overall well-being",
"     </li>",
"     <li>",
"      Health-related quality of life assessment",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     IMMUNOSUPPRESSIVE THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although immunosuppressive therapy is generally used to treat JDM and JPM, treatment regimens are based upon observational studies and clinical experience because there are no randomized controlled trials in the management of JDM. There is little consensus regarding the choice of medications, and the dose, mode, and duration of administration [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/1,9\">",
"     1,9",
"    </a>",
"    ]. In a survey of North American pediatric rheumatologists, the majority of respondents utilized a combination of glucocorticoids and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    to treat children with JDM [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/9\">",
"     9",
"    </a>",
"    ]. However, the dose, route of administration, and the use of adjunctive therapy (eg, intravenous immune globulin [IVIG] and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    ) varied.",
"   </p>",
"   <p>",
"    The following discussion will review the different immunosuppressive agents used in the treatment of JDM and JPM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoids are the initial agents of choice in treating patients with JDM or JPM. Early evidence demonstrating their efficacy was based upon a retrospective review of 47 children with JDM treated at a single center between 1964 and 1982 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/10\">",
"     10",
"    </a>",
"    ]. Patients who received high dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) within four months of the onset of their symptoms had better functional outcome and less calcinosis compared to those who received smaller doses of prednisone or who were treated later in the course of their disease. The mortality rate of children with JDM has dramatically decreased (from over 30 to less than 2 percent) with the routine use of glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Mortality'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The two most commonly used regimens are daily oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    and intravenous pulse",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    . Either is usually used in combination with a steroid-sparing agent, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Oral prednisone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Daily oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    has been the mainstay of treatment of JDM and JPM for many years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Our standard initial regimen is prednisone at 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day (to a maximum of 80",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    in divided doses for six weeks, after which it is consolidated into one daily dose. Others adjust the dose relative to the disease severity using lower doses in children with milder disease.",
"   </p>",
"   <p>",
"    In responsive patients, muscle weakness and rash improve, and serum muscle enzymes return to normal levels over six to eight weeks of therapy. In these patients, when",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    is used as a single treatment, it may be weaned slowly in a stepwise fashion over a prolonged period (eg, at least a two year period at our center) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/10,12\">",
"     10,12",
"    </a>",
"    ]. Muscle strength and enzymes are monitored for evidence of relapse. Relapses may be managed by increasing the steroid or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    doses or by adding additional medications, such as intravenous immunoglobulin (IVIG).",
"   </p>",
"   <p>",
"    Prolonged glucocorticoid therapy is associated with significant adverse effects. In children, these include growth retardation, Cushingoid appearance, elevation of blood pressure, hyperglycemia, cataracts, and osteoporosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10537?source=see_link&amp;anchor=H11#H11\">",
"     \"Causes of short stature\", section on 'Glucocorticoid therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although initial low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    therapy may decrease the total cumulative dose and reduce the adverse effects of glucocorticoid, the outcome of this approach is poorer than high-dose glucocorticoid therapy. In the previously mentioned observational study, patients who received smaller doses of prednisone generally had poorer outcome than those who received the high prednisone dose of 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/10\">",
"     10",
"    </a>",
"    ]. In another study, low-dose prednisone therapy (1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) was administered to 36 children with JDM. At a mean follow-up of 4.9 years, 28 had no functional impairment, 5 had persistent disability with inactive disease, and 3 had ongoing active disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/14\">",
"     14",
"    </a>",
"    ]. Fifteen children (42 percent) developed dystrophic calcifications.",
"   </p>",
"   <p>",
"    These findings suggest that low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    is not sufficient for all patients. As a result, most North American pediatric rheumatologists, including the authors, use a high-dose corticosteroid regimen to initially treat JDM and JPM [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Intravenous methylprednisolone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of concerns that patients with JDM, particularly those with gastrointestinal vasculopathy, may have decreased absorption of orally administered",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/15\">",
"     15",
"    </a>",
"    ], the use of intravenous pulse",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    (IVMP) has been proposed as an alternate regimen. The most commonly used regimen administers IVMP in a dose of 30",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day (maximum of 1 gm) for three consecutive days followed by additional weekly or monthly boluses as needed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/3\">",
"     3",
"    </a>",
"    ]. Most often, patients are concomitantly treated with oral prednisone; in some cases, those treated only with IVMP are transitioned to oral prednisone.",
"   </p>",
"   <p>",
"    A study of 139 newly diagnosed patients with JDM that compared IVMP to high-dose oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    found no differences in outcome at 36 months follow-up after matching patients for disease characteristics [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/16\">",
"     16",
"    </a>",
"    ]. However, in this study, patients who were most severely ill all received IVMP and, therefore, could not be matched. Because of this limitation, it remains uncertain whether IVMP has a sufficiently greater benefit compared to oral prednisone in patients with severe disease to justify its cost and invasiveness [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/17\">",
"     17",
"    </a>",
"    ]. Many experts, including the authors, believe that IVMP should be considered in more severely affected patients, particularly those in whom there is a concern for poor absorption of oral medications.",
"   </p>",
"   <p>",
"    In patients with mild disease, IVMP does not decrease the total cumulative dosage of glucocorticoids. Although some patients have an excellent response to pulse therapy, others have relapsing disease after IVMP or fail to respond to IVMP, and require oral daily",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. As a result, we no longer recommend IVMP alone for mild JDM because of the uncertainty of improved efficacy over oral prednisone, as well as cost, inconvenience, and invasiveness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Secondary agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;It had been common practice to reserve adjunctive immunosuppressive therapy for children with JDM and JPM to those with an incomplete response to glucocorticoids, relapses, or significant glucocorticoid toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. However, combination therapy using glucocorticoids and another immunosuppressive agent from the time of diagnosis is now the preferred approach to managing children with JDM and JPM because of its potential to decrease the total cumulative steroid dose and related adverse effects.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    is the most commonly added second agent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/9\">",
"     9",
"    </a>",
"    ]. Methotrexate and intravenous immune globulin have also been studied as primary therapy without glucocorticoids in select patients, who all responded favorably [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/22\">",
"     22",
"    </a>",
"    ]. The risk-to-benefit ratios and cost of each of these regimens needs to be considered in the context of the circumstances and disease severity of each patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Methotrexate",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    as a first line therapy for JDM with glucocorticoids has been reported to be as effective as glucocorticoid therapy alone. The addition of methotrexate to the initial therapy shortens the duration of glucocorticoid therapy and reduces the total cumulative glucocorticoid dose compared to glucocorticoid therapy alone [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Glucocorticoids'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    This was illustrated in a study that compared 31 patients newly diagnosed with JDM who were initially treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    (15",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    per week) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, maximum dose 75 mg per day) to 22 comparable historical controls who received prednisone therapy alone [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/23\">",
"     23",
"    </a>",
"    ]. Patients treated with combination therapy compared to those who received only prednisone had a shorter average time to discontinuation of prednisone (10 versus 27 months) and a lower average cumulative prednisone dose (7.5 versus 15.1 grams). Recovery of strength and physical function were similar in both groups. The children who received combination therapy had fewer side effects, greater height velocity, lower weight gain, and decreased risk of developing cataracts compared to controls.",
"   </p>",
"   <p>",
"    Favorable outcome has also been reported with the early use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    in combination with intravenous pulse",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    in newly diagnosed patients with severe JDM characterized by dysphagia and skin ulcerations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. In particular, the early use of combination therapy appeared to minimize long-term sequelae, including calcinosis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    is usually administered at a dose of 15",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    (rarely exceeding 25",
"    <span class=\"nowrap\">",
"     mg/dose)",
"    </span>",
"    once weekly either by mouth or subcutaneous injection. The CARRA protocols suggest the use of the subcutaneous route [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/6\">",
"     6",
"    </a>",
"    ].Side effects may include nausea and vomiting in the 12 to 24 hours following administration. Other adverse effects include aphthous oral ulcers, liver enzyme elevation, and increased susceptibility to infection. Children should be provided",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    (1",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    in order to limit toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Intravenous immune globulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous immune globulin (IVIG) is reported to be beneficial in several observational studies of children with JDM who had previously failed treatment with glucocorticoids and, in most cases, other immunosuppressive agents [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/26-30\">",
"     26-30",
"    </a>",
"    ]. The majority of reported patients experienced improvement in skin disease and muscle strength, and in most patients, the use of IVIG reduced the cumulative glucocorticoid dose [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/26-29,31-33\">",
"     26-29,31-33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IVIG is usually given as a dose of 2",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    (maximum dose of 70 g) administered as a single dose or divided over two days. IVIG may be given every two weeks initially for five doses, and is then generally administered monthly for up to two years. The decision to begin IVIG typically occurs months into treatment when patients experience persistent or increasing symptoms as glucocorticoids are weaned, indicating steroid-resistance or steroid-dependence; however, in very severe cases of JDM, IVIG is often used earlier.",
"   </p>",
"   <p>",
"    In children with JDM, IVIG is generally well-tolerated with reported side effects of headache, diarrhea, nausea, and low-grade fever [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/26,28\">",
"     26,28",
"    </a>",
"    ]. One study reported an increase in adverse events (eg, fever, lethargy, or malaise, nausea, and vomiting) with IVIG preparations that contained a high immunoglobulin A concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28857?source=see_link\">",
"     \"General principles in the use of immune globulin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Cyclosporine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    , a calcineurin inhibitor, has been primarily used in patients with refractory JDM and JPM. Small observational studies have shown that the addition of cyclosporine to patients with an inadequate response to glucocorticoid and other immunosuppressive agents was associated with clinical improvement (eg, recovery of muscle strength), leading to a reduction in",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    dose [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/34-37\">",
"     34-37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The starting dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    is 3 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day. The dose is adjusted depending upon the clinical response and the presence of cyclosporine toxicity (often earliest seen as a rising serum creatinine). Reported side effects in patients with JDM include hirsutism, gingival hypertrophy, hypertension, and diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/34-38\">",
"     34-38",
"    </a>",
"    ]. Treatment with cyclosporine generally continues until the disease has remained in stable remission off glucocorticoids for many months.",
"   </p>",
"   <p>",
"    Although",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    is used by other practitioners as a steroid-sparing agent early in treatment of children with JDM, it is not as commonly prescribed at the authors' institution. The Pediatric Rheumatology International Trials Organization (PRINTO) is currently conducting a multicenter trial comparing three treatment regimens (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    alone, prednisone plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , and prednisone in combination with cyclosporine) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Cyclophosphamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     Cyclophosphamide",
"    </a>",
"    is generally reserved for severe and life-threatening JDM, particularly chronic ulcerative disease of the gastrointestinal tract or skin, or respiratory involvement.",
"   </p>",
"   <p>",
"    In a retrospective review of 12 patients who received intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    for severe and refractory disease, 10 patients demonstrated improvement in muscle disease, extra-muscular disease, and skin disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/40\">",
"     40",
"    </a>",
"    ]. Two patients who required mechanical ventilation prior to receiving cyclophosphamide died shortly after beginning therapy. Death was attributed to their underlying disease and not to the use of cyclophosphamide. Observed side effects of cyclophosphamide included transient alopecia, lymphocytopenia, and herpes zoster infection, but no severe adverse events were noted. The authors concluded that in children with severe and refractory JDM, cyclophosphamide might provide clinical benefit without serious short-term toxicity.",
"   </p>",
"   <p>",
"    In our practice, we reserve the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    for patients with ulcerative skin disease or life-threatening major organ involvement. Cyclophosphamide is most often administered intravenously every four weeks at a dose of 500 to 750",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    for a total of seven doses, usually in combination with high dose glucocorticoids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Biologic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increasingly, biologic agents are being used in the treatment of autoimmune diseases. However, the use of these agents is limited in children with JDM and JPM.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       Rituximab",
"      </a>",
"      &mdash; In two small case series, the use of rituximab, a B cell lymphocyte depleting monoclonal anti-CD20 antibody, was associated with clinical improvement in children with JDM (three of four in one series [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/41\">",
"       41",
"      </a>",
"      ] and three of six in the other [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/42\">",
"       42",
"      </a>",
"      ]), although calcinosis did not improve. However, the fourth patient in the first series had deterioration of her clinical status following rituximab therapy. In a small case series in adults with refractory dermatomyositis and polymyositis, rituximab was associated with clinical improvement. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/48/13065?source=see_link&amp;anchor=H4#H4\">",
"       \"Treatment of recurrent and resistant dermatomyositis and polymyositis in adults\", section on 'Rituximab'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Anti-tumor necrosis factor agents &mdash; In children, a single case series of five children with refractory JDM reported clinical improvement following the initiation of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      therapy, an anti-tumor necrosis factor (anti-TNF) alpha monoclonal antibody [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/43\">",
"       43",
"      </a>",
"      ]. However, case series of adults with resistant dermatomyositis and polymyositis have failed to show a consistent beneficial response to anti-TNF agents.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/14/18662?source=see_link\">",
"       Abatacept",
"      </a>",
"      &mdash; Abatacept is a soluble fusion protein comprised of the extracellular domain of cytotoxic T lymphocyte antigen 4 (CTLA-4) and the Fc portion of immunoglobulin G1 (IgG1). It binds to",
"      <span class=\"nowrap\">",
"       CD80/CD86,",
"      </span>",
"      preventing CD28 binding and thereby downregulating T cell activation. A 14 year old girl with severe, refractory JDM with ulcerations and calcinosis was reported to have improvement in disease scores, ulcerations, pain medication and glucocorticoid use, and laboratory values after treatment with abatacept and thiosulfate [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/44\">",
"       44",
"      </a>",
"      ]. The utility of this agent in children with JDM remains to be determined. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Other agents'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further studies to determine whether there is a role for these agents in the treatment of JDM are needed. In the absence of such data, these agents should only be used in the setting of clinical investigation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Other agents",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"       Mycophenolate",
"      </a>",
"      mofetil &mdash; In a small case series of 12 children with JDM and refractory skin disease, improvement of the skin disease was seen in 10 patients within 4 to 8 weeks of treatment with mycophenolate mofetil at doses ranging from 500 mg to 1 g twice a day [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/45\">",
"       45",
"      </a>",
"      ]. A retrospective review of 50 patients with JDM treated with mycophenolate found that skin and muscle disease activity decreased and glucocorticoid doses were lower after 12 months of mycophenolate therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"       Tacrolimus",
"      </a>",
"      &mdash; Tacrolimus, a calcineurin inhibitor, has been reported to improve the clinical status of children with refractory JDM in case reports [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/47,48\">",
"       47,48",
"      </a>",
"      ]. Topical tacrolimus has been used for refractory skin disease with varied results [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/49,50\">",
"       49,50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"       Hydroxychloroquine",
"      </a>",
"      &mdash; Hydroxychloroquine, an anti-malarial agent, is reported to be effective in patients with an incomplete response to glucocorticoid therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/51\">",
"       51",
"      </a>",
"      ]. However, in our experience, it has not been an effective drug in the patients with JDM.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/18/17700?source=see_link\">",
"       Sodium thiosulfate",
"      </a>",
"      &mdash; Thiosulfate is an antioxidant and vasodilator that chelates and dissolves calcium deposits and promotes vascularization of peripheral neuronal units, with associated resolution of pain. It was reported effective in one patient with refractory skin disease and calcinosis who was also treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/14/18662?source=see_link\">",
"       abatacept",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/44\">",
"       44",
"      </a>",
"      ]. This interesting observation awaits confirmation in more cases. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Biologic agents'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     OTHER THERAPIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Sunscreen",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rash of JDM is generally photosensitive, and may be exacerbated by exposure to sunlight. For this reason, we recommend that all children with JDM use sunscreen regularly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Topical agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical agents (corticosteroids or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    ) are often used to treat localized skin disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/3,49\">",
"     3,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Physical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical and occupational therapy are important adjunctive measures to pharmacologic therapy because children with JDM have decreased aerobic exercise capacity and low levels of weight-bearing physical activity, which may worsen functional limitations and contribute to joint contractures [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. Therapy is focused on appropriate range of motion, muscle strengthening, and aerobic exercises. These measures prevent or improve joint contractures, and improve aerobic endurance.",
"   </p>",
"   <p>",
"    Physical therapy and exercise regimens do not exacerbate clinical disease in patients with JDM. This was illustrated in a study that included groups of patients with active and inactive JDM, and normal controls that showed no evidence of increased muscle inflammation following a physiotherapy-led exercise session [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the goals of treatment is to prevent and treat complications associated with JDM. These complications include osteoporosis, calcinosis, and intestinal perforation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Osteoporosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with JDM have low bone mineral density when compared with age-matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/55\">",
"     55",
"    </a>",
"    ] and an increased risk of vertebral fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/56\">",
"     56",
"    </a>",
"    ]. Several risk factors for the low bone density include low lean body mass, glucocorticoid therapy, and longer duration of untreated disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/55,57,58\">",
"     55,57,58",
"    </a>",
"    ]. In one study, dual energy x-ray absorptiometry (DXA) scan and measurement of the RANKL:osteoprotegerin ratio, a marker of osteoclastic activation, demonstrated that children with JDM compared to age-matched controls had increased osteoclast activation and bone resorption [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/11/2234?source=see_link&amp;anchor=H18#H18\">",
"     \"Investigational biologic markers in the diagnosis and assessment of rheumatoid arthritis\", section on 'Bone-specific markers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Limited observational data suggest that treatment with supplemental calcium and vitamin D increases spinal bone density by about 10 percent in children who receive glucocorticoid therapy for rheumatic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/59\">",
"     59",
"    </a>",
"    ]. Based upon available data, it is standard practice in the authors' institution to provide both calcium and vitamin D supplementation.",
"   </p>",
"   <p>",
"    Limited data suggest the oral bisphosphonate,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/10/24743?source=see_link\">",
"     alendronate",
"    </a>",
"    , may result in increased bone mineral density in children with connective tissue disease [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/60\">",
"     60",
"    </a>",
"    ]. However, bisphosphonate safety and efficacy in childhood have not been clearly established. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/36/17994?source=see_link\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Calcinosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcinosis is a well-recognized complication that is associated with delay in diagnosis or treatment, or inadequate treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/10,11,61\">",
"     10,11,61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/43/29368?source=see_link&amp;anchor=H13#H13\">",
"     \"Pathogenesis and clinical manifestations of juvenile dermatomyositis and polymyositis\", section on 'Calcinosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The primary focus is to prevent calcinosis through adequate treatment of JDM (eg, early use of combination therapy of high-dose glucocorticoids and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ). There is no established treatment for calcinosis. Although a number of therapies have been reported to be effective in case reports, none are consistently successful. These include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/18/37157?source=see_link\">",
"     probenecid",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/62-64\">",
"     62-64",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/16/12554?source=see_link\">",
"     diltiazem",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/65,66\">",
"     65,66",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/16/27910?source=see_link\">",
"     aluminum hydroxide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/67,68\">",
"     67,68",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/10/24743?source=see_link\">",
"     alendronate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/69\">",
"     69",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/62/3048?source=see_link\">",
"     pamidronate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/70\">",
"     70",
"    </a>",
"    ], intralesional corticosteroids [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/71\">",
"     71",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/18/17700?source=see_link\">",
"     sodium thiosulfate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical excision may be required for localized calcific deposits that interfere with joint function or are painful [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/72\">",
"     72",
"    </a>",
"    ]. However, in children with continuing active disease, surgical intervention is associated with a high frequency of poor wound healing, recurrence of calcinosis, and continuing problems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Intestinal perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intestinal perforation is a rare complication seen most often in children with severe vasculopathy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cutaneous ulcers as part of their dermatomyositis. Surgical intervention is required to treat intestinal perforation. This includes perforation closure, drainage, and excision of bowel when necessary, and supportive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    to allow healing [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/73\">",
"     73",
"    </a>",
"    ]. One report suggests the possible effectiveness of somatostatin in the treatment of persistent enteric fistulae in JDM [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     OUR APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed previously, there are no data from randomized controlled trials to guide management decisions in the children with JDM or JPM. Until such data exist, we use the following approach based upon observational studies and our clinical experience:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initial treatment of the majority of children with JDM or JPM with a combination of high-dose oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in divided doses to a maximum 80",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      (15",
"      <span class=\"nowrap\">",
"       mg/m2",
"      </span>",
"      to a maximum 25",
"      <span class=\"nowrap\">",
"       mg/dose",
"      </span>",
"      once weekly, administered as a subcutaneous injection). Children who receive methotrexate should also be given",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      at 1 mg per day to limit methotrexate toxicity. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Immunosuppressive therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We use intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"       methylprednisolone",
"      </a>",
"      in place of oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      for patients in the following settings:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Those with ulcerative disease or a poor response or worsening of their disease on oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      therapy",
"     </li>",
"     <li>",
"      Those with respiratory compromise who are unable to take oral medications",
"     </li>",
"     <li>",
"      Those with gastrointestinal complications that may limit absorption of orally administered medications",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We reserve the use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      for patients with severe and life-threatening disease (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Cyclophosphamide'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      The response to the treatment is assessed based upon the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Normalization of elevated serum muscle enzymes",
"     </li>",
"     <li>",
"      Resolution of skin rash",
"     </li>",
"     <li>",
"      Increased muscle strength both by history and objective measures, such as the Childhood Myositis Assessment Scale (CMAS)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is important to note that muscle strength and skin rash may heal slowly over months, and that as long as consistent progress is observed, treatment should not be considered a failure.",
"     </li>",
"     <li>",
"      If there is a response to therapy,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      is consolidated to a daily dose at about six weeks. Prednisone is then weaned every two weeks by 5 mg decrements until a daily dose of 25 mg is reached; at that point, prednisone is decreased by 2.5 mg every two weeks. The median length of time on prednisone in our clinic is about 10 months.",
"     </li>",
"     <li>",
"      For patients who become steroid-resistant or dependent during the course of treatment (generally after several months of therapy), intravenous immunoglobulin (IVIG) is added to the regimen to control persistent or recurrent symptoms, and to decrease the cumulative dose of glucocorticoids administered.",
"     </li>",
"     <li>",
"      In the case of persistent or recurrent symptoms despite the use of glucocorticoids,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      , and IVIG, we have added",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      with some success, which has limited the need for increasing cumulative doses of glucocorticoids.",
"     </li>",
"     <li>",
"      Adjunctive therapy includes the use of sunscreen to prevent sunburn, topical corticosteroids for local skin disease, physical therapy, which includes range of motion, muscle strengthening, and aerobic exercise, and supplemental calcium (1000",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      and vitamin D (1000",
"      <span class=\"nowrap\">",
"       units/day)",
"      </span>",
"      to prevent osteoporosis. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Other therapies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Osteoporosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in the treatment have improved mortality and morbidity rates in children with JDM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported mortality rate declined from greater than 30 percent in the 1960s [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/75\">",
"     75",
"    </a>",
"    ] before routine glucocorticoid therapy was administered, to less than 2 or 3 percent in the 2000s with the advent of early combination immunosuppressive therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/11,12,76,77\">",
"     11,12,76,77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Morbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term outcome of JDM has become increasingly important as the survival rate has improved. In general, the course of JDM is variable:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Monocyclic disease occurs in about one-third of patients with findings of rash and muscle weakness. These patients have a good response to standard therapy.",
"     </li>",
"     <li>",
"      Chronic continuous or polycyclic disease occurs in the remaining two-thirds of patients and is predictive of a poorer outcome [",
"      <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/77\">",
"       77",
"      </a>",
"      ]. These patients are at increased risk for persistent pain, calcinosis, and disability.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although data on long-term morbidity are limited, it appears that patients with JDM treated with combined therapy have a favorable prognosis.",
"   </p>",
"   <p>",
"    This was illustrated in a retrospective review of 65 of 80 patients from a cohort of patients diagnosed with JDM between 1984 and 1995 at four Canadian tertiary centers [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/76\">",
"     76",
"    </a>",
"    ]. Sixty-two (95 percent) were treated with high-dose glucocorticoids therapy (31 received intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    ), 41 (63 percent) also received a second-line agent (ie,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    [n=10], IVIG [n=6],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    [n=5] and two or more agents [n=20]), and three patients received no therapy. Patients were surveyed at a median follow-up time of 7.2 years (range 3.2 to 13.9 years) and median age of 13 years (range 7 to 26 years). There was one death in this cohort. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Twenty-four patients (37 percent) had monocyclic disease, and the remaining had chronic continuous or polycyclic disease.",
"     </li>",
"     <li>",
"      Physical function was excellent, with only five patients reporting moderate to severe disability. Almost 80 percent had no pain.",
"     </li>",
"     <li>",
"      About one-third of patients had calcinosis, which was severe in one patient. About 40 percent of patients continued to have a rash, although 22 of the 26 patients indicated that the rash was of little or no consequence.",
"     </li>",
"     <li>",
"      Data on growth demonstrated that most patients were within 1 standard deviation (SD) of their predicted height. However, 10 patients (16 percent) were &ge;2 SD below their predicted height.",
"     </li>",
"     <li>",
"      About one-third of patients continued on medication, despite being more than three years from diagnosis.",
"     </li>",
"     <li>",
"      Patients with chronic disease were more likely to have functional limitations, persistent pain, and calcinosis.",
"     </li>",
"     <li>",
"      All patients had either completed or were attending high school, and of those who had graduated, all went on to pursue postsecondary education. Three patients needed to repeat a single grade because of missing time from school because of their disease. Of the 14 patients who were working full or part-time (of whom 13 were still attending school), none of the patients felt that their disease interfered with their ability to work.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a long-term follow-up report of 60 patients (median duration of follow-up of 16.8 years), most patients had cumulative organ damage [",
"    <a class=\"abstract\" href=\"UTD.htm?2/5/2138/abstract/78\">",
"     78",
"    </a>",
"    ]. The risk of cumulative organ damage was greater in patients with higher scores of disease activity and organ damage six months after diagnosis. The following areas of injury and their frequency were noted at last follow-up:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cutaneous (calcinosis, scarring or atrophy, lipodystrophy) &mdash; 75 percent",
"     </li>",
"     <li>",
"      Muscle (atrophy, weakness, dysfunction) &mdash; 63 percent",
"     </li>",
"     <li>",
"      Skeletal (joint contractures, osteoporosis, avascular necrosis, arthropathic deformity) &mdash; 48 percent",
"     </li>",
"     <li>",
"      Endocrine (growth failure, menstrual abnormalities) &mdash; 23 percent",
"     </li>",
"     <li>",
"      Pulmonary &mdash;17 percent",
"     </li>",
"     <li>",
"      Other organ systems included peripheral vascular (8 percent), cardiovascular (7 percent), gastrointestinal (3 percent) damage",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children with juvenile dermatomyositis (JDM) and polymyositis (JPM), treatment goals include control of the underlying inflammatory myositis, and prevention",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treatment of complications (eg, contractures and calcinosis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immunosuppressive therapy is generally used to treat JDM and JPM based upon observational studies and clinical experience. There are no published randomized clinical trials that evaluate the treatment of JDM and JPM.",
"     </li>",
"     <li>",
"      In all patients with JDM, we recommend high-dose glucocorticoid therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). This recommendation is based upon the significant increase in survival rate and clinical outcome with the routine use of high-dose glucocorticoid therapy versus low-dose glucocorticoid or no treatment. In our institution, high-dose oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day, maximum dose of 80",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      is the preferred glucocorticoid regimen. In other centers, the initial dose of prednisone used is individualized based on the clinical presentation, and may be lower than 2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day. We reserve the use of intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"       methylprednisolone",
"      </a>",
"      for patients who fail to respond to oral prednisone, or who have pulmonary or gastrointestinal complications that limit their ability to either take or absorb oral medications. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest adding a steroid-sparing agent to high-dose glucocorticoid therapy versus glucocorticoid therapy alone (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In our institution,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      is the preferred steroid-sparing agent (at a once weekly dose of about 15",
"      <span class=\"nowrap\">",
"       mg/m2",
"      </span>",
"      once weekly, administered as a subcutaneous injection). Alternatively,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      is also used at a starting dose of 3 to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day, administered in one or two doses as a second agent. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Our approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with severe or life-threatening disease, we suggest the use of intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      (500 to 750",
"      <span class=\"nowrap\">",
"       mg/m2",
"      </span>",
"      every four weeks) in combination with high-dose glucocorticoid therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Adjunctive therapy includes the use of sunscreen, topical agents for localized skin care, physical therapy, and supplementation of calcium (1000",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      and vitamin D (1000",
"      <span class=\"nowrap\">",
"       units/day)",
"      </span>",
"      to prevent osteoporosis. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Other therapies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Outcome",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Advances in the treatment of JDM have improved survival mortality and morbidity rates in children with JDM. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with chronic disease are at risk for developing calcinosis and functional physical disabilities. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Morbidity'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Calcinosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other complications can be due to glucocorticoid toxicity and include growth retardation and osteoporosis. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Complications'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H25\">",
"       'Morbidity'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/1\">",
"      Stringer E, Feldman BM. Advances in the treatment of juvenile dermatomyositis. Curr Opin Rheumatol 2006; 18:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/2\">",
"      Miles L, Bove KE, Lovell D, et al. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients. Arthritis Rheum 2007; 57:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/3\">",
"      Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008; 371:2201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/4\">",
"      Stringer E, Bohnsack J, Bowyer SL, et al. Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey. J Rheumatol 2010; 37:1953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/5\">",
"      Christen-Zaech S, Seshadri R, Sundberg J, et al. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum 2008; 58:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/6\">",
"      Huber AM, Giannini EH, Bowyer SL, et al. Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference. Arthritis Care Res (Hoboken) 2010; 62:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/7\">",
"      Rider LG, Giannini EH, Brunner HI, et al. International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004; 50:2281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/8\">",
"      Ruperto N, Pistorio A, Ravelli A, et al. The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis. Arthritis Care Res (Hoboken) 2010; 62:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/9\">",
"      Stringer E, Ota S, Bohnsack J, et al. Diversity of treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM treatment study. Arthritis Rheum 2008; 58:S255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/10\">",
"      Bowyer SL, Blane CE, Sullivan DB, Cassidy JT. Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983; 103:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/11\">",
"      Huber A, Feldman BM. Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going? Curr Rheumatol Rep 2005; 7:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/12\">",
"      Sullivan DB, Cassidy JT, Petty RE, Burt A. Prognosis in childhood dermatomyositis. J Pediatr 1972; 80:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/13\">",
"      Spencer CH, Hanson V, Singsen BH, et al. Course of treated juvenile dermatomyositis. J Pediatr 1984; 105:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/14\">",
"      Tabarki B, Ponsot G, Prieur AM, Tardieu M. Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids. Eur J Paediatr Neurol 1998; 2:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/15\">",
"      Rouster-Stevens KA, Gursahaney A, Ngai KL, et al. Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. Arthritis Rheum 2008; 59:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/16\">",
"      Seshadri R, Feldman BM, Ilowite N, et al. The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis. Arthritis Rheum 2008; 59:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/17\">",
"      Klein-Gitelman MS, Waters T, Pachman LM. The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis. Arthritis Care Res 2000; 13:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/18\">",
"      Laxer RM, Stein LD, Petty RE. Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis. Arthritis Rheum 1987; 30:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/19\">",
"      Lang B, Dooley J. Failure of pulse intravenous methylprednisolone treatment in juvenile dermatomyositis. J Pediatr 1996; 128:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/20\">",
"      Fischer TJ, Rachelefsky GS, Klein RB, et al. Childhood dermatomyositis and polymyositis. Treatment with methotrexate and prednisone. Am J Dis Child 1979; 133:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/21\">",
"      Jacobs JC. Methotrexate and azathioprine treatment of childhood dermatomyositis. Pediatrics 1977; 59:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/22\">",
"      Levy DM, Bingham CA, Kahn PJ, et al. Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids. J Pediatr 2010; 156:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/23\">",
"      Ramanan AV, Campbell-Webster N, Ota S, et al. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum 2005; 52:3570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/24\">",
"      Al-Mayouf S, Al-Mazyed A, Bahabri S. Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate. Clin Rheumatol 2000; 19:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/25\">",
"      Fisler RE, Liang MG, Fuhlbrigge RC, et al. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002; 47:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/26\">",
"      Sansome A, Dubowitz V. Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases. Arch Dis Child 1995; 72:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/27\">",
"      Collet E, Dalac S, Maerens B, et al. Juvenile dermatomyositis: treatment with intravenous gammaglobulin. Br J Dermatol 1994; 130:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/28\">",
"      Al-Mayouf SM, Laxer RM, Schneider R, et al. Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety. J Rheumatol 2000; 27:2498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/29\">",
"      Lang BA, Laxer RM, Murphy G, et al. Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 1991; 91:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/30\">",
"      Lam CG, Manlhiot C, Pullenayegum EM, Feldman BM. Efficacy of intravenous Ig therapy in juvenile dermatomyositis. Ann Rheum Dis 2011; 70:2089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/31\">",
"      Roifman CM, Schaffer FM, Wachsmuth SE, et al. Reversal of chronic polymyositis following intravenous immune serum globulin therapy. JAMA 1987; 258:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/32\">",
"      Yang MC, Lee JH, Yang YH, Chiang BL. Improvement of juvenile dermatomyositis with calcinosis universalis after treatment with intravenous immunoglobulin. Int J Rheum Dis 2008; 11:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/33\">",
"      Manlhiot C, Tyrrell PN, Liang L, et al. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content. Pediatrics 2008; 121:e626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/34\">",
"      Heckmatt J, Hasson N, Saunders C, et al. Cyclosporin in juvenile dermatomyositis. Lancet 1989; 1:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/35\">",
"      Zeller V, Cohen P, Prieur AM, Guillevin L. Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases. J Rheumatol 1996; 23:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/36\">",
"      Reiff A, Rawlings DJ, Shaham B, et al. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. J Rheumatol 1997; 24:2436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/37\">",
"      Kobayashi I, Yamada M, Takahashi Y, et al. Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A. Rheumatology (Oxford) 2003; 42:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/38\">",
"      Dantzig P. Juvenile dermatomyositis treated with cyclosporine. J Am Acad Dermatol 1990; 22:310.",
"     </a>",
"    </li>",
"    <li>",
"     PRINTO. Juvenile Dermatomyositis Trial. https://www.printo.it/project_ongoing_detail.asp?ProjectID=14 (Accessed on September 14, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/40\">",
"      Riley P, Maillard SM, Wedderburn LR, et al. Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety. Rheumatology (Oxford) 2004; 43:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/41\">",
"      Cooper MA, Willingham DL, Brown DE, et al. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients. Arthritis Rheum 2007; 56:3107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/42\">",
"      Bader-Meunier B, Decaluwe H, Barnerias C, et al. Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry. J Rheumatol 2011; 38:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/43\">",
"      Riley P, McCann LJ, Maillard SM, et al. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. Rheumatology (Oxford) 2008; 47:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/44\">",
"      Arabshahi B, Silverman RA, Jones OY, Rider LG. Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis. J Pediatr 2012; 160:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/45\">",
"      Edge JC, Outland JD, Dempsey JR, Callen JP. Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. Arch Dermatol 2006; 142:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/46\">",
"      Rouster-Stevens KA, Morgan GA, Wang D, Pachman LM. Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis. Arthritis Care Res (Hoboken) 2010; 62:1446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/47\">",
"      Yamada A, Ohshima Y, Omata N, et al. Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A. Eur J Pediatr 2004; 163:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/48\">",
"      Hassan J, van der Net JJ, van Royen-Kerkhof A. Treatment of refractory juvenile dermatomyositis with tacrolimus. Clin Rheumatol 2008; 27:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/49\">",
"      Hollar CB, Jorizzo JL. Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study. J Dermatolog Treat 2004; 15:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/50\">",
"      Garc&iacute;a-Doval I, Cruces M. Topical tacrolimus in cutaneous lesions of dermatomyositis: lack of effect in side-by-side comparison in five patients. Dermatology 2004; 209:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/51\">",
"      Olson NY, Lindsley CB. Adjunctive use of hydroxychloroquine in childhood dermatomyositis. J Rheumatol 1989; 16:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/52\">",
"      Klepper SE. Exercise in pediatric rheumatic diseases. Curr Opin Rheumatol 2008; 20:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/53\">",
"      Hicks JE, Drinkard B, Summers RM, Rider LG. Decreased aerobic capacity in children with juvenile dermatomyositis. Arthritis Rheum 2002; 47:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/54\">",
"      Maillard SM, Jones R, Owens CM, et al. Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis. Arthritis Rheum 2005; 53:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/55\">",
"      Santiago RA, Silva CA, Caparbo VF, et al. Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use. Scand J Rheumatol 2008; 37:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/56\">",
"      Huber AM, Gaboury I, Cabral DA, et al. Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken) 2010; 62:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/57\">",
"      Rouster-Stevens KA, Langman CB, Price HE, et al. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis. Arthritis Rheum 2007; 56:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/58\">",
"      Alsufyani KA, Ortiz-Alvarez O, Cabral DA, et al. Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise. J Rheumatol 2005; 32:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/59\">",
"      Warady BD, Lindsley CB, Robinson FG, Lukert BP. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. J Rheumatol 1994; 21:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/60\">",
"      Bianchi ML, Cimaz R, Bardare M, et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. Arthritis Rheum 2000; 43:1960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/61\">",
"      Pachman LM, Hayford JR, Chung A, et al. Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 1998; 25:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/62\">",
"      Eddy MC, Leelawattana R, McAlister WH, Whyte MP. Calcinosis universalis complicating juvenile dermatomyositis: resolution during probenecid therapy. J Clin Endocrinol Metab 1997; 82:3536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/63\">",
"      Harel L, Harel G, Korenreich L, et al. Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications. J Rheumatol 2001; 28:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/64\">",
"      Nakamura H, Kawakami A, Ida H, et al. Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis. J Rheumatol 2006; 33:1691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/65\">",
"      Ichiki Y, Akiyama T, Shimozawa N, et al. An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem. Br J Dermatol 2001; 144:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/66\">",
"      Oliveri MB, Palermo R, Mautalen C, H&uuml;bscher O. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J Rheumatol 1996; 23:2152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/67\">",
"      Wananukul S, Pongprasit P, Wattanakrai P. Calcinosis cutis presenting years before other clinical manifestations of juvenile dermatomyositis: report of two cases. Australas J Dermatol 1997; 38:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/68\">",
"      Wang WJ, Lo WL, Wong CK. Calcinosis cutis in juvenile dermatomyositis: remarkable response to aluminum hydroxide therapy. Arch Dermatol 1988; 124:1721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/69\">",
"      Ambler GR, Chaitow J, Rogers M, et al. Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy. J Rheumatol 2005; 32:1837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/70\">",
"      Marco Puche A, Calvo Penades I, Lopez Montesinos B. Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis. Clin Exp Rheumatol 2010; 28:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/71\">",
"      Al-Mayouf SM, Alsonbul A, Alismail K. Localized calcinosis in juvenile dermatomyositis: successful treatment with intralesional corticosteroids injection. Int J Rheum Dis 2010; 13:e26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/72\">",
"      Wu JJ, Metz BJ. Calcinosis cutis of juvenile dermatomyositis treated with incision and drainage. Dermatol Surg 2008; 34:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/73\">",
"      Downey EC Jr, Woolley MM, Hanson V. Required surgical therapy in the pediatric patient with dermatomyositis. Arch Surg 1988; 123:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/74\">",
"      Inamdar S, Slim MS, Bostwick H, Godine L. Treatment of duodenocutaneous fistula with somatostatin analog in a child with dermatomyositis. J Pediatr Gastroenterol Nutr 1990; 10:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/75\">",
"      BITNUM S, DAESCHNER CW Jr, TRAVIS LB, et al. DERMATOMYOSITIS. J Pediatr 1964; 64:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/76\">",
"      Huber AM, Lang B, LeBlanc CM, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000; 43:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/77\">",
"      Ravelli A, Trail L, Ferrari C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken) 2010; 62:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/5/2138/abstract/78\">",
"      Sanner H, Gran JT, Sjaastad I, Flat&oslash; B. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset. Rheumatology (Oxford) 2009; 48:1541.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6418 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-52D7E7C181-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2138=[""].join("\n");
var outline_f2_5_2138=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9448576\">",
"      EVALUATION OF RESPONSE TO THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      IMMUNOSUPPRESSIVE THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Oral prednisone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Intravenous methylprednisolone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Secondary agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Methotrexate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Intravenous immune globulin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Cyclosporine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Cyclophosphamide",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Biologic agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Other agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      OTHER THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Sunscreen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Topical agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Physical therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Calcinosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Intestinal perforation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      OUR APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Morbidity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10537?source=related_link\">",
"      Causes of short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=related_link\">",
"      Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31079?source=related_link\">",
"      Diagnosis of juvenile dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28857?source=related_link\">",
"      General principles in the use of immune globulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/11/2234?source=related_link\">",
"      Investigational biologic markers in the diagnosis and assessment of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/43/29368?source=related_link\">",
"      Pathogenesis and clinical manifestations of juvenile dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/36/17994?source=related_link\">",
"      Prevention and treatment of glucocorticoid-induced osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/48/13065?source=related_link\">",
"      Treatment of recurrent and resistant dermatomyositis and polymyositis in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_5_2139="Sonographic signs appendicitis";
var content_f2_5_2139=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F61146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F61146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Ultrasonographic signs of acute appendicitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Non-compressible tubular structure in the right lower quadrant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wall thickness &gt;2 mm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Overall diameter &gt;6 mm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Free fluid in the right lower quadrant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thickening of the mesentery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Localized tenderness with graded compression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Presence of a calcified appendicolith",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2139=[""].join("\n");
var outline_f2_5_2139=null;
var title_f2_5_2140="SSI eligibility children";
var content_f2_5_2140=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F77994&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F77994&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Information required for supplemental security income determination in children with chronic illness",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       Diagnosis and tests listed in the Social Security Administration's childhood \"Listing of Impairments\"*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Medical history of the child for the previous 12 months",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Complete, detailed, clinical findings (eg, results of physical, intelligence, developmental, and mental status examinations)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Complete, detailed laboratory findings (eg, blood pressure, radiographs)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Specific diagnosis (statement of disease or injury based upon signs and symptoms)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Review of treatment(s) prescribed and description of response and prognosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       The probable duration of the impairment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       An assessment of the child's physical or mental abilities to function independently, appropriately, and effectively in an age-appropriate manner and to perform age-appropriate daily activities",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       The nature and limiting effects of the impairment(s) on the child's ability to function independently, appropriately, and effectively in an age-appropriate manner and to perform age-appropriate daily activities",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       School documents, reports, or information indicating the child's need for special education services and deviations from age-appropriate performance in the school setting",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * This listing contains criteria for evaluation of the impairments of children younger than 18 years. A copy of \"Disability Evaluation Under Social Security\" may be obtained from the SSA Office of Public Affairs, Public Information Distribution Center, PO Box 17743, Baltimore, MD 21235; Phone: 410-965-0945 Fax: 410-965-0696.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from American Academy of Pediatrics Committee on Children with Disabilities. Pediatrics 1995; 95: 603 and Pediatrics 2001; 107: 790 and American Academy of Pediatrics: Policy statements--Supplemental Security Income (SSI) for children and youth with disabilities. Pediatrics 2009; 124:1702.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2140=[""].join("\n");
var outline_f2_5_2140=null;
var title_f2_5_2141="HRV arrhythmia cardiomyopathy";
var content_f2_5_2141=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F68774&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F68774&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Heart rate variabilty predicts arrhythmic events in cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 337px; height: 242px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a study of 116 patients with an idiopathic dilated cardiomyopathy absence of heart rate variability, defined as a standard deviation of normal-to-normal RR intervals (SDNN) &le;100 ms, predicted a higher incidence of sudden death and arrythmic events according to standard compared to the presence of heart rate varibility (SDNN &gt;100 ms) (p = 0.03).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Fauchier L, Babuty D, Cosnay P, Fauchier JP. J Am Coll Cardiol 1999; 33:1203.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2141=[""].join("\n");
var outline_f2_5_2141=null;
var title_f2_5_2142="Incubation of infection in travelers";
var content_f2_5_2142=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F55035&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F55035&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Infections by interval between exposure and onset of fever or other symptoms",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Short incubation (7 to 10 days or less)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Arboviruses (many)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Anthrax",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Brucellosis*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chikungunya virus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Dengue fever",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Diphtheria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ehrlichiosis*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hantavirus infections (eg, hemorrhagic fever with renal syndrome*, hantavirus pulmonary syndrome, others)*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Histoplasmosis (acute)*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            HIV (acute)*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Influenza",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Japanese encephalitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lassa and other viruses that cause hemorrhagic fever*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Legionnaire's disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leptospirosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lyme disease*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Malaria*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Measles*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Melioidosis*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Meningococcal infections",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Plague",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Psittacosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Q fever*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Rabies*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Relapsing fever",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Rickettsial infections (multiple)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tickborne encephalitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Toxoplasmosis*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Trichinosis*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tularemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Typhoid and paratyphoid fever* (and nontyphoidal salmonellosis)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Yellow fever",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Intermediate incubation (within 1 month)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Amebic liver abscess",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Brucellosis&nbsp;",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Clonorchiasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Coccidioidomycosis (acute)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cytomegalovirus (CMV)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Fascioliasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hepatitis A",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hepatitis C",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hepatitis E",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Human immunodeficiency virus infection (HIV)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leishmaniasis, visceral",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Rubella",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Schistosomiasis (acute)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Toxoplasmosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Trypanosomiasis, African",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Trypanosomiasis, American",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Long incubation (&ge;3 months)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Amebic liver abscess",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bartonellosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Brucellosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Clonorchiasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            CMV",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Fascioliasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Filariasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Gnathostomiasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hepatitis B",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hepatitis C",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Histoplasmosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            HIV",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Leishmaniasis, visceral",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lyme disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Malaria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Melioidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Penicilliosis marneffii",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Rabies",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Syphilis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Trypanosomiasis, African",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Trypanosomiasis, American",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tuberculosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Visceral larva migrans",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Lists are not exhaustive.",
"    <div class=\"footnotes\">",
"     * Incubation period is commonly longer than 10 days.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Tropical Infectious Diseases: Principles, Pathogens, and Practice (listed as Box 125-3).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2142=[""].join("\n");
var outline_f2_5_2142=null;
var title_f2_5_2143="Tetanus epidemiology US";
var content_f2_5_2143=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53397&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53397&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tetanus cases in the United States",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 410px; height: 678px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Tetanus. In: Epidemiology and Prevention of Vaccine-Preventable Diseases. The Pink Book, 12th ed, Atkinson W, Wolfe S, Hamborsky J (Eds), Public Health Foundation, Washington, DC 2011. Available at:&nbsp;",
"     <a href=\"file://www.cdc.gov/vaccines/pubs/pinkbook/downloads/tetanus.pdf\">",
"      www.cdc.gov/vaccines/pubs/pinkbook/downloads/tetanus.pdf",
"     </a>",
"     (Accessed on September 12, 2011).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_5_2143=[""].join("\n");
var outline_f2_5_2143=null;
